ANNUAL STATEMENT FOR THE YEAR 2020 OF THE of Kansas, Inc. ASSETS Current Year Prior Year 1 2 3 4 Net Admitted Assets Net Admitted Assets Nonadmitted Assets (Cols. 1 - 2) Assets 1. Bonds (Schedule D) 12,067,386 0 12,067,386 10,401,827 2. Stocks (Schedule D): 2.1 Preferred stocks 0 0 0 0 2.2 Common stocks 0 0 0 0 3. Mortgage loans on real estate (Schedule B): 3.1 First liens 0 0 0 0 3.2 Other than first liens 0 0 0 0 4. Real estate (Schedule A): 4.1 Properties occupied by the company (less $ 0 encumbrances) 0 0 0 0 4.2 Properties held for the production of income (less $ 0 encumbrances) 0 0 0 0 4.3 Properties held for sale (less $ 0 encumbrances) 0 0 0 0 5. Cash ($ 16,309,983 , Schedule E - Part 1), cash equivalents ($ 8,508,627 , Schedule E - Part 2) and short-term investments ($ 0 , Schedule DA) 24,818,610 0 24,818,610 7,996,467 6. Contract loans, (including $ 0 premium notes) 0 0 0 0 7. Derivatives (Schedule DB) 0 0 0 0 8. Other invested assets (Schedule BA) 0 0 0 0 9. Receivables for securities 0 0 0 0 10. Securities lending reinvested collateral assets (Schedule DL) 0 0 0 0 11. Aggregate write-ins for invested assets 0 0 0 0 12. Subtotals, cash and invested assets (Lines 1 to 11) 36,885,996 0 36,885,996 18,398,294 13. Title plants less $ 0 charged off (for Title insurers only) 0 0 0 0 14. Investment income due and accrued 71,505 0 71,505 133,915 15. Premiums and considerations: 15.1 Uncollected premiums and agents' balances in the course of collection 3,539 3,298 241 150,213 15.2 Deferred premiums and agents' balances and installments booked but deferred and not yet due (including $ 0 earned but unbilled premiums) 0 0 0 0 15.3 Accrued retrospective premiums ($ 0 ) and contracts subject to redetermination ($ 1,144,139 ) 1,144,139 0 1,144,139 17,866 16. Reinsurance: 16.1 Amounts recoverable from reinsurers 0 0 0 0 16.2 Funds held by or deposited with reinsured companies 0 0 0 0 16.3 Other amounts receivable under reinsurance contracts 0 0 0 0 17. Amounts receivable relating to uninsured plans 2,019,780 0 2,019,780 839,122 18.1 Current federal and foreign income tax recoverable and interest thereon 0 0 0 0 18.2 Net deferred tax asset 4,220,658 2,133,491 2,087,167 1,320,041 19. Guaranty funds receivable or on deposit 0 0 0 0 20. Electronic data processing equipment and software 0 0 0 0 21. Furniture and equipment, including health care delivery assets ($ 0 ) 670,368 670,368 0 0 22. Net adjustment in assets and liabilities due to foreign exchange rates 0 0 0 0 23. Receivables from parent, subsidiaries and affiliates 235 235 0 0 24. Health care ($ 1,063,201 ) and other amounts receivable 1,075,224 12,023 1,063,201 200,236 25. Aggregate write-ins for other than invested assets 437,645 0 437,645 497,802 26. Total assets excluding Separate Accounts, Segregated Accounts and Protected Cell Accounts (Lines 12 to 25) 46,529,089 2,819,415 43,709,674 21,557,489 27. From Separate Accounts, Segregated Accounts and Protected Cell Accounts 0 0 0 0 28. Total (Lines 26 and 27) 46,529,089 2,819,415 43,709,674 21,557,489 DETAILS OF WRITE-INS 1101. 1102. 1103. 1198. Summary of remaining write-ins for Line 11 from overflow page 0 0 0 0 1199. Totals (Lines 1101 thru 1103 plus 1198)(Line 11 above) 0 0 0 0 2501. Recoverable state premium taxes 437,645 0 437,645 489,616 2502. State income tax receivable 0 0 0 8,186 2503. 2598. Summary of remaining write-ins for Line 25 from overflow page 0 0 0 0 2599. Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) 437,645 0 437,645 497,802

2 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. LIABILITIES, CAPITAL AND SURPLUS Current Year Prior Year 1 2 3 4

Covered Uncovered Total Total 1. Claims unpaid (less $ 17,145 reinsurance ceded) 7,287,866 993,800 8,281,666 840,589 2. Accrued medical incentive pool and bonus amounts 31,901 0 31,901 43,667 3. Unpaid claims adjustment expenses 95,989 0 95,989 6,806 4. Aggregate health policy reserves, including the liability of $ 1,895,591 for medical loss ratio rebate per the Public Health Service Act 2,969,662 0 2,969,662 2,549,869 5. Aggregate life policy reserves 0 0 0 0 6. Property/casualty unearned premium reserves 0 0 0 0 7. Aggregate health claim reserves 0 0 0 267 8. Premiums received in advance 6,986 0 6,986 15,301 9. General expenses due or accrued 1,106,834 0 1,106,834 1,496 10.1 Current federal and foreign income tax payable and interest thereon (including $ 0 on realized capital gains (losses)) 3,354,310 0 3,354,310 4,081 10.2 Net deferred tax liability 0 0 0 0 11. Ceded reinsurance premiums payable 0 0 0 0 12. Amounts withheld or retained for the account of others 0 0 0 0 13. Remittances and items not allocated 120,474 0 120,474 109,813 14. Borrowed money (including $ 0 current) and interest thereon $ 0 (including $ 0 current) 0 0 0 0 15. Amounts due to parent, subsidiaries and affiliates 926,795 0 926,795 741,022 16. Derivatives 0 0 0 0 17. Payable for securities 0 0 0 0 18. Payable for securities lending 0 0 0 0 19. Funds held under reinsurance treaties (with $ 22,052 authorized reinsurers, $ 0 unauthorized reinsurers and $ 0 certified reinsurers) 22,052 0 22,052 1,996 20. Reinsurance in unauthorized and certified ($ 0 ) companies 0 0 0 0 21. Net adjustments in assets and liabilities due to foreign exchange rates 0 0 0 0 22. Liability for amounts held under uninsured plans 0 0 0 0 23. Aggregate write-ins for other liabilities (including $ 0 current) 117,871 0 117,871 195,278 24. Total liabilities (Lines 1 to 23) 16,040,740 993,800 17,034,540 4,510,185 25. Aggregate write-ins for special surplus funds XXX XXX 0 135,700 26. Common capital stock XXX XXX 5,000 5,000 27. Preferred capital stock XXX XXX 0 0 28. Gross paid in and contributed surplus XXX XXX 125,271,800 132,771,800 29. Surplus notes XXX XXX 0 0 30. Aggregate write-ins for other than special surplus funds XXX XXX 0 0 31. Unassigned funds (surplus) XXX XXX (98,601,666) (115,865,196) 32. Less treasury stock, at cost: 32.1 0 shares common (value included in Line 26 $ 0 ) XXX XXX 0 0 32.2 0 shares preferred (value included in Line 27 $ 0 ) XXX XXX 0 0 33. Total capital and surplus (Lines 25 to 31 minus Line 32) XXX XXX 26,675,134 17,047,304 34. Total liabilities, capital and surplus (Lines 24 and 33) XXX XXX 43,709,674 21,557,489 DETAILS OF WRITE-INS 2301. Escheat payable 117,871 0 117,871 195,278 2302. 2303. 2398. Summary of remaining write-ins for Line 23 from overflow page 0 0 0 0 2399. Totals (Lines 2301 thru 2303 plus 2398)(Line 23 above) 117,871 0 117,871 195,278 2501. Estimated health insurer fee accrual XXX XXX 0 135,700 2502. XXX XXX 2503. XXX XXX 2598. Summary of remaining write-ins for Line 25 from overflow page XXX XXX 0 0 2599. Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) XXX XXX 0 135,700 3001. XXX XXX 3002. XXX XXX 3003. XXX XXX 3098. Summary of remaining write-ins for Line 30 from overflow page XXX XXX 0 0 3099. Totals (Lines 3001 thru 3003 plus 3098)(Line 30 above) XXX XXX 0 0

3 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. STATEMENT OF REVENUE AND EXPENSES Current Year Prior Year 1 2 3 Uncovered Total Total

1. Member Months XXX 38,211 4,572

2. Net premium income ( including $ 0 non-health premium income) XXX 68,361,483 6,716,210

3. Change in unearned premium reserves and reserve for rate credits XXX (422,574) 702,691

4. Fee-for-service (net of $ 0 medical expenses) XXX 0 0

5. Risk revenue XXX 0 0

6. Aggregate write-ins for other health care related revenues XXX 0 (93)

7. Aggregate write-ins for other non-health revenues XXX 0 0

8. Total revenues (Lines 2 to 7) XXX 67,938,909 7,418,808

Hospital and Medical: 9. Hospital/medical benefits 3,497,585 29,146,542 2,932,969

10. Other professional services 481,926 4,016,052 270,565

11. Outside referrals 190,208 1,585,063 144,707

12. Emergency room and out-of-area 287,680 2,397,332 370,759

13. Prescription drugs 0 4,908,519 292,186

14. Aggregate write-ins for other hospital and medical 0 0 0

15. Incentive pool, withhold adjustments and bonus amounts 0 28,084 357

16. Subtotal (Lines 9 to 15) 4,457,399 42,081,592 4,011,543

Less: 17. Net reinsurance recoveries 0 157,235 21,816

18. Total hospital and medical (Lines 16 minus 17) 4,457,399 41,924,357 3,989,727

19. Non-health claims (net) 0 0 0

20. Claims adjustment expenses, including $ 785,665 cost containment expenses 0 1,068,208 168,456

21. General administrative expenses 0 6,509,964 791,987

22. Increase in reserves for life and accident and health contracts (including $ 0

increase in reserves for life only) 0 0 0

23. Total underwriting deductions (Lines 18 through 22) 4,457,399 49,502,529 4,950,170

24. Net underwriting gain or (loss) (Lines 8 minus 23) XXX 18,436,380 2,468,638

25. Net investment income earned (Exhibit of Net Investment Income, Line 17) 0 392,953 511,836 26. Net realized capital gains (losses) less capital gains tax of $ 6,810 0 (263,760) 74,682

27. Net investment gains (losses) (Lines 25 plus 26) 0 129,193 586,518

28. Net gain or (loss) from agents’ or premium balances charged off [(amount recovered

$ 0 ) (amount charged off $ 0 )] 0 0 0

29. Aggregate write-ins for other income or expenses 0 0 0

30. Net income or (loss) after capital gains tax and before all other federal income taxes (Lines 24 plus 27 plus 28 plus 29) XXX 18,565,573 3,055,156

31. Federal and foreign income taxes incurred XXX 3,125,813 70,626

32. Net income (loss) (Lines 30 minus 31) XXX 15,439,760 2,984,530

DETAILS OF WRITE-INS 0601. Non medical income XXX 0 (93) 0602. XXX 0603 XXX 0698. Summary of remaining write-ins for Line 6 from overflow page XXX 0 0 0699. Totals (Lines 0601 thru 0603 plus 0698)(Line 6 above) XXX 0 (93) 0701. XXX 0702. XXX 0703 XXX 0798. Summary of remaining write-ins for Line 7 from overflow page XXX 0 0 0799. Totals (Lines 0701 thru 0703 plus 0798)(Line 7 above) XXX 0 0 1401. 1402. 1403. 1498. Summary of remaining write-ins for Line 14 from overflow page 0 0 0 1499. Totals (Lines 1401 thru 1403 plus 1498)(Line 14 above) 0 0 0 2901. 2902. 2903 2998. Summary of remaining write-ins for Line 29 from overflow page 0 0 0 2999. Totals (Lines 2901 thru 2903 plus 2998)(Line 29 above) 0 0 0

4 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. STATEMENT OF REVENUE AND EXPENSES (Continued) 1 2 Current Year Prior Year

CAPITAL AND SURPLUS ACCOUNT

33. Capital and surplus prior reporting year 17,047,304 13,701,044

34. Net income or (loss) from Line 32 15,439,760 2,984,530

35. Change in valuation basis of aggregate policy and claim reserves 0 0

36. Change in net unrealized capital gains (losses) less capital gains tax of $ 1,589 5,979 48,178

37. Change in net unrealized foreign exchange capital gain or (loss) 0 0

38. Change in net deferred income tax (773,567) (731,594)

39. Change in nonadmitted assets 2,455,658 1,045,146

40 Change in unauthorized and certified reinsurance 0 0

41. Change in treasury stock 0 0

42. Change in surplus notes 0 0

43. Cumulative effect of changes in accounting principles 0 0

44. Capital Changes:

44.1 Paid in 0 0

44.2 Transferred from surplus (Stock Dividend) 0 0

44.3 Transferred to surplus 0 0

45. Surplus adjustments:

45.1 Paid in (7,500,000) 0

45.2 Transferred to capital (Stock Dividend) 0 0

45.3 Transferred from capital 0 0

46. Dividends to stockholders 0 0

47. Aggregate write-ins for gains or (losses) in surplus 0 0

48. Net change in capital and surplus (Lines 34 to 47) 9,627,830 3,346,260

49. Capital and surplus end of reporting period (Line 33 plus 48) 26,675,134 17,047,304

DETAILS OF WRITE-INS

4701.

4702.

4703.

4798. Summary of remaining write-ins for Line 47 from overflow page 0 0

4799. Totals (Lines 4701 thru 4703 plus 4798)(Line 47 above) 0 0

5 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. CASH FLOW 1 2

Current Year Prior Year

Cash from Operations

1. Premiums collected net of reinsurance 67,394,303 6,033,336

2. Net investment income 434,319 493,577

3. Miscellaneous income 0 (93)

4. Total (Lines 1 through 3) 67,828,622 6,526,820

5. Benefit and loss related payments 35,370,301 3,958,009

6. Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts 0 0

7. Commissions, expenses paid and aggregate write-ins for deductions 7,504,152 2,324,487

8. Dividends paid to policyholders 0 0

9. Federal and foreign income taxes paid (recovered) net of $ 0 tax on capital gains (losses) (217,606) (414,375)

10. Total (Lines 5 through 9) 42,656,847 5,868,121

11. Net cash from operations (Line 4 minus Line 10) 25,171,775 658,699

Cash from Investments

12. Proceeds from investments sold, matured or repaid:

12.1 Bonds 5,311,506 10,486,565

12.2 Stocks 0 482,259

12.3 Mortgage loans 0 0

12.4 Real estate 0 0

12.5 Other invested assets 0 0

12.6 Net gains or (losses) on cash, cash equivalents and short-term investments (9) 12

12.7 Miscellaneous proceeds 0 0

12.8 Total investment proceeds (Lines 12.1 to 12.7) 5,311,497 10,968,836

13. Cost of investments acquired (long-term only):

13.1 Bonds 7,205,394 9,639,914

13.2 Stocks 0 0

13.3 Mortgage loans 0 0

13.4 Real estate 0 0

13.5 Other invested assets 0 0

13.6 Miscellaneous applications 0 0

13.7 Total investments acquired (Lines 13.1 to 13.6) 7,205,394 9,639,914

14. Net increase (decrease) in contract loans and premium notes 0 0

15. Net cash from investments (Line 12.8 minus Line 13.7 minus Line 14) (1,893,897) 1,328,922

Cash from Financing and Miscellaneous Sources

16. Cash provided (applied):

16.1 Surplus notes, capital notes 0 0

16.2 Capital and paid in surplus, less treasury stock (7,500,000) 0

16.3 Borrowed funds 0 0

16.4 Net deposits on deposit-type contracts and other insurance liabilities 0 0

16.5 Dividends to stockholders 0 0

16.6 Other cash provided (applied) 1,044,265 (1,218,329)

17. Net cash from financing and miscellaneous sources (Lines 16.1 to 16.4 minus Line 16.5 plus Line 16.6) (6,455,735) (1,218,329)

RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

18. Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17) 16,822,143 769,292

19. Cash, cash equivalents and short-term investments:

19.1 Beginning of year 7,996,467 7,227,175

19.2 End of year (Line 18 plus Line 19.1) 24,818,610 7,996,467

Note: Supplemental disclosures of cash flow information for non-cash transactions: 20.0001. Non-cash transaction - tax free bond exchange 212,634 0

6 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. ANALYSIS OF OPERATIONS BY LINES OF BUSINESS 1 2 3 4 5 6 7 8 9 10 Federal Employees Title Title Comprehensive Medicare Dental Vision Health XVIII XIX Other Total (Hospital & Medical) Supplement Only Only Benefits Plan Medicare Medicaid Other Health Non-Health 1. Net premium income 68,361,483 11,253,355 0 0 0 0 57,108,128 0 0 0 2. Change in unearned premium reserves and reserve for rate credit (422,574) 0 0 0 0 1,100,000 (1,522,574) 0 0 0 3. Fee-for-service (net of $ 0 medical expenses) 0 0 0 0 0 0 0 0 0 XXX 4. Risk revenue 0 0 0 0 0 0 0 0 0 XXX 5. Aggregate write-ins for other health care related revenues 0 0 0 0 0 0 0 0 0 XXX 6. Aggregate write-ins for other non-health care related revenues 0 XXX XXX XXX XXX XXX XXX XXX XXX 0 7. Total revenues (Lines 1 to 6) 67,938,909 11,253,355 0 0 0 1,100,000 55,585,554 0 0 0 8. Hospital/medical benefits 29,146,542 (2,700,906) 0 0 0 (29,084) 31,876,532 0 0 XXX 9. Other professional services 4,016,052 0 0 0 0 0 4,016,052 0 0 XXX 10. Outside referrals 1,585,063 0 0 0 0 0 1,585,063 0 0 XXX 11. Emergency room and out-of-area 2,397,332 0 0 0 0 0 2,397,332 0 0 XXX 12. Prescription drugs 4,908,519 (985) 0 0 0 0 4,909,504 0 0 XXX 13. Aggregate write-ins for other hospital and medical 0 0 0 0 0 0 0 0 0 XXX 14. Incentive pool, withhold adjustments and bonus amounts 28,084 (43,667) 0 0 0 0 71,751 0 0 XXX 15. Subtotal (Lines 8 to 14) 42,081,592 (2,745,558) 0 0 0 (29,084) 44,856,234 0 0 XXX 16. Net reinsurance recoveries 157,235 0 0 0 0 0 157,235 0 0 XXX 17. Total medical and hospital (Lines 15 minus 16) 41,924,357 (2,745,558) 0 0 0 (29,084) 44,698,999 0 0 XXX

18. Non-health claims (net) 0 XXX XXX XXX XXX XXX XXX XXX XXX 0 7 19. Claims adjustment expenses including $ 785,665 cost containment expenses 1,068,208 (109,187) 0 0 0 8 1,177,387 0 0 0 20. General administrative expenses 6,509,964 582,376 0 0 0 28,389 5,899,199 0 0 0 21. Increase in reserves for accident and health contracts 0 0 0 0 0 0 0 0 0 XXX 22. Increase in reserves for life contracts 0 XXX XXX XXX XXX XXX XXX XXX XXX 0 23. Total underwriting deductions (Lines 17 to 22) 49,502,529 (2,272,369) 0 0 0 (687) 51,775,585 0 0 0 24. Total underwriting gain or (loss) (Line 7 minus Line 23) 18,436,380 13,525,724 0 0 0 1,100,687 3,809,969 0 0 0 DETAILS OF WRITE-INS 0501. XXX 0502. XXX 0503. XXX 0598. Summary of remaining write-ins for Line 5 from overflow page 0 0 0 0 0 0 0 0 0 XXX 0599. Totals (Lines 0501 thru 0503 plus 0598) (Line 5 above) 0 0 0 0 0 0 0 0 0 XXX 0601. XXX XXX XXX XXX XXX XXX XXX XXX 0602. XXX XXX XXX XXX XXX XXX XXX XXX 0603. XXX XXX XXX XXX XXX XXX XXX XXX 0698. Summary of remaining write-ins for Line 6 from overflow page 0 XXX XXX XXX XXX XXX XXX XXX XXX 0 0699. Totals (Lines 0601 thru 0603 plus 0698) (Line 6 above) 0 XXX XXX XXX XXX XXX XXX XXX XXX 0 1301. XXX 1302. XXX 1303. XXX 1398. Summary of remaining write-ins for Line 13 from overflow page 0 0 0 0 0 0 0 0 0 XXX 1399. Totals (Lines 1301 thru 1303 plus 1398) (Line 13 above) 0 0 0 0 0 0 0 0 0 XXX ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 1 - PREMIUMS 1 2 3 4

Net Premium Direct Reinsurance Reinsurance Income Line of Business Business Assumed Ceded (Cols. 1 + 2 - 3)

1. Comprehensive (hospital and medical) 11,253,355 0 0 11,253,355

2. Medicare Supplement 0 0 0 0

3. Dental only 0 0 0 0

4. Vision only 0 0 0 0

5. Federal Employees Health Benefits Plan 0 0 0 0

6. Title XVIII - Medicare 57,285,400 0 177,272 57,108,128

7. Title XIX - Medicaid 0 0 0 0

8. Other health 0 0 0 0

9. Health subtotal (Lines 1 through 8) 68,538,755 0 177,272 68,361,483

10. Life 0 0 0 0

8 11. Property/casualty 0 0 0 0

12. Totals (Lines 9 to 11) 68,538,755 0 177,272 68,361,483 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2 - CLAIMS INCURRED DURING THE YEAR 1 2 3 4 5 6 7 8 9 10 Federal Employees Title Title Comprehensive Medicare Health XVIII XIX Other Total (Hospital & Medical) Supplement Dental Only Vision Only Benefits Plan Medicare Medicaid Other Health Non-Health 1. Payments during the year: 1.1 Direct 35,472,536 (2,441,972) 0 0 0 (24,907) 37,939,415 0 0 0 1.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 1.3 Reinsurance ceded 142,086 0 0 0 0 0 142,086 0 0 0 1.4 Net 35,330,450 (2,441,972) 0 0 0 (24,907) 37,797,329 0 0 0 2. Paid medical incentive pools and bonuses 39,850 0 0 0 0 0 39,850 0 0 0 3. Claim liability December 31, current year from Part 2A: 3.1 Direct 8,298,811 31,373 0 0 0 4,250 8,263,188 0 0 0 3.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 3.3 Reinsurance ceded 17,145 0 0 0 0 0 17,145 0 0 0 3.4 Net 8,281,666 31,373 0 0 0 4,250 8,246,043 0 0 0 4. Claim reserve December 31, current year from Part 2D: 4.1 Direct 0 0 0 0 0 0 0 0 0 0 4.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 4.3 Reinsurance ceded 0 0 0 0 0 0 0 0 0 0 4.4 Net 0 0 0 0 0 0 0 0 0 0 5. Accrued medical incentive pools and bonuses, current year 31,901 0 0 0 0 0 31,901 0 0 0 6. Net healthcare receivables (a) 874,987 0 0 0 0 0 874,987 0 0 0 7. Amounts recoverable from reinsurers December 31,

9 current year 0 0 0 0 0 0 0 0 0 0 8. Claim liability December 31, prior year from Part 2A: 8.1 Direct 842,585 291,026 0 0 0 8,427 543,132 0 0 0 8.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 8.3 Reinsurance ceded 1,996 0 0 0 0 0 1,996 0 0 0 8.4 Net 840,589 291,026 0 0 0 8,427 541,136 0 0 0 9. Claim reserve December 31, prior year from Part 2D: 9.1 Direct 267 267 0 0 0 0 0 0 0 0 9.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 9.3 Reinsurance ceded 0 0 0 0 0 0 0 0 0 0 9.4 Net 267 267 0 0 0 0 0 0 0 0 10. Accrued medical incentive pools and bonuses, prior year 43,667 43,667 0 0 0 0 0 0 0 0 11. Amounts recoverable from reinsurers December 31, prior year 0 0 0 0 0 0 0 0 0 0 12. Incurred Benefits: 12.1 Direct 42,053,508 (2,701,892) 0 0 0 (29,084) 44,784,484 0 0 0 12.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 12.3 Reinsurance ceded 157,235 0 0 0 0 0 157,235 0 0 0 12.4 Net 41,896,273 (2,701,892) 0 0 0 (29,084) 44,627,249 0 0 0 13. Incurred medical incentive pools and bonuses 28,084 (43,667) 0 0 0 0 71,751 0 0 0 (a) Excludes $ 0 loans or advances to providers not yet expensed. ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2A - CLAIMS LIABILITY END OF CURRENT YEAR 1 2 3 4 5 6 7 8 9 10 Federal Employees Title Title Comprehensive Medicare Health XVIII XIX Other Total (Hospital & Medical) Supplement Dental Only Vision Only Benefits Plan Medicare Medicaid Other Health Non-Health 1. Reported in Process of Adjustment: 1.1 Direct 2,147,051 0 0 0 0 0 2,147,051 0 0 0 1.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 1.3 Reinsurance ceded 0 0 0 0 0 0 0 0 0 0 1.4 Net 2,147,051 0 0 0 0 0 2,147,051 0 0 0

2. Incurred but Unreported: 2.1 Direct 6,151,760 31,373 0 0 0 4,250 6,116,137 0 0 0 2.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 2.3 Reinsurance ceded 17,145 0 0 0 0 0 17,145 0 0 0 2.4 Net 6,134,615 31,373 0 0 0 4,250 6,098,992 0 0 0

3. Amounts Withheld from Paid Claims and Capitations:

3.1 Direct 0 0 0 0 0 0 0 0 0 0 10 3.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 3.3 Reinsurance ceded 0 0 0 0 0 0 0 0 0 0 3.4 Net 0 0 0 0 0 0 0 0 0 0

4. TOTALS: 4.1 Direct 8,298,811 31,373 0 0 0 4,250 8,263,188 0 0 0 4.2 Reinsurance assumed 0 0 0 0 0 0 0 0 0 0 4.3 Reinsurance ceded 17,145 0 0 0 0 0 17,145 0 0 0 4.4 Net 8,281,666 31,373 0 0 0 4,250 8,246,043 0 0 0 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2B - ANALYSIS OF CLAIMS UNPAID - PRIOR YEAR - NET OF REINSURANCE Claim Reserve and Claim Liability 5 6 Claims Paid During the Year December 31 of Current Year 1 2 3 4 Estimated Claim Reserve and Claim On Claims Incurred On Claims Unpaid Claims Incurred Liability Prior to January 1 On Claims Incurred December 31 of On Claims Incurred In Prior Years December 31 of Line of Business of Current Year During the Year Prior Year During the Year (Columns 1 + 3) Prior Year

1. Comprehensive (hospital and medical) (2,441,972) 0 31,373 0 (2,410,599) 291,293

2. Medicare Supplement 0 0 0 0 0 0

3. Dental Only 0 0 0 0 0 0

4. Vision Only 0 0 0 0 0 0

5. Federal Employees Health Benefits Plan (24,907) 0 4,250 0 (20,657) 8,427

6. Title XVIII - Medicare 707,010 37,090,320 4,910 8,241,133 711,920 541,136

7 Title XIX - Medicaid 0 0 0 0 0 0

8. Other health 0 0 0 0 0 0

9. Health subtotal (Lines 1 to 8) (1,759,869) 37,090,320 40,533 8,241,133 (1,719,336) 840,856

11

10. Healthcare receivables (a) 0 1,075,224 0 0 0 200,236

11. Other non-health 0 0 0 0 0 0

12. Medical incentive pools and bonus amounts (43,667) 83,517 0 31,901 (43,667) 43,667

13. Totals (Lines 9 - 10 + 11 + 12) (1,803,536) 36,098,613 40,533 8,273,034 (1,763,003) 684,287 (a) Excludes $ 0 loans or advances to providers not yet expensed. ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2C - DEVELOPMENT OF PAID AND INCURRED HEALTH CLAIMS ($000 Omitted) Section A - Paid Health Claims - Comprehensive (Hospital & Medical) Cumulative Net Amounts Paid 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 9,520 9,520 9,520 9,520 9,520 2. 2016 44,852 47,258 47,258 47,258 47,258 3. 2017 XXX 12,170 13,222 13,222 13,222 4. 2018 XXX XXX 3,993 3,672 3,672 5. 2019 XXX XXX XXX 6 (2,480) 6. 2020 XXX XXX XXX XXX 44

Section B - Incurred Health Claims - Comprehensive (Hospital & Medical) Sum of Cumulative Net Amount Paid and Claim Liability, Claim Reserve and Medical Incentive Pool and Bonuses Outstanding at End of Year 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 62,666 62,666 62,666 62,666 62,666

12.HM 2. 2016 50,285 52,840 52,840 52,840 52,840 3. 2017 XXX 13,180 14,429 14,429 14,429 4. 2018 XXX XXX 4,447 4,461 4,461 5. 2019 XXX XXX XXX 6 (2,448) 6. 2020 XXX XXX XXX XXX 44

Section C - Incurred Year Health Claims and Claims Adjustment Expense Ratio - Comprehensive (Hospital & Medical) 1 2 3 4 5 6 7 8 9 10 Claim and Claim Total Claims and Years in which Adjustment Expense Unpaid Claims Claims Adjustment Premiums were Earned and Claims Claim Adjustment (Col. 3/2) Payments (Col. 5/1) Adjustment Expense Incurred (Col. 9/1) were Incurred Premiums Earned Claims Payment Expense Payments Percent (Col. 2 + 3) Percent Claims Unpaid Expenses (Col. 5+7+8) Percent 1. 2016 71,143 47,258 0 0.0 47,258 66.4 0 0 47,258 66.4 2. 2017 14,612 13,222 0 0.0 13,222 90.5 0 0 13,222 90.5 3. 2018 7,143 3,672 0 0.0 3,672 51.4 0 0 3,672 51.4 4. 2019 281 (2,480) 0 0.0 (2,480) (882.6) 31 0 (2,449) (871.5) 5. 2020 11,253 44 (109) (247.7) (65) (0.6) 0 0 (65) (0.6) ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2C - DEVELOPMENT OF PAID AND INCURRED HEALTH CLAIMS ($000 Omitted) Section A - Paid Health Claims - Federal Employees Health Benefits Plan Premium Cumulative Net Amounts Paid 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 2,467 2,467 2,467 2,467 2,467 2. 2016 89 108 108 108 108 3. 2017 XXX 0 (6) (6) (6) 4. 2018 XXX XXX (3) 33 33 5. 2019 XXX XXX XXX 0 (25) 6. 2020 XXX XXX XXX XXX 0

Section B - Incurred Health Claims - Federal Employees Health Benefits Plan Premium Sum of Cumulative Net Amount Paid and Claim Liability, Claim Reserve and Medical Incentive Pool and Bonuses Outstanding at End of Year 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 7,679 7,679 7,679 7,679 7,679

12.FE 2. 2016 111 143 143 143 143 3. 2017 XXX 0 0 0 0 4. 2018 XXX XXX (3) 42 42 5. 2019 XXX XXX XXX 0 (21) 6. 2020 XXX XXX XXX XXX 0

Section C - Incurred Year Health Claims and Claims Adjustment Expense Ratio - Federal Employees Health Benefits Plan Premium 1 2 3 4 5 6 7 8 9 10 Claim and Claim Total Claims and Years in which Adjustment Expense Unpaid Claims Claims Adjustment Premiums were Earned and Claims Claim Adjustment (Col. 3/2) Payments (Col. 5/1) Adjustment Expense Incurred (Col. 9/1) were Incurred Premiums Earned Claims Payment Expense Payments Percent (Col. 2 + 3) Percent Claims Unpaid Expenses (Col. 5+7+8) Percent 1. 2016 502 108 0 0.0 108 21.5 0 0 108 21.5 2. 2017 0 (6) 0 0.0 (6) 0.0 0 0 (6) 0.0 3. 2018 (1,100) 33 0 0.0 33 (3.0) 0 0 33 (3.0) 4. 2019 562 (25) 0 0.0 (25) (4.4) 4 0 (21) (3.7) 5. 2020 1,100 0 0 0.0 0 0.0 0 0 0 0.0 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2C - DEVELOPMENT OF PAID AND INCURRED HEALTH CLAIMS ($000 Omitted) Section A - Paid Health Claims - Title XVIII Cumulative Net Amounts Paid 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 10,040 10,040 10,040 10,040 10,040 2. 2016 261,100 261,042 261,042 261,042 261,042 3. 2017 XXX 0 0 0 0 4. 2018 XXX XXX 0 0 0 5. 2019 XXX XXX XXX 4,040 4,747 6. 2020 XXX XXX XXX XXX 36,055

Section B - Incurred Health Claims - Title XVIII Sum of Cumulative Net Amount Paid and Claim Liability, Claim Reserve and Medical Incentive Pool and Bonuses Outstanding at End of Year 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 49,819 49,819 49,819 49,819 49,819

12.XV 2. 2016 261,973 261,915 261,915 261,915 261,915 3. 2017 XXX 0 0 0 0 4. 2018 XXX XXX 0 0 0 5. 2019 XXX XXX XXX 4,581 5,293 6. 2020 XXX XXX XXX XXX 44,328

Section C - Incurred Year Health Claims and Claims Adjustment Expense Ratio - Title XVIII 1 2 3 4 5 6 7 8 9 10 Claim and Claim Total Claims and Years in which Adjustment Expense Unpaid Claims Claims Adjustment Premiums were Earned and Claims Claim Adjustment (Col. 3/2) Payments (Col. 5/1) Adjustment Expense Incurred (Col. 9/1) were Incurred Premiums Earned Claims Payment Expense Payments Percent (Col. 2 + 3) Percent Claims Unpaid Expenses (Col. 5+7+8) Percent 1. 2016 299,801 261,042 0 0.0 261,042 87.1 0 0 261,042 87.1 2. 2017 (1,503) 0 0 0.0 0 0.0 0 0 0 0.0 3. 2018 0 0 0 0.0 0 0.0 0 0 0 0.0 4. 2019 6,576 4,747 0 0.0 4,747 72.2 5 0 4,752 72.3 5. 2020 55,586 36,055 1,088 3.0 37,143 66.8 8,273 96 45,512 81.9 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2C - DEVELOPMENT OF PAID AND INCURRED HEALTH CLAIMS ($000 Omitted) Section A - Paid Health Claims - Title XIX Cumulative Net Amounts Paid 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 0 0 0 0 0 2. 2016 (9) (9) (9) (9) (9) 3. 2017 XXX 0 0 0 0 4. 2018 XXX XXX 0 0 0 5. 2019 XXX XXX XXX 0 0 6. 2020 XXX XXX XXX XXX 0

Section B - Incurred Health Claims - Title XIX Sum of Cumulative Net Amount Paid and Claim Liability, Claim Reserve and Medical Incentive Pool and Bonuses Outstanding at End of Year 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 1,846 1,846 1,846 1,846 1,846

2. 2016 (9) (9) (9) (9) (9) 12.XI 3. 2017 XXX 0 0 0 0 4. 2018 XXX XXX 0 0 0 5. 2019 XXX XXX XXX 0 0 6. 2020 XXX XXX XXX XXX 0

Section C - Incurred Year Health Claims and Claims Adjustment Expense Ratio - Title XIX 1 2 3 4 5 6 7 8 9 10 Claim and Claim Total Claims and Years in which Adjustment Expense Unpaid Claims Claims Adjustment Premiums were Earned and Claims Claim Adjustment (Col. 3/2) Payments (Col. 5/1) Adjustment Expense Incurred (Col. 9/1) were Incurred Premiums Earned Claims Payment Expense Payments Percent (Col. 2 + 3) Percent Claims Unpaid Expenses (Col. 5+7+8) Percent 1. 2016 0 (9) 0 0.0 (9) 0.0 0 0 (9) 0.0 2. 2017 0 0 0 0.0 0 0.0 0 0 0 0.0 3. 2018 0 0 0 0.0 0 0.0 0 0 0 0.0 4. 2019 0 0 0 0.0 0 0.0 0 0 0 0.0 5. 2020 0 0 0 0.0 0 0.0 0 0 0 0.0 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2C - DEVELOPMENT OF PAID AND INCURRED HEALTH CLAIMS ($000 Omitted) Section A - Paid Health Claims - Grand Total Cumulative Net Amounts Paid 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 22,027 22,027 22,027 22,027 22,027 2. 2016 306,032 308,399 308,399 308,399 308,399 3. 2017 XXX 12,170 13,216 13,216 13,216 4. 2018 XXX XXX 3,990 3,705 3,705 5. 2019 XXX XXX XXX 4,046 2,242 6. 2020 XXX XXX XXX XXX 36,099

Section B - Incurred Health Claims - Grand Total Sum of Cumulative Net Amount Paid and Claim Liability, Claim Reserve and Medical Incentive Pool and Bonuses Outstanding at End of Year 1 2 3 4 5 Year in Which Losses Were Incurred 2016 2017 2018 2019 2020 1. Prior 122,010 122,010 122,010 122,010 122,010

12.GT 2. 2016 312,360 314,889 314,889 314,889 314,889 3. 2017 XXX 13,180 14,429 14,429 14,429 4. 2018 XXX XXX 4,444 4,503 4,503 5. 2019 XXX XXX XXX 4,587 2,824 6. 2020 XXX XXX XXX XXX 44,372

Section C - Incurred Year Health Claims and Claims Adjustment Expense Ratio - Grand Total 1 2 3 4 5 6 7 8 9 10 Claim and Claim Total Claims and Years in which Adjustment Expense Unpaid Claims Claims Adjustment Premiums were Earned and Claims Claim Adjustment (Col. 3/2) Payments (Col. 5/1) Adjustment Expense Incurred (Col. 9/1) were Incurred Premiums Earned Claims Payment Expense Payments Percent (Col. 2 + 3) Percent Claims Unpaid Expenses (Col. 5+7+8) Percent 1. 2016 371,446 308,399 0 0.0 308,399 83.0 0 0 308,399 83.0 2. 2017 13,109 13,216 0 0.0 13,216 100.8 0 0 13,216 100.8 3. 2018 6,043 3,705 0 0.0 3,705 61.3 0 0 3,705 61.3 4. 2019 7,419 2,242 0 0.0 2,242 30.2 40 0 2,282 30.8 5. 2020 67,939 36,099 979 2.7 37,078 54.6 8,273 96 45,447 66.9 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 2D - AGGREGATE RESERVE FOR ACCIDENT AND HEALTH CONTRACTS ONLY 1 2 3 4 5 6 7 8 9 Federal Employees Title Title Comprehensive Medicare Health XVIII XIX Total (Hospital & Medical) Supplement Dental Only Vision Only Benefits Plan Medicare Medicaid Other 1. Unearned premium reserves 0 0 0 0 0 0 0 0 0 2. Additional policy reserves (a) 0 0 0 0 0 0 0 0 0 3. Reserve for future contingent benefits 0 0 0 0 0 0 0 0 0 4. Reserve for rate credits or experience rating refunds (including

$ 0 ) for investment income 2,969,662 0 0 0 0 1,054,718 1,914,944 0 0 5. Aggregate write-ins for other policy reserves 0 0 0 0 0 0 0 0 0 6. Totals (gross) 2,969,662 0 0 0 0 1,054,718 1,914,944 0 0 7. Reinsurance ceded 0 0 0 0 0 0 0 0 0 8. Totals (Net)(Page 3, Line 4) 2,969,662 0 0 0 0 1,054,718 1,914,944 0 0 9. Present value of amounts not yet due on claims 0 0 0 0 0 0 0 0 0 10. Reserve for future contingent benefits 0 0 0 0 0 0 0 0 0 11. Aggregate write-ins for other claim reserves 0 0 0 0 0 0 0 0 0

13 12. Totals (gross) 0 0 0 0 0 0 0 0 0 13. Reinsurance ceded 0 0 0 0 0 0 0 0 0 14. Totals (Net)(Page 3, Line 7) 0 0 0 0 0 0 0 0 0

DETAILS OF WRITE-INS 0501.

0502.

0503. 0598. Summary of remaining write-ins for Line 5 from overflow page 0 0 0 0 0 0 0 0 0 0599. Totals (Lines 0501 thru 0503 plus 0598) (Line 5 above) 0 0 0 0 0 0 0 0 0 1101.

1102.

1103. 1198. Summary of remaining write-ins for Line 11 from overflow page 0 0 0 0 0 0 0 0 0 1199. Totals (Lines 1101 thru 1103 plus 1198) (Line 11 above) 0 0 0 0 0 0 0 0 0

(a) Includes $ 0 premium deficiency reserve. ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. UNDERWRITING AND INVESTMENT EXHIBIT PART 3 - ANALYSIS OF EXPENSES Claim Adjustment Expenses 3 4 5 1 2 Cost Other Claim General Containment Adjustment Administrative Investment Expenses Expenses Expenses Expenses Total

1. Rent ($ 0 for occupancy of

own building) 17,570 6,285 10,419 740 35,014

2. Salary, wages and other benefits 466,649 157,478 1,548,202 18,400 2,190,729

3. Commissions (less $ 0

ceded plus $ 0 assumed) 0 0 1,459,389 0 1,459,389

4. Legal fees and expenses 0 0 30,264 0 30,264

5. Certifications and accreditation fees 0 0 0 0 0

6. Auditing, actuarial and other consulting services 0 19,296 650,730 4,500 674,526

7. Traveling expenses 634 373 11,700 34 12,741

8. Marketing and advertising 133 3,155 239,823 0 243,111

9. Postage, express and telephone 5,853 24,309 104,922 60 135,144

10. Printing and office supplies 0 7,043 43,077 22 50,142

11. Occupancy, depreciation and amortization 8,670 3,620 (12,290) 131 131

12. Equipment 0 663 42,729 503 43,895

13. Cost or depreciation of EDP equipment and software 28 6,645 161,807 387 168,867

14. Outsourced services including EDP, claims, and other services 249,769 39,026 647,991 3,425 940,211

15. Boards, bureaus and association fees 68 60 5,271 72 5,471

16. Insurance, except on real estate 1,095 458 47,645 14 49,212

17. Collection and bank service charges 0 493 7,787 2,125 10,405

18. Group service and administration fees 0 0 0 0 0

19. Reimbursements by uninsured plans 0 0 0 0 0

20. Reimbursements from fiscal intermediaries 0 0 0 0 0

21. Real estate expenses 58 14 36,120 1 36,193

22. Real estate taxes 0 0 8,670 0 8,670

23. Taxes, licenses and fees:

23.1 State and local insurance taxes 0 0 475,716 0 475,716

23.2 State premium taxes 0 0 652,168 0 652,168

23.3 Regulatory authority licenses and fees 0 0 76,281 0 76,281

23.4 Payroll taxes 35,124 11,853 96,410 1,385 144,772

23.5 Other (excluding federal income and real estate taxes) 0 0 118,139 0 118,139

24. Investment expenses not included elsewhere 0 0 0 0 0

25. Aggregate write-ins for expenses 14 1,772 46,994 1 48,781

26. Total expenses incurred (Lines 1 to 25) 785,665 282,543 6,509,964 31,800 (a) 7,609,972

27. Less expenses unpaid December 31, current year 70,600 25,389 1,106,834 0 1,202,823

28. Add expenses unpaid December 31, prior year 4,752 2,054 1,496 0 8,302

29. Amounts receivable relating to uninsured plans, prior year 0 0 839,122 0 839,122

30. Amounts receivable relating to uninsured plans, current year 0 0 2,019,780 0 2,019,780

31. Total expenses paid (Lines 26 minus 27 plus 28 minus 29 plus 30) 719,817 259,208 6,585,284 31,800 7,596,109

DETAILS OF WRITE-INS

2501. Miscellaneous 14 1,044 (32,854) 1 (31,795)

2502. Loss adjustment expense 0 1 89,181 0 89,182

2503. Interest expense 0 727 (9,333) 0 (8,606)

2598. Summary of remaining write-ins for Line 25 from overflow page 0 0 0 0 0

2599. Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) 14 1,772 46,994 1 48,781 (a) Includes management fees of $ 6,200,929 to affiliates and $ 0 to non-affiliates.

14 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. EXHIBIT OF NET INVESTMENT INCOME

1 2 Collected During Year Earned During Year 1. U.S. government bonds (a) 45,403 39,933 1.1 Bonds exempt from U.S. tax (a) 0 0 1.2 Other bonds (unaffiliated) (a) 417,979 361,045 1.3 Bonds of affiliates (a) 0 0 2.1 Preferred stocks (unaffiliated) (b) 0 0 2.11 Preferred stocks of affiliates (b) 0 0 2.2 Common stocks (unaffiliated) 0 0 2.21 Common stocks of affiliates 0 0 3. Mortgage loans (c) 0 0 4. Real estate (d) 0 0 5 Contract Loans 0 0 6 Cash, cash equivalents and short-term investments (e) 20,225 20,225 7 Derivative instruments (f) 0 0 8. Other invested assets 0 0 9. Aggregate write-ins for investment income 3,550 3,550 10. Total gross investment income 487,157 424,753 11. Investment expenses (g) 30,415 12. Investment taxes, licenses and fees, excluding federal income taxes (g) 1,385 13. Interest expense (h) 0 14. Depreciation on real estate and other invested assets (i) 0 15. Aggregate write-ins for deductions from investment income 0 16. Total deductions (Lines 11 through 15) 31,800 17. Net investment income (Line 10 minus Line 16) 392,953 DETAILS OF WRITE-INS 0901. Miscellaneous interest 3,550 3,550 0902. 0903. 0998. Summary of remaining write-ins for Line 9 from overflow page 0 0 0999. Totals (Lines 0901 thru 0903 plus 0998) (Line 9, above) 3,550 3,550 1501. 1502. 1503. 1598. Summary of remaining write-ins for Line 15 from overflow page 0 1599. Totals (Lines 1501 thru 1503 plus 1598) (Line 15, above) 0

(a) Includes $ 76,987 accrual of discount less $ 55,943 amortization of premium and less $ 5,872 paid for accrued interest on purchases.

(b) Includes $ 0 accrual of discount less $ 0 amortization of premium and less $ 0 paid for accrued dividends on purchases.

(c) Includes $ 0 accrual of discount less $ 0 amortization of premium and less $ 0 paid for accrued interest on purchases.

(d) Includes $ 0 for company’s occupancy of its own buildings; and excludes $ 0 interest on encumbrances.

(e) Includes $ 20,196 accrual of discount less $ 0 amortization of premium and less $ 0 paid for accrued interest on purchases.

(f) Includes $ 0 accrual of discount less $ 0 amortization of premium.

(g) Includes $. 0 investment expenses and $ 0 investment taxes, licenses and fees, excluding federal income taxes, attributable to segregated and Separate Accounts.

(h) Includes $ 0 interest on surplus notes and $ 0 interest on capital notes. (i) Includes $ 0 depreciation on real estate and $ 0 depreciation on other invested assets.

EXHIBIT OF CAPITAL GAINS (LOSSES) 1 2 3 4 5

Total Realized Capital Change in Change in Unrealized Realized Gain (Loss) Other Realized Gain (Loss) Unrealized Capital Foreign Exchange On Sales or Maturity Adjustments (Columns 1 + 2) Gain (Loss) Capital Gain (Loss) 1. U.S. Government bonds 21 (15,497) (15,476) 0 0 1.1 Bonds exempt from U.S. tax 0 0 0 0 0 1.2 Other bonds (unaffiliated) (76,131) (165,334) (241,465) 7,568 0 1.3 Bonds of affiliates 0 0 0 0 0 2.1 Preferred stocks (unaffiliated) 0 0 0 0 0 2.11 Preferred stocks of affiliates 0 0 0 0 0 2.2 Common stocks (unaffiliated) 0 0 0 0 0 2.21 Common stocks of affiliates 0 0 0 0 0 3. Mortgage loans 0 0 0 0 0 4. Real estate 0 0 0 0 0 5. Contract loans 0 0 0 0 0 6. Cash, cash equivalents and short-term investments (9) 0 (9) 0 0 7. Derivative instruments 0 0 0 0 0 8. Other invested assets 0 0 0 0 0 9. Aggregate write-ins for capital gains (losses) 0 0 0 0 0 10. Total capital gains (losses) (76,119) (180,831) (256,950) 7,568 0 DETAILS OF WRITE-INS 0901. 0902. 0903. 0998. Summary of remaining write-ins for Line 9 from overflow page 0 0 0 0 0 0999. Totals (Lines 0901 thru 0903 plus 0998) (Line 9, above) 0 0 0 0 0

15 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. EXHIBIT OF NON-ADMITTED ASSETS 1 2 3 Change in Total Current Year Total Prior Year Total Nonadmitted Assets Nonadmitted Assets Nonadmitted Assets (Col. 2 - Col. 1) 1. Bonds (Schedule D) 0 0 0 2. Stocks (Schedule D): 2.1 Preferred stocks 0 0 0 2.2 Common stocks 0 0 0 3. Mortgage loans on real estate (Schedule B): 3.1 First liens 0 0 0 3.2 Other than first liens 0 0 0 4. Real estate (Schedule A): 4.1 Properties occupied by the company 0 0 0 4.2 Properties held for the production of income 0 0 0 4.3 Properties held for sale 0 0 0 5. Cash (Schedule E - Part 1), cash equivalents (Schedule E - Part 2) and short-term investments (Schedule DA) 0 0 0 6. Contract loans 0 0 0 7. Derivatives (Schedule DB) 0 0 0 8. Other invested assets (Schedule BA) 0 0 0 9. Receivables for securities 0 0 0 10. Securities lending reinvested collateral assets (Schedule DL) 0 0 0 11. Aggregate write-ins for invested assets 0 0 0 12. Subtotals, cash and invested assets (Lines 1 to 11) 0 0 0 13. Title plants (for Title insurers only) 0 0 0 14. Investment income due and accrued 0 0 0 15. Premiums and considerations: 15.1 Uncollected premiums and agents' balances in the course of collection 3,298 23,515 20,217 15.2 Deferred premiums, agents' balances and installments booked but deferred and not yet due 0 0 0 15.3 Accrued retrospective premiums and contracts subject to redetermination 0 0 0 16. Reinsurance: 16.1 Amounts recoverable from reinsurers 0 0 0 16.2 Funds held by or deposited with reinsured companies 0 0 0 16.3 Other amounts receivable under reinsurance contracts 0 0 0 17. Amounts receivable relating to uninsured plans 0 0 0 18.1 Current federal and foreign income tax recoverable and interest thereon 0 0 0 18.2 Net deferred tax asset 2,133,491 3,675,773 1,542,282 19. Guaranty funds receivable or on deposit 0 0 0 20. Electronic data processing equipment and software 0 0 0 21. Furniture and equipment, including health care delivery assets 670,368 1,573,612 903,244 22. Net adjustment in assets and liabilities due to foreign exchange rates 0 0 0 23. Receivable from parent, subsidiaries and affiliates 235 2,173 1,938 24. Health care and other amounts receivable 12,023 0 (12,023) 25. Aggregate write-ins for other than invested assets 0 0 0 26. Total assets excluding Separate Accounts, Segregated Accounts and Protected Cell Accounts (Lines 12 to 25) 2,819,415 5,275,073 2,455,658 27. From Separate Accounts, Segregated Accounts and Protected Cell Accounts 0 0 0 28. Total (Lines 26 and 27) 2,819,415 5,275,073 2,455,658 DETAILS OF WRITE-INS 1101. 1102. 1103. 1198. Summary of remaining write-ins for Line 11 from overflow page 0 0 0 1199. Totals (Lines 1101 thru 1103 plus 1198)(Line 11 above) 0 0 0 2501. 2502. 2503. 2598. Summary of remaining write-ins for Line 25 from overflow page 0 0 0 2599. Totals (Lines 2501 thru 2503 plus 2598)(Line 25 above) 0 0 0

16 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. EXHIBIT 1 - ENROLLMENT BY PRODUCT TYPE FOR HEALTH BUSINESS ONLY Total Members at End of 6 1 2 3 4 5 Current Year Source of Enrollment Prior Year First Quarter Second Quarter Third Quarter Current Year Member Months

1. Health Maintenance Organizations 0 0 0 0 0 0

2. Provider Service Organizations 0 0 0 0 0 0

3. Preferred Provider Organizations 0 0 0 0 0 0

4. Point of Service 575 2,550 3,191 3,761 3,884 38,211

5. Indemnity Only 0 0 0 0 0 0

6. Aggregate write-ins for other lines of business 0 0 0 0 0 0

7. Total 575 2,550 3,191 3,761 3,884 38,211

DETAILS OF WRITE-INS

0601. 0 0 0 0 0 0

0602. 0 0 0 0 0 0

0 0 0 0 0 0

17 0603.

0698. Summary of remaining write-ins for Line 6 from overflow page 0 0 0 0 0 0

0699. Totals (Lines 0601 thru 0603 plus 0698) (Line 6 above) 0 0 0 0 0 0            

      

 1NFF:KRH?1B@GB?B<:GM <L:G=%HBG@!HG<>KG

 <L

2A> :<F>GML H? !HO>GMKR &>:EMA !:K> H? ):GL:L  : ):GL:L  W!HFI:GRX  BG=BK>= LN;LB=B:KR H? !41 &>:EMA !HKIHK:MBHG W!41 &>:EMAX  A:O> ;>>G IK>I:K>= BG LIK>L=HKI>KFBMM>=;RMA>):GL:L'GLNK:G<>">I:KMF>GMW):GL:L">I:KMF>GMX  ):GL:L <L 2A>):GL:L">I:KMF>GMK>LLM:MNMHKR:<LIK>L=HKI>KFBMM>= ;R MA> 1M:M> H? ):GL:L ?HK =>M>KFBGBG@ :G= K>IHKMBG@ MA> ?BG:GLNEML H? HI>K:MBHGL H? :G BGLNK:G<>  :<L :G= IKH<>=NK>L :=HIM>= ;R MA> ,:MBHG:E LLH !HFFBLLBHG>KLW, '!X   % $ "$# " %"# % W, '!1 .X 

 K> !HFI:GRZL G>M BG :G= <:IBM:E :G= LNKIENL ;>MP>>G , '! 1 . :G= IK:L IK>L= :G= I>KFBMM>=;RMA>1M:M>H?):GL:L?HKMA>R>:KL>G=BG@"><>F;>K :G=BL:L?HEEHPL

$1 $1 11 . .:@> *BG>   ,#2',!-+#  1M:M>;:LBL.:@> *BG> !HENFGL  666 666 666          1M:M>.K>L=.K:LMA:MBG:L>=>:L> , '! 1 .  V  V        1M:M>.>KFBMM>=.K:LMA:MBG:L>=>:L> , '! 1 .  V  V        , '!1 .    666 666 666        

130.*31  1M:M>;:LBL.:@> *BG> !HENFGL  666 666 666        

 1M:M>.K>L=.K:LMA:MBG:L>=>:L> , '! 1 .  V  V        1M:M>.>KFBMM>=.K:LMA:MBG:L>=>:L> , '! 1 .  V  V        , '!1 .    666 666 666        

3L>H?#LMBF:M>LBGMA>.K>I:K:MBHGH?MA>$BG:GF>GML

2A>IK>I:K:MBHGH?MA>L>?BG:GF>GMLBGLK>JNBK>LF:G:@>F>GMMHF:D> >LMBF:M>L:G=:LLNFIMBHGLMA:M:??>K>IHKM>=:FHNGMLH?:LL>ML:G=EB:;BEBMB>L:G=K>O>GN>:G=>QI>GL>L  LNEML K?KHFMAHL>>LMBF:M>L

!  <L

2A>!HFI:GR:IIEB>LMA>?HEEHPBG@LB@GB?B<:GM:<L

 !:LA !:LA#JNBO:E>GML:G=1AHKM 2>KF'GO>LMF>GML

!:LA  <:LA >JNBO:E>GML :G= LAHKM M>KF BGO>LMF>GML  R F:KD>M BGLMKNF>GML :G= HMA>K =>;M BLLN>LPBMA:GHKB@BG:EF:MNKBMRH?NIMHHG>R>:K :K><:KKB>=:M:FHKMBS>=KFBGO>LMF>GMLLMF>GML INK= PBMA :G HKB@BG:E F:MNKBMR =:M> H? @K>:M>K MA:G MAK>> FHGMAL ;NM E>LL MA:G HG> R>:K  !:LA >JNBO:E>GML GML  PAB PBMABG MAK>> FHGMAL ?KHF MA> =:M> H? INK  2A> <:KKRBG@ :FHNGM H? <:LA  <:LA >JNBO:E>GML :G= LAHKM M>KF BGO>LMF>GML :IIKHQBF:M>L ?:BK O:EN>  !:LA :<;:E:G<>LLA:EEGHM;>K>IHKM>=L>I:K:M>ER?KHF<:LA:<@:MBO>;:E:G<>L '?BGMA>:@@K>@:M> MA> K>IHKMBG@>GMBMRA:L:G>MG>@:MBO><:LA;:E:G<> BMLA:EE;>K>IHKM>=:L:G>@:MBO>:LL>M:G=LA:EEGHM;>K>=:L: EB:;BEBMR

  HG=L

HG=L PABLI>IHLBML :K><:KKB>=:M:FHKMBS>=Q<>IM?HKMAHL>;HG=LPBMA:G, '!=>LB@G:MBHGH?  MAKHN@A   PAB <:KKB>= :M MA> EHP>K H? :FHKMBS>=  2A> :FHNGM <:KKB>= :M ?:BK O:EN> BL GHM F:M>KB:EMHMA>?BG:GF>GML  HG=IK>FBNFL:G==BL:FHKMBS>=NLBG@MA>LGMB?B<BGM>K>LMF>MAH= 

26            

      

5A>GJNHM>=IKB<>LBG:F:KD>ML?HKB=>GMB<:E:LL>ML:K>:O:BE:;E> MA>!HFI:GRNL>LMA>L>JNHM>=F:KD>MIKB<>LMH =>M>KFBG>MA>?:BKO:EN>H?;HG=L 2ABLBLNL>=IKBF:KBER?HK3 1 @HO>KGF>GML>L 'GHMA>K<:L>LPA>K>:JNHM>= F:KD>MIKB<>?HKB=>GMB<:E:LL>MLBG:G:F:KD>MBL>BMA>KGHM:O:BE:;E>HKGHMH;L>KO:;E> MA>!HFI:GR>LMBF:M>L?:BK O:EN>LNLBG@O:EN:MBHGF>MAH=HEH@B>L;:L>=HG:O:BE:;E>:G=H;L>KO:;E>F:KD>MBG?HKF:MBHGHK;RNLBG@:F:MKBQIKBE '?JNHM>=F:KD>MIKB<>L:K>GHM:O:BE:;E> MA>!HFI:GR=>M>KFBG>L?:BKO:EN>NLBG@;KHD>KJNHM>LHK:GBGM>KG:E :G:ERLBLH?>:LMF>GMZL?BG:GK?HKF:G<>:G=<:LA?EHPIKHC>!HFI:GRA:=GHBGO>LMF>GMLPA>K> ?:BKO:EN>P:L=>M>KFBG>=NLBG@;KHD>KJNHM>LHK:GBGM>KG:E:G:ERLBLH??BG:GK?HKF:G<>:G=<:LA?EHPIKHC><>F;>K :G=  HG=LBG:EEBGO>LMF>GMLPAHL>F:MNKBMRBL@K>:M>KMA:GHG>R>:KPA>GINK=  *H:G ;:=:G=LMKN=L>L:K><:KKB>=:M:FHKMBS>==?HKNG:FHKMBS>=IK>FBNFL:G==BL:<=?HKNLBG@MA>K>MKHLI>:=CNLMF>GMF>MAH= .K>FBNFL:G==BL=:G=LMKN= L>L :K> :FHKMBS>= NLBG@ MA> LGMB?B< F>MAH= HO>K MA> >LMBF:M>= K>F:BGBG@ M>KF H? MA> L>L  :=CNLM>= ?HK :GMB=IK>I:RF>GML  EE:=CNLMF>GML;>MP>>G:FHKMBS>=:K>K>?E>=BGNGK>:EBS>=<:IBM:E @:BGL:G=EHLL>L:G=:K>K>IHKM>=:L=BK>GMLMHLNKIENL

HG=L:K>K>=:LINKLHKL:E>LHGMA>MK:=>=:M>

2A>!HFI:GRI>KBH=B<:EERK>OB>PLBML;HG=LMH=>M>KFBG>PA>MA>K:=>BG?:BKO:EN>;>EHPMA><:KKRBG@O:EN>BL HMA>K MA:G M>FIHK:KR $HK;HG=L HMA>KMA:GEH:G ;:=:G=LMKN=L>L* 11 :GHMA>K MA:G M>FIHK:KR BFI:BKF>GM W-22'X  LA:EE ;> K>= B? BM BL IKH;:;E> MA:M MA> !HFI:GR PBEE ;> NG:;E> MH  :<KFLBG>??>=:M>H?:L=>>F>=MH;>-22'BGMA> K>=:LK>:EBS>=<:IBM:EEHLL>L 7B>E= K>E:M>=BFI:BKF>GML:K>=>>F>=HMA>K MA:G M>FIHK:KRPA>GMA>!HFI:GR BGM>G=LMHL>EE:GBGO>LMF>GM:MMA>K>IHKMBG@=:M>;>?HK>K>KRH?MA>BGO>LMF>GM

$HK* 11 MA>!HFI:GRK>GMA>?:BKO:EN>H?MA>EH:G ;:=HKLMKN=L>LLMA:GMA> :FHKMBS>=;:E:G<>LA>>M=:M>:G= MA>!HFI:GRBGM>G=LMHL>EEMA>BGO>LMF>GM HK MA>!HFI:GR =H>LGHMA:O>MA>BGM>GM:G=:;BEBMRMHK>M:BGMA>BGO>LMF>GM?HKMA>MBF>LN??BGMMHK>KMA>:FHKMBS>=!HFI:GR=H>LGHM>QI>KMA>>GMBK>:FHKMBS>=L>O>GB?BM=H>LGHMBGM>G=MH L>EEMA>L>BGM>GM:G=:;BEBMRMHAHE= '?BMBL=>M>KFBG>=:G-22'A:LH<=;><:NL>H? HK MA> :FHNGMH?MA>-22'BL>JN:EMHMA>=B??>K>G<>;>MP>>GMA>:FHKMBS>=?:BKO:EN>H?MA>L>;:E:G<> LA>>M=:M>:G=MABL=B??>K>G<>BLK>=:L:K>:EBS>=<:IBM:EEHLL '?BMBL=>M>KFBG>=:G-22'A:LH<=;><:NL>H?  MA>:FHNGMH?MA>-22'BL>JN:EMHMA>=B??>K>G<>;>MP>>GMA>:FHKMBS>=IK>L>GMO:EN>H?<:LA?EHPL >QI>=MH;>= =BL=:MMA>EH:G ;:=HKLMKN=L>??>BGM>K>LMK:M>:G=MABL=B??>K>G<> BL:ELH:<=?HK:L:K>:EBS>=<:IBM:EEHLL

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

2A> !HFI:GR A:= GH 1>L 4:EN:MBHG -??B<> B=>GMB?B>= BGO>LMF>GML MA:M :K> ;>BG@ K>IHKM>= :M : =B??>K>GM F>:LNK>F>GMF>MAH=?KHFMA>IKBHKR>:K:GGN:ELM:M>F>GM

 !HFFHG1MH

2A>!HFI:GR=B=GHMHPG:GR<>F;>K HK

 2A>!HFI:GR=B=GHMHPG:GRIK>?>KK>=LMH<>F;>K HK

 2A>!HFI:GR=B=GHMA:O>:GRFHKM@:@>EH:GL:M"><>F;>K HK

 'GO>LMF>GMLBG1N;LB=B:KB>L !HGMKHEE>=HK ??BEB:M>=!HFI:GB>L

2A>!HFI:GR=B=GHMA:O>:GRBGO>LMF>GMLBGLN;LB=B:KB>L =HK:??BEB:M>=L:M"><>F;>K HK 

 -MA>K'GO>LM>= LL>ML

2A> !HFI:GR =B= GHM A:O> :GR BGO>LMF>GML BG :GR CHBGM O>GMNK>L  I:KMG>KLABIL :G= EBFBM>= EB:;BEBMR L :M "><>F;>K HK

 ">KBO:MBO>L

2A>!HFI:GR=B=GHMA:O>:GR=>KBO:MBO>L:M"><>F;>K HK

  @@K>@:M>&>:EMA.HEBL>KO>L:G=0>E:M>=#QI>GL>L

26.1            

      

.K>FBNF=>?BGL>KO>LW."0X :K>K>=PA>GBMBLIKH;:;E>MA:MMA>>QI>=?NMNK>AHLIBM:E:G=F>=B<:E G:G<> Q<>>= :GMB= ?NMNK> IK>FBNFL :G= K>BGLNK:G<> K>KB>L HG >QBLMBG@ = BGO>LMF>GM BG BL K>= BG MA> <:EL H? <:E @KHNI>= BG : F:GG>K GM PBMA MA> F>MAH= H? :KOB:LNKBG@ MA> IKH?BM:;BEBMRH?LN

3G>:KG>=IK>FBNFK>L>KO>LW3#.X :K>K>=?HKIK>FBNFLMA:M:K>K>=;RMA>!HFI:GRMA:MA:O>GHM;>>G >:KG>=:LH?MA>LM:M>F>GM=:M> 2A>!HFI:GRA:=GH3#.:M"><>F;>K :G=

2A>!HFI:GRBLK>JNBK>=MHF:D>IK>FBNFK>;:M>I:RF>GMLMHKLMA:M:K>>GKHEE>=NG=>K<>KM:BGA>:EMABGLNK:G<> IHEBLB?LI>=B<:EEHLLK:MBHLW+*0X P>K>GHMF>MBGMA>IKBHKR>:K 2A>!HFI:GRLK>LNEML ?HK ?NEE R>:K  :G=  BG >LMBF:M>L H?    :G=    K>LI>ER  H? FBGBFNF +*0 K>;:M>L  PABK> BG= BG :@@K>@:M> A>:EMA IHEBL>KO>L BG MA> 1M:MNMHKR 1M:M>F>GML H? *B:;BEBMB>L :G= !:IBM:E :G= 1NKIENL

2A>!HFI:GRK>IHKM>=EB:;BEBMB>L:LLH=PBMA=>M>KFBG:MBHG:L:@@K>@:M>A>:EMAIHEBL>KO>L BG:<PBMA11 .,H 0  &%  " %!  $ $ $"$# W11 .,H 0X :G=11 . ,H   #" " &# # $ " "$ W11 .,H X *B:;BEBMB>L:LLH=PBMA>LMBF:M>= :=CNLMF>GMLMHIK>FBNFI:RF>GMLMHMA>!HFI:GRL+>=B<:K>IE:GL;:L>=HGMA>A>:EMALM:MNLH?BML+>=B<:K>F>F;>KL :K>BG=:LI:KMH?MA>!HFI:GRL=>M>KFBG:MBHG  FHNGMLK>E:M>=MHMA>L>EB:;BEBMB>LH?  :G= P>K>BG=BG:@@K>@:M>A>:EMAIHEBL>KO>L:M"><>F;>K :G= K>LI>ER 

 &HLIBM:E:G=+>=B<:E!HLML:G=!E:BFL =CNLMF>GM#QI>GL>L:G=0>E:M>=0>L>KO>L

&HLIBM:E:G=F>=B<:E> ?HK L>KOB<>F>=B<:E@:M>A>:EMAL>KO>LBGMA>!HFI:GRL>LMBF:M>H?I:RF>GMLMH;>F:=>HGIHKM>=;NMGHMR>M I:B=:G=?HKA>:EMA<:K>L>KOB<>LK>G=>K>=MH>GKHEE>>L;NMGHMR>MK>IHKM>=MHMA>!HFI:GR:LH?MA>1M:MNMHKR1M:M>F>GML H? LL>ML :G= *B:;BEBMB>L  !:IBM:E :G= 1NKIENL =:M>  1NLMBF:M>L :K> =>O>EHI>= NLBG@ :L :G= :LLNFIMBHGL  PABK  :FHG@ HMA>K MABG@L  ABLMHKB<:E :G= IKHC>= LLBG@ I:RF>GM I:MM>KGL  F>=B<:E G=L  ABLMHKB<:E NMBEBS:MBHG H? A>:EMA <:K> L>KOB<>L  GMHKR E>O>EL  F>=B<:E BG?E:MBHG  JNBK>F>GM L BG F>F;>KLABI :G= IKH=N:LHG:EBMR :G= HMA>K K>E>O:GM ?: !HFI:GR K>?E>LBG>LMBF:M>LBGAHLIBM:E:G=F>=B<:E1M:MNMHKR1M:M>F>GMLH?0>O>GN>:G=#QI>GL>LBGMA> I>KBH= MA>R :K> =>M>KFBG>=  !:IBM:MBHG  K>= BG AHLIBM:E :G= F>=B<:E >QI>GL>L BG MA> 1M:MNMHKR 1M:M>F>GML H? 0>O>GN> :G= #QI>GL>L  K>IK>L>GM >L I:B= MH I:KMBK F>=B<:EIKHOB=>KL?HKIKHOB=BG@F>=B<:E<:K> K>@:K=E>LLH?MA>F>=B<:EL>KOB<>LIKHOB=>=MHMA>>GKHEE>>

2A>!HFI:GRNL>LMA>MKB:G@NE:MBHGF>MAH=MH>LMBF:M>K>L>KO>L?HK=;NMGHMK>IHKM>= 2A>F>MAH=H? MKB:G@NE:MBHGF:D>L>LMBF:M>LH?MBHG?:MA>G:IIEB>=MHMA>MHM:EI:B=MH?G>?BML  MH =:M> ?HK >:L :G >LMBF:M> H? MA> MHM:E IKHC>= BG= =;NMGHMK>IHKM>=FHLMGM=:M>LH?L>KOB<>PA>K>MA>K> BL BGLN??BGM I:B= ER LHE>ER HG MA> MKB:G@NE:MBHG F>MAH=  MA> !HFI:GR >Q:FBG>L G=L:LP>EE:L>GOBKHGF>GM:E?:L IKHOB=>KLBGF>F;>KLABI:G=HK;>G>?BML :G= ABLMHKB<:EL>:LHG:EI:MM>KGLMH>LMBF:M>MA>K>L>KO>K>JNBK>=?HKMA>L>FHGMAL

!E:BFL:=CNLMF>GM>QI>GL>L PABGM>QI>GL>L K>IK>L>GMMA>=K>E:M>=MHMA>MME>F>GM IKH<>LL LNLL :G= :=CNLM L> >QI>GL>L :K> BG= BG MA> !HFI:GRL F:G:@>F>GM:@K>>F>GMPBMA:G:??BEB:M>=>L=BG,HM>

 !:IBM:EBS:MBHG.HEB

2A>!HFI:GRA:LGHMFH=B?B>=BML<:IBM:EBS:MBHGIHEBIKBHKI>KBH=

 .A:KF:<>NMB<:E0>;:M>0><>BO:;E>L

2A>!HFI:GR>LMBF:M>LIA:KF:<>NMB<:EK>;:M>K><>BO:;E>L;:L>=NIHGABLMHKB<:EI:RF>GMMK>G=L :KO:KB:;E>L .A:KF:<>NMB<:EK>;:M>L?HK:JN:KM>K:K>;BEE>=MHMA>O>G=HKPBMABGHG>FHGMAH?MA>MBHGH?MA> JN:KM>K PBMA :GR :=CNLMF>GM MH IK>OBHNLER K>= :FHNGML K>?E>= :M MA> MBF> H? ;BEEBG@  2A> !HFI:GR K>IHKML IA:KF:<>NMB<:EK>;:M>K><>BO:;E>L:LA>:EMA<:K>K><>BO:;E>L .A:KF:;:M>K><>BO:;E>LGHMBG:<PBMA11 . ,H   U $ "   &"  $ #%"   &# HK :K> HO>K  =:RL I:LM =N> :K> GHG:=FBMM>=  EE K>;:M>L:K>IKH<>LL>=:G=L>MME>=FHGMAERPBMA:G:??BEB:M>=>GMBMR BGGMLMHIK>OBHNLER;BEE>=I>KBH=L  2A>IA:KF:<>NMB<:EK>;:M>K><>BO:;E>L:K>FHK>?NEER=BL=BG,HM>

 .K>FBNFL:G= FHNGML"N>:G=3GI:B=

.K>FBNFK>O>GN>?HKIK>I:B=A>:EMAHK=>GM:E<:K>IKH=N=:LBGBGMA>FHGMABGPABGKHEE>>L:K> >GMBME>= MH A>:EMA HK =>GM:E <:K> L>KOB<>L  .K>FBNFL = ;>?HK> MA> >??> I>KBH= :K> K>IHKM>= :L IK>FBNFL K><>BO>=BG:=O:G<> .K>FBNFLK>E:M>=MHNG>QIBK>=K:@>I>KBH=L:K>K>IHKM>=:LNG>:KG>=IK>FBNFL:G= :K>BG=BG:@@K>@:M>A>:EMAIHEBL>KO>LBGMA>1M:MNMHKR1M:M>F>GMLH?*B:;BEBMB>L !:IBM:E:G=1NKIENL

,HG:=FBMM>= :FHNGML FBNFL =N> :G= NGI:B= @K>:M>K MA:G  =:RL I:LM =N>  PBMA MA> >Q<>IMBHG H? :FHNGML=N>NG=>K@HO>KGF>GMBGLNK>=IE:GL PAB:=FBMM>=:LL>MLNG=>K<>KM:BGL 'G:==BMBHG ?HK :GRK?HKPABIK>FBNFL=N>:G=NGI:B=@K>:M>KMA:G=:RLI:LM=N>BLFHK>MA:G:=>FBGBFNLIHKMBHGH? MA>>GMBK>;:E:G<>H?IK>FBNFL=N>:G=NGI:B=?HKMA:MK MA>>GMBK>;:E:G<>H?IK>FBNFL=N>:G=NGI:B=?HKMA:M

26.2            

      

K BL GHG:=FBMM>=  +:G:@>F>GM :ELH I>K?HKFL : LI>OB>P H? :<= HG MA> K>LNEML H? MA> K>OB>P :==BMBHG:E:FHNGMLF:R;>GHG:=FBMM>= 3G:FHNGML:K>@>G>K:EERPKBMM>G H??:G==MHK>O>GN> BGMA>I>KBH=BGPABKK>M>=:G=:@K>>=MH;RMA>KK>MKH:G MA>:<M>KFBG>=MH;>NG;RMA>!HFI:GR

2AKHN@A MA> !HFI:GRZL +>=B<:K> =O:GM:@> .:KM " :GGN:E  !HFI:GR K><>BO>L FHGMAER IK>FBNF I:RF>GML ?KHF !+1 :G= F>F;>KL  :L =>M>KFBG>= ;R MA> !HFI:GRZL :GGN:E ;B= IKH<>LL  2A> !HFI:GR K>LMA>K>O>GN>K>E:M>=MHMA>!+1KMA>M>KFH?BML:GGN:E

2A>!+1I:RF>GMBLLN;C>!+1KBLD=?HK :L : K>MKHLI>ER K:M>=  PBMA 11 . ,H    $" #!$&( $ $"$#  0><>BO:;E>L K>E:M>= MH MA> !+1 KBLD  BG= BG :<= K>MKHLI> IK>FBNFL :G= =>M>KFBG:MBHGHGMA>1M:MNMHKR1M:M>F>GMH? LL>ML

2A>!HFI:GRZL!+1I:RF>GMBL:ELHLN;C>!+1KBLD:=CNLMF>GMIKH<>LL?HK>:F;>K PAB= ?HK :L : =>M>KFBG:MBHG BG :< PBMA 11 . ,H    0><>BO:;E>L K>E:M>= MH MA> !+1 KBLD :=CNLMF>GM IKH<>LL :K> BG= BG :<= K>MKHLI> IK>FBNFL :G= =>M>KFBG:MBHG HG MA> 1M:MNMHKR1M:M>F>GMH? LL>ML

  @@K>@:M>&>:EMA!E:BF0>L>KO>L

2A>K>L>KO>?HK?NMNK>GM;>G>?BMLBGLMA>>LMBF:M>=KOB<>LMA:MPBEEMH;>BG=:?M>K MA>1M:MNMHKR1M:M>F>GMLH?*B:;BEBMB>L !:IBM:E:G=1NKIENL=:M>B?MA>!HFI:GRBLH;EB@:M>=MHI:R?HKLNKOB<>LBG :<PBMA@NE:MHKRK>JNBK>F>GML 2A>L>;:E:G<>L:K>K>=BG:@@K>@:M>A>:EMAL>KO>LBGMA>1M:MNMHKR1M:M>F>GMLH?*B:;BEBMB>L !:IBM:E:G=1NKIENL:G=:K>>LMBF:M>=NLBG@:I>K<>GM:@>H?GM AHLIBM:E:G=F>=B<:E=HGMA>!HFI:GRLABLMHKB<:EQI>KB>G<>

 'GO>LMF>GM'G"N>:G= <=

<=BGO>LMF>GMBGK>LM 'GM>K>LMBLK>=HG:G:<G=L:K> K>=:L>:KG>=HGMA>>Q =BOB=>G==:M> "N>:G=:<=BGBLGHMK>=HG: ;HG=LBG=>?:NEM:G=;  ;HG=L=>EBGJN>GMFHK>MA:G=:RLHKPA>K>K>LMBLBFIKH;:;E>  M"><>F;>K :G= MA> !HFI:GR=B=GHMA:O>:GRGHG:=FBMM>=BGO>LMF>GMBG=N>:G=:<= 

 !HO>K>=:G=3GK>=#QI>GL>L:G=0>E:M>=*B:;BEBMB>L

!HO>K>=>QI>GL>L:G=K>E:M>=EB:;BEBMB>LK>IK>L>GM:EMA<:K>>QI>GL>L?HKPABF;>KBLGHMK>LIHGLB;E>BG MA>>O>GMH?MA>BGLHEO>G!HFI:GR 3GK>=>QI>GL>L:G=K>E:M>=EB:;BEBMB>LK>IK>L>GM!HFI:GR ?HKA>:EMA<:K>L>KOB<>LMA:M:K>MA>H;EB@:MBHGH?MA>!HFI:GR:G=?HKPABF;>KF:R:ELH;>EB:;E>BGMA>>O>GMH? MA>!HFI:GRLBGLHEO>G

 $>>L.:B=MHMA>$>=>K:E%HO>KGF>GM;R&>:EMA'GLNK>KL

11 .,H    " "$$ #### $ W11 .,H X K>JNBK>= MA:MMA>:GGN:E?>>;> K>=BG?NEEHG(:GN:KRH?MA>?>>R>:KMA><:E>G=:KR>:KBGPAB:LL>LLF>GMFNLM;>I:B=MHMA>?>=>K:E @HO>KGF>GM BGMA>HI>K:MBG@>QI>GL><:M>@HKRH?@>G>K:E:=FBGBLMK:MBO>>QI>GL>L >Q=>K:EBGM:Q>L:G=  MA:MBG>::KIK><>=BG@:?>>R>:K:K>IHKMBG@>GMBMRIKH K:M:;ER:<;RK>= LNKIENLMHLI>JN:EMHBML>LMBF:M>=LN;L>JN>GM?>>R>:K:LL>LLF>GM 2ABLK>O>KL>=BG?NEEHG(:GN:KRH?MA>?>>R>:K 1>>,HM>?HK=BL H?:EE:FHNGMLK>E:M>=MHMA>:GGN:E?>>?HKMA>!HFI:GR

 2A>.:MB>GM.KHM>!:K> &>:EMA!:K>:G=#=N<:MBHG0>ER MA>W ! X 0BLD =CNLMF>GM

2A> ! >LM:;EBLA>=:I>KF:G>GMKBLD:=CNLMF>GMIKH@K:FMHMK:GL?>K?NG=L?KHFJN:EB?B>=BG=BOB=N:E:G=LF:EE@KHNI BGLNK:G<>IE:GLPBMA;>EHP:O>K:@>KBLDLLMHIE:GLPBMA:;HO>:O>K:@>KBLDLL  :L>=HGMA>KBLDH?MA> !HFI:GRZLJN:EB?B>=IE:GF>F;>KLK>E:MBO>MHMA>:O>K:@>KBLDH?F>F;>KLH?HMA>KJN:EB?B>=IE:GLBG F:KD>ML MA>!HFI:GR>LMBF:M>LBMLNEMBF:M>KBLD:=CNLMF>GMK><>BO:;E>HKI:R:;E>?HKMA>GM<:E>G=:KR>:K:G= K>?E>BFI:GMMHBMLIK>FBNFK>O>GN>BG:<PBMA11 .,H 

 $>=>K:E:G=1M:M>'G:G=.K>FBNF2:Q>L

>MG:'G<  >MG: :G=BMLPAHEER HPG>=LN;LB=B:KB>L:K>BG=BGMA>=?>=>K:EBGM:QK>MNKGH?BML NEMBF:M> I:K>GM :EMA  INKLN:GM MH MA> M>KFL H? : M:Q LA:KBG@ :@K>>F>GM  'G :< PBMA MA> :@K>>F>GM MA>!HFI:GRZLGM?>=>K:E:G=LM:M>BGM:QIKHOBLBHGL:K>@>G>K:EER=:LB?MA>!HFI:GR P>K>?BEBG@:L>I:K:M>?>=>K:E:G=LM:M>BGM:QK>MNKGGMBGM:Q;>G>?BML BGK>LNEMBG@?KHFG>M HI>K:MBG@ EHLL>L  :K> K>= MH MA> >QM>GM >QI>= MH ;> K>:EBS>= BG MA> = K>MNKG  .NKLN:GM MH MA> :@K>>F>GM MA>!HFI:GRA:LMA>>G?HK<>:;E>KB@AMMHK>=>K:E:G=LM:M>BGM:Q>LI:B=BGIKBHKR>:KLBGMA> >O>GMH??NMNK>G>MEHLL>L PABMEHLL>L<:KKB>=?HKP:K=:L:GH??L>MMH?NMNK>G>MBG LN;C>=>K:E:G=LM:M>BGM:Q>L

'GM:Q>L:K>:<=?HKNG=>KMA>:LL>M:G=EB:;BEBMRF>MAH= ">?>KK>=BGM:Q:LL>MLW"2 LX :G=EB:;BEBMB>L W"2*LX K>IK>L>GMMA>>QI>=?NMNK>M:QJN>G<>LH?M>FIHK:KR=B??>K>G<>L@>G>K:M>=;RLM:MNMHKR:<?BG>=BG11 .,H    '# "2 L:G="2*L:K>F>:LNK>=NLBG@>G:=M:QK:M>L>QI>=MH:IIERMH

26.3            

      

M:Q:;E>BGBGMA>R>:KLBGPABM>FIHK:KR=B??>K>G<>L:K>>QI>=MH;>K>K>=HKL>MME>= "2 L:G= "2*L:K>=;RF>:GLH?B=>GMB?RBG@M>FIHK:KR=B??>K>G<>LPABF>:LNK>=NLBG@:;:E:G<>LA>>M:IIKH:K>;RLM:MNMHKR:G=M:Q;:LBL;:E:G<>LA>>ML:K>= !NKK>GMBGM:QK>K:;E>LBG:EEGMBG M:Q>L BGK>LM K>:LHG:;ER>QI>=MH;>K>K>=BG:LN;L>JN>GM:<KBH=

.NKLN:GMMH11 .,H  @KHLL"2 L:K>?BKLMK>=N<>=;R:LM:MNMHKRO:EN:MBHG:EEHP:G<>:=CNLMF>GMMH:G:FHNGMMA:M BLFHK>EBD>ERMA:GGHMMH;>K>:EBS>=W:=CNLM>=@KHLL"2 LX  =CNLM>=@KHLL"2 L:K>MA>G:=FBMM>=BG:G:FHNGM >JN:EMHMA>LNFH?I:K:@K:IAL: ; :G=< ;>EHP

: $>=>K:EBGM:Q>LI:B=BGIKBHKR>:KLMA:M<:G;>K>K>=MAKHN@AEHLL<:KKR;:QBLMBG@M>FIHK:KR =B??>K>G<>L MA:M K>O>KL> =NKBG@ : MBF>?K:F> LIHG=BG@ PBMA 'GM>KG:E 0>O>GN> !H=> W'0!  M:Q EHLL <:KKR;:

; 2A>:FHNGMH?:=CNLM>=@KHLL"2 L :?M>KMA>:IIEB<:MBHGH?I:K:@K:IA: :;HO> >QI>=MH;>K>:EBS>=PBMABG MA>:IIEB<:;E>I>KBH=:G=MA:MBLGH@K>:M>KMA:GMA>:IIEB<:;E>I>K<>GM:@>:L=>M>KFBG>=NLBG@MA>:IIEB<:;E> 0>:EBS:MBHG2AK>LAHE=*BFBM:MBHG2:;E> 2A>:IIEB<:;E>I>KBH=K>?>KLMHMA>GNF;>KH?R>:KLBGPAB"2  PBEE K>O>KL> BG MA> !HFI:GRZL M:Q K>MNKG :G= MA> :IIEB<:;E> I>K<>GM:@> K>?>KL MH MA> I>K<>GM:@> H? MA> !HFI:GRZL LM:MNMHKR <:IBM:E :G= LNKIENL :L K>JNBK>= MH ;> LAHPG HG MA> LM:MNMHKR ;:E:G<> LA>>M :=CNLM>= MH >Q :GR G>M "2 L  >E>LLBG@ >JNBIF>GM :G= HI>K:MBG@ LRLM>F LH?MP:K> :G= :GR G>M IHLBMBO>@HH=PBEEW1M:M!:I#Q"2 X

2A>0>:EBS:MBHG2AK>LAHE=*BFBM:MBHG2:;E>L:EEHP"2 LMH;>:=FBMM>=;:L>=NIHG>BMA>KK>:EBS:MBHGPBMABG R>:KL:G=H?1M:M!:I#Q"2 R>:K:G=H?1M:M!:I#Q"2 HKGH"2 :=FBMM>=INKLN:GMMHMABL I:K:@K:IA; 'G@>G>K:E MA>0>:EBS:MBHG2AK>LAHE=*BFBM:MBHG2:;E>L:EEHPMA>!HFI:GRMH:=FBMFHK>"2 LB? MHM:E"2 L:LK>IHKM>=;RMA>!HFI:GR:K>:LF:EE>KI>K<>GM:@>H?LM:MNMHKR<:IBM:E:G=LNKIENL

< 2A>:FHNGMH?@KHLL"2 L :?M>KMA>:IIEB<:MBHGH?I:K:@K:IAL: :G=; :;HO>MA:M<:G;>H??L>M:@:BGLM>QBLMBG@ @KHLL"2*L 'G:IIERBG@MABLH??L>M MA>!HFI:GRKLMA>KB > HK=BG:KRO>KLNL<:IBM:E H?MA> "2 L:G="2*LLNMMBG@PHNE=;>I>KFBMM>=BGMA>M:QK>MNKGNG=>K>QBLMBG@>G:=?>=>K:EBG M:QE:PL:G=K>@NE:MBHGL:G=MA>K>O>KL:EI:MM>KGLH?M>FIHK:KR=B??>K>G<>L

!A:G@>L BG "2 L :G= "2*L :K> K>= :L : L>I:K:M> GM H? @:BGL :G= EHLL>L BG LNKIENL W!A:G@> BG G>M =>?>KK>=BGM:QX >Q<>IMMHMA>>QM>GM:EEH<:M>=MHLBGNGK>:EBS>=@:BGL:G=EHLL>L !A:G@>LBG"2 L:G= "2*L:EEH<:M>=MHNGK>:EBS>=@:BGL:G=EHLL>L:K>G>MM>=:@:BGLMMA>K>E:M>=LBGNGK>:EBS>=@:BGL:G=EHLL>L:G= :K> K>IHKM>= :L W!A:G@> BG G>M NGK>:EBS>= <:IBM:E @:BGL EHLL>L X  :ELH : L>I:K:M> GM H? @:BGL :G= EHLL>L BG LNKIENL

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

2A>!HFI:GRBLLN;C>FBNFM:Q>LBGO:KBHNLLM:M>L 2A>L>M:Q>QI>GL>LP>K>K>=BG@>G>K:E:=FBGBLMK:MBO> >QI>GL>L BG MA> 1M:MNMHKR 1M:M>F>GML H? 0>O>GN> :G= #QI>GL>L   2A> >QI>GL>L ?HK MA>L> M:Q>L P>K>   :G=  ?HKMA>R>:KL>G=>="><>F;>K :G= K>LI>ER 2A>!HFI:GRA:=:GHO>KI:RF>GMH?IK>FBNF M:Q>LH?  :G=  :M"><>F;>K :G= K>LI>ER PABK>BG=:L:PKBM> BGBGMA> 1M:MNMHKR1M:M>F>GMLH? LL>ML

 0>BGLNK:G<>

'GMA>GHKF:EH?;NLBG>LL MA>!HFI:GRL>>DLMHK>=N<>MA>EHLLMA:MF:R:KBL>?KHF<:M:LMKHIA>LHKHMA>K>O>GML MA:M<:NL>NG?:OHK:;E>NG=>KPKBMBG@K>LNEML:G=MHA>EI;:E:G<>BMLKBLDL:G=<:IBM:E;RK>BGLNKBG@<>KM:BGE>O>ELH?KBLD PBMA HMA>K BGLNK:G<> >GM>KIKBL>L  2A> K>BGLNK:G<> K:@> =H>L GHM K>EB>O> MA> !HFI:GR H? BML IKBF:KR H;EB@:MBHGL  0>BGLNK:G<>IK>FBNFL:G=K>L>KO>LK>E:M>=MHK>BGLNK>=;NLBG>LL:K>:<=?HKHG:;:LBLGMPBMAMAHL>NL>= BG:<HKB@BG:EIHEBLBLLN>=:G=MA>M>KFLH?MA>K>BGLNK:G<>FBNFL:G==>=:G= MA>K>E:M>=NGI:B=K>L>KO>LA:O>;>>GK>IHKM>=:LK>=NL>BM>FL 2A>K>BGLNK:G<>:@K>>F>GML:K>FHK>?NEER =BL=BG,HM>

" %HBG@!HG<>KG

LH?$>;KN:KR  F:G:@>F>GM>O:EN:M>=PA>MA>KMA>K>:K>O>GML K>=BGMA>:@@K>@:M> MA:M K:BL>LN;LM:GMB:E=HN;M:;HNMMA>!HFI:GRZL:;BEBMRMH:L:@HBG@KG:G=F:G:@>F>GMA:L=>M>KFBG>=MA:MBMBL GHMIKH;:;E>MA:MMA>!HFI:GRPBEE;>NG:;E>MHF>>MBMLH;EB@:MBHGL:LMA>R;>=N>PBMABGHG>R>:K:?M>KMA>?BG:GF>GML:K>:O:BE:;E>MH;>BLLN>= +:G:@>F>GMPBEEO:EN:M>MA>!HFI:GRZL:;BEBMRMH:L:@HBG@ KG:G=PBEEM:D>:IIKHIKB:M>::IIKHIKB:M>=BLLB?MA>K>BL:GRBG:GRO>GMLMA:MPHNE=K:BL>LN;LM:GMB:E=HN;M:;HNMMA>!HFI:GRZL:;BEBMRMH:L:@HBG@KG

  <L:G=!HKK>

26.4            

      

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

  NLBG>LL!HF;BG:MBHGL:G=%HH=PBEE

2A>!HFI:GRP:LGHM:I:KMH?:GR;NLBG>LL=MA>LM:MNMHKRINKF>MAH= :LM:MNMHKRF>K@>K :G :LLNFIMBHGK>BGLNK:G<> HK:GBFI:BKF>GMEHLLBGMA>R>:KL>G=BG@"><>F;>K :G=   "BL=-I>K:MBHGL

2A> !HFI:GR =B= GHM A:O> :GR HI>K:MBHGL K><>BOBG@ =BL= HI>K:MBHGL :<:MF>GM =NKBG@ MA> R>:KL >G=BG@ "><>F;>K :G= 

 'GO>LMF>GML

2A>!HFI:GR=B=GHMA:O>:GRFHKM@:@>EH:GL BGSS:GBG>0>:E#LM:M>*H:GL :M"><>F;>K HK

2A>!HFI:GR=B=GHMA:O>:GR=>;MK>LMKNR>:KL>G=BG@"><>F;>K HK

! 2A>!HFI:GR=B=GHMA:O>:GRK>O>KL>FHKM@:@>L:M"><>F;>K HK

" *H:G :=1>L

   .K>I:RF>GM :LLNFIMBHGL ?HK LBG@E> ;:=EH:G ;:= L>L P>K> H;M:BG>= ?KHF BG=NLMKRF:KD>MLHNK<>L

  2A> !HFI:GR =B= GHM K> :GR HMA>K MA:G M>FIHK:KR BFI:BKF>GML W-22'X  HG EH:G ;:= :G= LMKN= L>LBGPAB!HFI:GRA:=MA> BGM>GMMHL>EE  =B=GHMA:O>MA>BGM>GM:G=:;BEBMRMHK>M:BG?HK:I>KBH=H? MBF>LN??BGMMHK>KMA>:FHKMBS>=L>GMO:EN>H?<:LA?EHPL>QI>=MH;>=BLE>LLMA:G MA>:FHKMBS>=L>LBG:<PBMA11 .,H 0    $"%$%"%"$# 11 .,H 0 :M"><>F;>K 

 2A>!HFI:GRA:=GHK>=-22'HGEH:G ;:=:G=LMKN=L>LGMERA>E= BGPABIK>L>GM O:EN>H?<:LA?EHPL>QI>=MH;>=BLE>LLMA:GMA>:FHKMBS>=<>F;>K 

   2A> !HFI:GR A:= GH NGK>:EBS>= EHLL IHLBMBHG HG EH:G ;:= :G= LMKN= L>L A>E= ;R MA> !HFI:GR :M "><>F;>K 

 ,HM:IIEB<:;E>

# 2A>!HFI:GRA:=GH=HEE:KK>INK:@K>>F>GML:G=HKL>LE>G=BG@MK:GL:<>F;>K 

$ 2A>!HFI:GR=B=GHMA:O>:GRK>INK:@K>>F>GMLMK:GL:=?HK:LL>=;HKKHPBG@:M"><>F;>K 

%  2A> !HFI:GR =B= GHM A:O> :GR K>O>KL> K>INK :@K>>F>GML MK:GL:= ?HK :L L>= ;HKKHPBG@ :M "><>F;>K 

& 2A>!HFI:GR=B=GHMA:O>:GRK>INK:@K>>F>GMLMK:GL:=?HK:L:L:E>:M"><>F;>K 

' 2A>!HFI:GR=B=GHMA:O>:GRK>O>KL>K>INK:@K>>F>GMLMK:GL:=?HK:L:L:E>:M"><>F;>K 

( 2A>!HFI:GR=B=GHMA:O>:GRK>:E>LM:M>:M"><>F;>K 

) 2A>!HFI:GR=B=GHMA:O>:GREHP BGAHNLBG@M:Q=BML:M"><>F;>K HK

* 0>LMKB= LL>ML

 0>LMKB=:LL>MLBG=@>= 

26.5            

      

       2HM:E%KHLL 2HM:E%KHLL %KHLL  =FBMM>=  =FBMM>= 2HM:E!NKK>GM  =FBMM>= =FBMM>= ,HG:=FBMM>=  ,HG:=FBMM>=  2HM:E!NKK>GM 7>:K ,HG:=FBMM>=  0>LMKB=MH 0>LMKB= 0>LMKB= 'G:L> 7>:K =FBMM>= 0>LMKB=MH 2HM:E ?KHF!NKK>GM ?KHF.KBHK ">:L>  ,HG:=FBMM>= 0>LMKB= 2HM:E LL>ML =FBMM>= 0>LMKB= LL>M!:M>@HKR 7>:K 7>:K FBGNL  0>LMKB= FBGNL  :  LL>ML; 

: 1N;C>K:EA>E=NG=>KL>G=BG@:@K>>F>GML < 1N;C>INK :@K>>F>GML = 1N;C>O>KL>K>INK :@K>>F>GML > 1N;C>INK :@K>>F>GML ? 1N;C>O>KL> K>INK:@K>>F>GML @ .E:<>=NG=>KHIMBHGMM>KLMHL K>LMKB=:LMHL:E> >QIHLBMPBMALM:M>L             V         D -G=>IHLBMPBMAHMA>KK>@NE:MHKR ;H=B>L E .E>=@>=K:EMH$&*  BGML;:>F>GML F .E>=@>=:LK:EGHM <:IMNK>=BGHMA>K<:M>@HKB>L G -MA>KK>LMKB=:LL>ML H 2HM:E0>LMKB= LL>ML             V         : !HENFG=BOB=>=;R LL>M.:@> !HENFG *BG> ; !HENFG=BOB=>=;R LL>M.:@> !HENFG *BG>

 2A>!HFI:GR=B=GHMA:O>:GR:LL>MLIE>=@>=:LK:EGHM<:IMNK>=BGHMA>K<:M>@HKB>L:M"><>F;>K HK  

 2A>!HFI:GR=B=GHMA:O>:GRHMA>KK>LMKB=:LL>ML:M"><>F;>K HK

 2A>!HFI:GR=B=GHMA:O>:GRK:EK><>BO>=:G=K>?E>=PBMABGBML?BG:GF>GML:M"><>F;>K 

+ 2A>!HFI:GR=B=GHMA:O>:GRPHKDBG@<:IBM:E?BG:G<>BGO>LMF>GML:M"><>F;>K 

,   2A> !HFI:GR =B= GHM A:O> :GR H??L>MMBG@ :G= G>MMBG@ H? =>KBO:MBO>  K>INK :G= K>O>KL> K>INK  :G= L>L ;HKKHPBG@:G=L>LE>G=BG@:LL>MLHKEB:;BEBMB>L:M"><>F;>K 

- 2A>!HFI:GR=B=GHMA:O>:GR%'L>L:M"><>F;>K HK

. 2A>!HFI:GR=B=GHMA:O>:GRLAHKML:E>LPBMABGMA>K>IHKMBG@I>KBH=

/ .K>I:RF>GM.>G:EMR:G= <<>E>K:MBHG$>>L:M"><>F;>K 

.K>I:RF>GM.>G:EMR:G= <<>E>K:MBHG$>>L %>G>K:E <KH?!31'.L    @@K>@:M> FHNGMH?'GO>LMF>GM'G   

 (HBGM4>GMNK>L .:KMG>KLABIL :G=*BFBM>=*B:;BEBMR!HFI:GB>L

2A>!HFI:GR=B=GHMA:O>:GRCHBGMO>GMNK>L I:KMG>KLABIL HKEBFBM>=EB:;BEBMRLMA:M>Q<>>=>=H?BML:=FBMM>= :LL>ML:M"><>F;>K HK

  2A> !HFI:GR =H>L GHM A:O> :GR BFI:BK>= BGO>LMF>GML BG CHBGM O>GMNK>L  I:KMG>KLABIL  HK EBFBM>= EB:;BEBMR L :M "><>F;>K HK 

 'GO>LMF>GM'G

"N>:G=:<=BGP:L>Q=?KHFLNKIENLHGMA>?HEEHPBG@;:L>L

HG=L PA>K>K>LMBLNG<>KM:BG 

26.6            

      

2A>K>P:LGH:FHNGM>Q=:M"><>F;>K HK 

 ">KBO:MBO>'GLMKNF>GML

2A>!HFI:GR=B=GHMA:O>:GR=>KBO:MBO>BGLMKNF>GML:M"><>F;>K HK 

 'G2:Q>L

 2A>GMLH?MA>G>M"2 LK>=BGMA>!HFI:GRL1M:MNMHKR1M:M>F>GMLH? LL>ML:G=*B:;BEBMB>L !:IBM:E :G=1NKIENL:K>:L?HEEHPL

  !A:G@>          !HE   !HE   !HE   !HE   !HE   -K=BG:KR !:IBM:E 2HM:E -K=BG:KR !:IBM:E 2HM:E -K=BG:KR !:IBM:E 2HM:E : %KHLL">?>KK>=2:Q LL>ML                              ; 1M:MNMHKR4:EN:MBHG EEHP:G<> =CNLMF>GM  V  V  V  V  V  V  V  V  V < =CNLM>=%KHLL">?>KK>=2:Q LL>ML: ;                                   = ">?>KK>=2:Q LL>ML ,HG:=FBMM>=      V          V           V      > 1N;MHM:E,>M =FBMM>= ">?>KK>=2:Q LL>M< =                                 ? ">?>KK>=2:Q*B:;BEBMB>L                            @ ,>M =FBMM>=">?>KK>=2:Q LL>M,>M">?>KK>=2:Q *B:;BEBMR > ?                              

 2A>:FHNGMH?:=FBMM>=@KHLL"2 L:=FBMM>=NG=>K>:GMH?11 .,H 

  !A:G@>          !HE   !HE   !HE   !HE   !HE   -K=BG:KR !:IBM:E 2HM:E -K=BG:KR !:IBM:E 2HM:E -K=BG:KR !:IBM:E 2HM:E =FBLLBHG!:EGML 11 .,H  $>=>K:E'G2:Q>L.:B='G .KBHK7>:KL0>K:;E> : 2AKHN@A*HLL!:KKR;:

=%KHLL">?>KK>=2:Q LL>ML#QI>=2H > 0>:EBS>=#Q FHNGM-?">?>KK>=2:Q LL>ML$KHF: :;HO>  ?M>K IIEB<:MBHGH?MA>2AK>LAHE= *BFBM:MBHG 2A>*>LL>KH? ; ; :G=;  >EHP      V         V          V       =CNLM>=%KHLL">?>KK>= 2:Q LL>ML#QI>=MH;> 0>:EBS>=$HEEHPBG@MA> :E:G<>1A>>M":M>      V         V          V       =CNLM>=%KHLL">?>KK>= 2:Q LL>ML EEHP>=I>K *BFBM:MBHG2AK>LAHE=  66 66     66 66     66 66      =CNLM>=%KHLL">?>KK>=2:Q LL>ML#Q FHNGM-?">?>KK>=2:Q LL>ML$KHF: :G=;  :;HO> -??L>M;R%KHLL < ">?>KK>=2:Q*B:;BEBMB>L                              ">?>KK>=2:Q LL>ML =FBMM>= :LMA>K>LNEMH?:IIEB<:MBHGH? 11 .,H  2HM:E:   = ;  <                            



  : 0:MBH.>K<>GM:@>3L>=2H">M>KFBG>0>KR.>KBH= G=2AK>LAHE=*BFBM:MBHG FHNGM      ; FHNGM-? =CNLM>=!:IBM:E G=1NKIENL3L>=2H">M>KFBG>0>KR.>KBH= G=2AK>LAHE=*BFBM:MBHG'G;  ;HO>         

 2A>BFI:@B>LBL:L?HEEHPL

26.7            

      

  !A:G@>       !HE   !HE   -K=BG:KR !:IBM:E -K=BG:KR !:IBM:E -K=BG:KR !:IBM:E 'FI:@B>L

: ">M>KFBG:MBHGH?:=CNLM>=@KHLL=>?>KK>=M:Q:LL>ML:G=G>M:=FBMM>= =>?>KK>=M:Q:LL>ML ;RM:QK:L:I>K<>GM:@>   =CNLM>=%KHLL"2 L:FHNGM?KHF,HM> <                      .>K<>GM:@>H?:=CNLM>=@KHLL"2 L;RM:QK:MMKB;NM:;E> MHMA>BFI:@B>L V V V V V V  ,>M =FBMM>= =CNLM>=%KHLL"2 L:FHNGM?KHF,HM> >                       .>K<>GM:@>H?G>M:=FBMM>=:=CNLM>=@KHLL"2 L;RM:QK :=FBMM>=;><:NL>H?MA>BFI:@B>L V V V V V V

; "HMA>!HFI:GRYLM:Q IE:GGBG@LMK:M>@B>LBGMA>NL>H?K>BGLNK:G<> 7>L89,H869

2A>K>:K>GH"2*LMA:MP>K>GHMK>=:M"><>F;>K HK 

! !NKK>GMBGM:Q>LBG=?HEEHPBG@F:CHKGML

26.8            

      

   !HE    !NKK>GM'G2:Q   !A:G@> : $>=>K:E            ; $HK>B@G  V  V  V < 1N;MHM:E            = $>=>K:EBGM:QHGG>M<:IBM:E@:BGL           > 3MBEBS:MBHGH?<:IBM:EEHLL<:KKR ?HKP:K=L  V  V  V ? -MA>K  V  V  V @ $>=>K:E:G=?HK>B@GBGM:Q>LBG=           

 ">?>KK>=2:Q LL>ML : -K=BG:KR  "BLL           3G>:KG>=IK>FBNFK>L>KO>         .HEBKK>L>KO>L  V  V  V  'GO>LMF>GML  V  V  V  ">?>KK>=:K=BOB=>G=L:<= LL>ML            !HFI>GL:MBHG:G=;>G>?BML:<GLBHG:<<>BO:;E>L GHG:=FBMM>=            ,>MHI>K:MBG@EHLL<:KKR ?HKP:K=  V         2:Q=BM<:KKR ?HKP:K=  V  V  V  -MA>KBGFLH?MHM:EHK=BG:KRM:Q:LL>ML               1N;MHM:E             ; 1M:MNMHKRO:EN:MBHG:EEHP:G<>:=CNLMF>GM  V  V  V < ,HG:=FBMM>=              = =FBMM>=HK=BG:KR=>?>KK>=M:Q:LL>ML: ; <             > !:IBM:E  'GO>LMF>GML           ,>M<:IBM:EEHLL<:KKR ?HKP:K=  V  V  V  0>:E>LM:M>  V  V  V  -MA>KBGFLH?MHM:EHK=BG:KRM:Q:LL>ML   V  V  V  1N;MHM:E          ? 1M:MNMHKRO:EN:MBHG:EEHP:G<>:=CNLMF>GM  V  V  V @ ,HG:=FBMM>=  V  V  V A =FBMM>=<:IBM:E=>?>KK>=M:Q:LL>ML> ? @           B =FBMM>==>?>KK>=M:Q:LL>ML= A            

 ">?>KK>=2:Q*B:;BEBMB>L : -K=BG:KR  'GO>LMF>GML           $BQ>=:LL>ML  V  V  V  ">?>KK>=:G=NG=IK>FBNF  V  V  V  .HEBKK>L>KO>L  V  V  V  -MA>KBGFLH?MHM:EHK=BG:KRM:QEB:;BEBMB>L            1N;MHM:E          ; !:IBM:E  'GO>LMF>GML           0>:E>LM:M>  V  V  V  -MA>KBGFLH?MHM:E<:IBM:EM:QEB:;BEBMB>L   V  V  V  1N;MHM:E          < ">?>KK>=M:QEB:;BEBMB>L: ;            ,>M=>?>KK>=M:Q:LL>MLEB:;BEBMB>LB <            

2A>BGG>M=>?>KK>=BGM:Q>LBL=H?MA>?HEEHPBG@

  !A:G@> 2HM:E">?>KK>=2:Q LL>ML             2HM:E">?>KK>=2:Q*B:;BEBMB>L             ,>M">?>KK>=2:Q LL>ML*B:;BEBMB>L             2:Q#??>:EBS>=%:BGL*HLL>L    !A:G@>BG,>M">?>KK>='G2:Q    

26.9            

      

2A>K> P:L GH O:EN:MBHG :EEHP:G<> :=CNLMF>GM MH @KHLL "2 L :L H? "><>F;>K    HK   2A> !HFI:GR ;:L>L BML >LMBF:M>LH?MA>?NMNK>K>:EBS:MBHGH?"2 LIKBF:KBERHGABLMHKB<M:Q:;E>BG:G=>QBLMBG@"2*L 

"   2A> IKHOBLBHG ?HK ?>=>K:E BG M:Q>L BL =B??>K>GM ?KHF MA:M PAB H;M:BG>= ;R :IIERBG@ MA> LM:MNMHKR ?>=>K:E BGM:QK:M>MHBG;>?HK>BGM:Q>L 2A>BM>FL<:NLBG@MABL=B??>K>G<>P>K>:L?HEEHPL

 #??>2:Q0:M>  #??>2:Q0:M> .KHOBLBHG=:MLM:MNMHKRK:M>           

&>:EMABGLNK>K?>>       V   2K:GL?>KIKBGM               2:Q >Q>FIMBGM>K>LM               !A:G@>BGGHG:=FBMM>=:LL>ML           .KBHKR>:KMKN> NI             -MA>KI>KF:G>GMBM>FL       V   #QIBK:MBHGH?G>MHI>K:MBG@EHLL             -MA>K          2HM:E           

$>=>K:E:G=?HK>B@GBGM:Q>LBG=            !A:G@>BGG>M=>?>KK>=BGM:Q>L           2HM:ELM:MNMHKRBGM:Q>L           

2A>MK:GL?>KIKBGM:EEHPLM:QI:R>KLMH:IIER=B??>K>GMF>MAH=LMHIKB<>GMI>KBH=BGM>KKOB<>L:M :KFZL E>G@MA IKB<>L B >  IKB<>L :M PABE:M>= >GMBMB>L PHNE= ;> PBEEBG@ MH MK:GL:LNEML BG : I>KF:G>GM =>=NIHKMBG@INKIHL>L 

#

  M"><>F;>K MA>!HFI:GRA:=GHG>M<:IBM:EEHLL<:KKR?HKP:K=LHKG>MHI>K:MBG@EHLL<:KKR?HKP:K=L?HKM:Q INKIHL>L  M "><>F;>K     MA> !HFI:GR A:= GH G>M <:IBM:E EHLL <:KKR?HKP:K=L :G= G>M HI>K:MBG@ EHLL <:KKR?HKP:K=LH? >QIBKBG@MAKHN@AMA>R>:K

   2A> :FHNGM H? ?>=>K:E BG M:Q>L BG= MA:M BL :O:BE:;E> ?HK K>GM BG MA> >O>GM H? ?NMNK> G>M EHLL>L BL :L ?HEEHPL

7>:K -K=BG:KR !:IBM:E 2HM:E               V  V  V 1MN; ,   V  V 2HM:E           

 2A>!HFI:GR=B=GHMK>IHKM:GR=>IHLBML:L:=FBMM>=:LL>MLNG=>K'GM>KG:E0>O>GN>!H=>1><>F;>K  :G=

$ 

  M"><>F;>K  MA>!HFI:GRL$>=>K:E'G2:Q0>MNKGP:L=PBMAMA>?HEEHPBG@>GMBMB>L

!K>=>GMB:EL'G< !!#,"-',130 ,!#!-+. ,7 !1 &>:EMA+:G:@>F>GM 'G< "+',!- 'G< =FBGBLMK:MBO>#GM>KIKBL>L 'G< =O:G<>=!:K>1MG: >MM>K&>:EMA'G< %>HK@B:

>MG: >MM>K&>:EMA'G< ,( >MG: >MM>K&>:EMA'G< ,7 >MG: >MM>K&>:EMA'G< -& >MG: >MM>K&>:EMA'G< 2>GG>LL>> >MG: >MM>K&>:EMAH?!:EB?HKGB: 'G< >MG: >MM>K&>:EMAH?$EHKB=: 'G< >MG: >MM>K&>:EMAH?'EEBGHBL'G< >MG: >MM>K&>:EMAH?):GL:L'G< >MG: >MM>K&>:EMAH?)>GMN!H >MG: >MM>K&>:EMAH?+BMG: >MM>K&>:EMAH?+BLLHNKB**! >MG: >MM>K&>:EMAH?,>O:=:'G< >MG: >MM>K&>:EMAH?,HKMA!:KHEBG: 'G< >MG: >MM>K&>:EMAH?-DE:AHF:'G< >MG: >MM>K&>:EMAH?2>Q:L 'G< >MG: >MM>K&>:EMAH?5:LABG@MHG 'G< >MG: >MM>K&>:EMA.K>FB>K.E:G++ ''G< >MG: >MM>K&>:EMA 'G< !HGG>MG: >MM>K&>:EMA 'G< * >MG: >MM>K&>:EMA 'G< . >MG:">GM:E'G< ,>P(>KL>R >MG:">GM:E'G< 2>Q:L >MG:">GM:EH?!:EB?HKGB: 'G< >MG:$EHKB=: 'G<

26.10            

      

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

!HK:F&>:EMA<:K>!HKIHK:MBHGH?%K>:M>K,>P7HKD !HK:F&>:EMA<:K>!HKIHK:MBHGH?'G=B:G: !HK:F&>:EMA<:K>!HKIHK:MBHGH?+:LL:MML !HK:F&>:EMA<:K>!HKIHK:MBHGH?+BLLBLLBIIB !HK:F&>:EMA<:K>!HKIHK:MBHGH?,>O:=: !HK:F&>:EMA<:K>!HKIHK:MBHGH?,HKMA2>Q:L

!HK:F&>:EMA<:K>!HKIHK:MBHGH?,HKMA>KG!:EB?HKGB: !HK:F&>:EMA<:K>!HKIHK:MBHGH?1HNMA>KG!:EB?HKGB:

!-0 +&# *2&! 0#!-0.-0 2'-,-$1-32�,$*-0'" !HK:F&>:EMA<:K>!HKIHK:MBHGH?3M:A !HO>GMKR!HGLNF>K =O:GM:@> 'G< !HO>GMKR&>:EMA:G=*B?>'GLNK:G<>!HFI:GR !HO>GMKR&>:EMA!:K>,:MBHG:E <GMKR&>:EMA!:K>,:MBHG:E,>MPHKD 'G< !HO>GMKR&>:EMA!:K>H?'EEBGHBL 'G< !HO>GMKR&>:EMA!:K>H?):GL:L 'G< !HO>GMKR&>:EMA!:K>H?+BLLHNKB 'G< !HO>GMKR&>:EMA!:K>H?,>;K:LD: 'G< !HO>GMKR&>:EMA!:K>H?4BK@BGB: 'G< !HO>GMKR&>:EMA!:K>H?5>LM4BK@BGB: 'G< !HO>GMKR&>:EMA.E:GH?$EHKB=: 'G< !HO>GMKR&>:EMA!:K>+:G:@>F>GM!HKIHK:MBHG !HO>GMKR.K>LF>GM1>KOB<>L 'G< !HO>GMKR0>A:;BEBM:MBHG1>KOB<>L 'G< !HO>GMKR2K:GLIE:GM,>MPHKD 'G< !41 -!!HKIHK:MBHG !41 0!*'%&2 ',! !41! 0#+ 0)',"#+,'27*2" !41$-0#'%, ',!  !41&# *2&!-0.-0 2'-, !41',2#0, 2'-, * * * ! !41.& 0+ !7',! !41.0!>GM>K 'G< !41061#04'!#1 ',!  !41550# ',! "#* 5 0#!41.& 0+ !7 * * ! ">E:P:K>.ARLB 'G< # 2 ',! #K@>K1N; 'G< #!)#0"!-0.-0 2'-,-$$* ',! #O>K@K>>G.A:KF:<>NMB<:EH?!:EB?HKGB: 'G< $BKLM&>:EMA%KHNI!HKI $BKLM&>:EMA*B?>:G=&>:EMA'GLNK:G<>!HFI:GR $EHKB=:&>:EMA.E:G =FBGBLMK:MHKL **! %KHNI">GM:E1>KOB<>H?+:KRE:G= 'G< %KHNI">GM:E1>KOB<> 'G< &>:EMA:G=&NF:G0>LHNK<>!>GM>K 'G< &>:EMA":M:+:G:@>F>GM1HENMBHGL 'G< &>:EMA0> 'G< &>:EMA LLNK:G<>.>GGLREO:GB: 'G< &-*'" 7!41 * * ! '-5 !41.& 0+ !7 * * ! (&! =!:K>!HHK=BG:MHKL 'G< + 07* ,"!41.& 0+ !7 * * ! + 11 !&31#221!41.& 0+ !7 ',! +>=5HKE= GM:E&>:EMA LLHL 'G< +>GM:E&>:EMA,>MPHKDH?,>P7HKD'. 'G< +>KBM:BG&>:EMA 'G< +&,>M*B?>:G=&>:EMA'GLNK:G<>!HFI:GR +&,>MH?$EHKB=: 'G< +',32#!*','!"' %,-12'!-$'**',-'1 **! +BGNM>!EBGB<.ARLBH?2>Q:L +BGNM>!EBGB<2>E>A>:EMA1>KOB<>LH?2>Q:L LLH:EMA<:K>H?)>GMN:EMA<:K> **! ,>B@A;HK!:K>&HE=BG@L 'G< ,>B@A;HK!:K>.A:KF:KOB<>L 'G< ,>B@A;HK!:K>1>KOB<>L!HKIHK:MBHG ,>B@A;HK!:K> 'G< ,B:@:K:0> 'G< ,-02&! 0-*', !41.& 0+ !7 * * ! -)* &-+ !41.& 0+ !7 * * ! -FGB<:K>&HE=BG@!HFI:GR -FGB<:K> 'G< .:R$E>Q&HE=BG@L 'G< .:R$E>Q1RLM>FL31 'G< .#,,17*4 ,' *'$#',130 ,!#!-+. ,7 .>K?HKF:Q 'G< .K>G>?BM1>KOB<>L 'G< .KBF>,>M 'G< .KH=B@R&>:EMA%KHNI 'G< .KH?>LLBHG:E0BLD+:G:@>F>GM 'G< 0>LHNK<>L?HK*BOBG@ **! 0#20 ! ',!  0'!&+-,"&#'%&21 !/3'1'2'-,!-0. 1K G=>KLHG+>=B<:E =FBGBLMK:MHKL'G< 1'*4#01!0'.2',130 ,!#!-+. ,7 1)7 !/3'1'2'-,**! 2+>=B<:E 'G< 2#,,#11##!41.& 0+ !7 * * !

26.11            

      

2A>4:LJN>S%KHNI 'G< 3 1 &>:EMA<:K>.KHI>KMB>L 'G< 3 !&-*"',% ',! 4'0%',' !41.& 0+ !7 * * ! 5HKD$:FBER >G>?BML 'G<

  L>QIE:BG>=BG,HM> MA>!HFI:GRI:KMBLBG:M:QLA:KBG@:@K>>F>GMPBMABMLI:K>GM:G=:??BEB:M>L

% 2A>!HFI:GR=H>LGHMA:O>:GRM:QEHLLGL?HKPAB:LHG:;ERIHLLB;E>MA:MMA>MHM:EEB:;BEBMRPBEE LB@GB?B<:GMERBG:L>PBMABGMP>EO>FHGMALH?MA>K>IHKMBG@=:M>

& 2A>!HFI:GRP:LGHMLN;C>0>I:MKB:MBHG2K:GLBMBHG2:Q:M"><>F;>K :G=

' 2A>!HFI:GR=B=GHMK>:GR@KHLL EM>KG:MBO>+BGBFNF2:Q=BM:M"><>F;>K :G=

 'G?HKF:MBHG!HG<>KGBG@.:K>GM 1N;LB=B:KB>L  ??BEB:M>L :G=-MA>K0>E:M>=.:KMB>L

:G=  

2K:GL:MP>>GMA>!HFI:GR:G=BMLI:K>GM LN;LB=B:KB>L:G=:??BEB:M>L>QBGLNK:G<>MK:GL: MK:GL:LL MA:G \ H?  H? MA> !HFI:GRZL MHM:E :=FBMM>= :LL>ML :G=

"><>F;>K 

LL>MLK><>BO>=;RBGLNK>K LL>MLMK:GL?>KK>=;RBGLNK>K #QIE:G:MBHGH? ,:F>H?K>IHKMBG@ 1M:M>F>GM 1M:M>F>GM 1M:M>F>GM 1M:M>F>GM ":M>H?MK:GL:GMBMR ,:F>H?:??BEB:M> O:EN> =>L =>LGMKR&>:EMA >MG:&>:EMA "><>F;>K  "BOB=>G= !:K>H?):GL:L 'G< &HE=BG@L **!     !:LA

2A>!HFI:GR=B=GHMA:O>:GRMK:GL:<>F;>K 

! 2A>!HFI:GR=B=GHMA:O>:GRMK:GL:E:M>=I:KMB>LPAH:K>GHMK>IHKM>=HG1=NE>7:M"><>F;>K 

"  M"><>F;>K :G= MA>!HFI:GRA:=MA>?HEEHPBG@:FHNGML=N>MH:G==N>?KHF:??BEB:M>L PABQ :FHNGML K>E:M>= MH IA:KF:;:M> MK:GL:= FHK> ?NEER BG ,HM>  :G= MA> !HFI:GRL K>BGLNK:G<> :@K>>F>GMLB?:IIEB<:;E>

"><>F;>K  

FHNGML=N>MH:??BEB:M>L >MG:&>:EMA+:G:@>F>GM **!       !HO>GMKR&>:EMA:G=*B?>'GLNK:G<>!HFI:GR  V    %KHNI">GM:E1>KOB<>L'G<  V    2HM:E=N>MH:??BEB:M>L      

 M"><>F;>K :G= MA>!HFI:GRA:=GH:FHNGML=N>?KHF:??BEB:M>L

2A>M>KFLH?L>MME>F>GMK>JNBK>MA:MMA>L>:FHNGML;>L>MME>=PBMABG=:RL:?M>KMA>>G=H?MA><:E>G=:KJN:KM>K 

#  LH?:G=?HKMA>R>:KL>G=>="><>F;>K :G= MA>!HFI:GRA:=MA>?HEEHPBG@LB@GB?B<:GMMK:GL:L

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

2A>!HFI:GRBL:I:KMRMH:G:@K>>F>GMPABG:;E>LMA>!HFI:GRMHK><>BO>F:GN?:KLIA:KF:;:M>L?KHF &+ NG=>KPAB!HFI:GRK>FBML:I>K<>GM:@>H?BML>:KG>=IA:KF:<>NMB<:EK>;:M>LMH &+:L:?>> 2A>!HFI:GR>:KG>= IA:KF:<>NMB<:EK>;:M>LH?  :G=  PABK>K>=:L:K>=N=B<:ELI>ER 2A>!HFI:GRP:L=  PAB=:L:=FBGBLMK:MBO>>QI>GL>L ?HKMA>L>L>KOB<>LBG  2A>!HFI:GRP:LGHM=?HKMA>L>L>KOB<>LBG:L &+P:BO>=?>> 

26.12            

      

2A>L>:@K>>F>GML:ELHIKHOB=>?HKBGM>K>LMHG:EEBGM>KL 'GM>K>LM>:KG>=HG:FHNGML=N>?KHF:??BEB:M>LP:L  BG:G=GHBGM>K>LM>:KG>=HG:FHNGML=N>?KHF:??BEB:M>LBG 'GM>K>LMBG=HG:FHNGML=N>MH:??BEB:M>L P:L BG:G= BG

L >QIE:BG>= BG ,HM>   >MG: :G= BML PAHEER HPG>= LN;LB=B:KB>L  BG !HFI:GR  I:KMB BG : M:Q LA:KBG@ :@K>>F>GMPBMA!41&>:EMA  EE?>=>K:EBGM:QK><>BO:;E>LI:R:;E>L:K>=N>?KHF=N>MH!41&>:EMA

+&,>M1I>KOB<>L **!W+&,>MX :K>E:M>=I:KMR IKHOB=>LF>GM:EA>:EMAL>KOB<>LMHMA>!HFI:GRZLF>F;>KL  2A> !HFI:GR I:RL +&,>M : FHGMAER ?>> ;:L>= HG : .+.+ <:IBM:MBHG K:M>  2A> K:M>L :K> :F>G=>= :GGN:EER :G= MA> :F>G=F>GML:K>:IIKHO>=;RMA>):GL:L">I:KMF>GM 2A>!HFI:GRA:=GHI:RF>GMLMH+&,>MBG :G=I:B= BG <:IBM:MBHG?>>L?HKMA>R>:K>G=>=  K>LI>ER

$  M"><>F;>K  MA>!HFI:GRA:L:@N:K:GMHK:@K>>F>GMPBMA >MG:&>:EMA&HE=BG@L **! 2A>:@K>>F>GMIKHOB=>L MA:M BG MA> >O>GM H? MA> !HFI:GRL BGLHEO>GMG: PBEE I:R :EE >QI>GL>L :G= = ;R MA> !HFI:GR =NKBG@ BGLHEO>GH;EB@:MBHGPBMA>FIEHR>K@KHNIL:G=LN;LKLNGMBEMA>>G=H?MA>LN;LKBH= ?HKPABFBNFLA:O>;>>GK><>BO>=

%  EEHNMLM:G=BG@LA:K>LH?MA>!HFI:GR:K>HPG>=;R >MG:&>:EMA&HE=BG@L **! PAHL>NEMBF:M>I:K>GMBL!41&>:EMA

&  M"><>F;>K  MA>!HFI:GR=B=GHMHPGLA:K>LH?:GNILMK>:FBGM>KF>=B:M>>GMBMRHK!41&>:EMA >BMA>K=BK>

'  M"><>F;>K  MA>!HFI:GR=B=GHMAHE=:GRBGO>LMF>GMLBG:GRLN;LB=B:KR =HK:??BEB:M>=W1! X >GMBMR MA:M>Q<>>=>=H?MA>!HFI:GRZL:=FBMM>=:LL>ML

(  M"><>F;>K  MA>!HFI:GR=B=GHMAHE=:GRBGO>LMF>GMLBG:GRBFI:BK>=1! >GMBMR

)  M"><>F;>K  MA>!HFI:GR=B=GHMAHE=:GRBGO>LMF>GMLBG:GR?HK>B@GBGLNK:G<>LN;LB=B:KB>L

*  M"><>F;>K  MA>!HFI:GR=B=GHMAHE=:GRBGO>LMF>GMLBG:=HPGLMK>:FGHGBGLNK:G<>AHE=BG@

+  M"><>F;>K  MA>!HFI:GR=B=GHMA:O>:GR1! BGO>LMF>GML

,  M"><>F;>K  MA>!HFI:GR=B=GHMA:O>:GRBGO>LMF>GMLBG:GBGLNK:G<>1!

- 2A>!HFI:GR=B=GHMA:O>:GR1! HK11 .,H >GMBMRBGO>LMF>GMLPA>K>MA>!HFI:GRLLA:K>H?EHLL>LBGMA>1!  >Q<>>=LBMLBGO>LMF>GMBGMA>1!

 ">;M

2A>!HFI:GR=B=GHMA:O>:GRBM>FLK>E:M>=MH=>;M BGL:M"><>F;>K  

2A>!HFI:GR=B=GHMA:O>:GR$>=>K:E&HF>*H:G :GD:@K>>F>GML:M"><>F;>K  

  0>MBK>F>GM .E:GL  ">?>KK>= !HFI>GL:MBHG  .HLM>FIEHRF>GM >G>?BML :G= !HFI>GL:M>= ;L>G<>L :G= -MA>K .HLMK>MBK>F>GM >G>?BM.E:GL

2A>!HFI:GR=B=GHMA:O>:K>MBK>F>GMIE:G =>?>KK>=GL:MBHGIE:G HKHMA>KIHLMK>MBK>F>GM;>G>?BMIE:G:M"><>F;>K  HK 

 !:IBM:E:G=1NKIENL "BOB=>G=0>LMKBHK@:GBS:MBHGL

2A>!HFI:GRA:= LA:K>LH?= BLLN>=:G=HNMLM:G=BG@PBMA:I:KO:EN>H?I>KLA:K>:M "><>F;>K :G=

2A>!HFI:GRA:=GHLA:K>LH?IK>?>KK>=LMH=:G=HNMLM:G=BG@:M"><>F;>K :G=

! "BOB=>G=0>LMKB

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

" 2A>!HFI:GRI:B=  :L:G>QMK:HK=BG:KR=BOB=>G=MHBMLI:K>GMHG"><>F;>K  2A>):GL:L">I:KMF>GM :IIKHO>=MABL=BOB=>G=HG"><>F;>K  

2A>!HFI:GR=B=GHMK><>BO>:GR<:IBM:EMNKGLH?<:IBM:EBGHK 

# 5BMABGMA>EBFBM:MBHGLH?! :;HO> MA>K>:K>GHHMA>KK>LMKB=HGMA>IHKMBHGH?MA>!HFI:GRIKH?BMLMA:MF:R;> I:B=:LHK=BG:KR=BOB=>G=LMHMA>LMHK

26.13            

      

$ 2A>K>P>K>GHK>LMKB=HGMA>!HFI:GRZLLNKIENL BGLNKIENLBL;>BG@A>E=

% 2A>!HFI:GRA:=GH:=O:G<>LMHLNKIENLGHMK>I:B=

& 2A>!HFI:GR=B=GHMAHE=:GRLMHL:M"><>F;>K HK

' !A:G@>LBGMA>;:E:G<>LH?LI>IKBHKR>:K:K>=N>MHMA>:<LMBF:M>= ! A>:EMA BGLNK>K?>>LK>=?KHFNG:LLB@G>=?NG=LLNKIENL MH:@@K>@:M>PKBM> BGL?HKLI>=FHK> ?NEERBG,HM> 

(  M"><>F;>K :G= MA>K>P>K>  :G=  K>LI>ER H?NG:LLB@G>=?NG=LMA:MP:LK>IK>L>GM>=HK K>=N<>=;RNGK>:EBS>=@:BGL:G=EHLL>L

) 2A>!HFI:GRA:LGHMBLLN>=:GRLNKIENLGHM>LHK=>;>GMNK>LHKLBFBE:KH;EB@:MBHGL:M"><>F;>K HK

* 2A>!HFI:GR=B=GHMI:KMBBG:GRJN:LB K>HK@:GBS:MBHGL=NKBG@MA>LM:M>F>GMR>:K

+ 2A>!HFI:GR=B=GHMI:KMBBG:GRJN:LB K>HK@:GBS:MBHGLBGMA>I:LMR>:KL

 *B:;BEBMB>L !HGMBG@>GL:G= LL>LLF>GML

2A>!HFI:GR=B=GHMA:O>:GRGMGML:M"><>F;>K HK 

 LL>LLF>GML

%N:K:GMR$NG= LL>LLF>GML

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

2A>!HFI:GR=B=GHMA:O>:GRGM:LL>LLF>GML:M"><>F;>K HK

! 2A>!HFI:GR=B=GHMA:O>:GR@:BGGL:M"><>F;>K HK 

" 2A>!HFI:GR=B=GHMA:O>:GRE:M>=>QMK:LLM>FFBG@?KHFE:PLNBML:M "><>F;>K HK 

# 2A>!HFI:GR=B=GHMA:O>:GRCHBGM:G=L>O>K:EEB:;BEBMR:KK:G@>F>GML:M"><>F;>K HK 

$   4:KBHNL EB:;BEBMB>L :KBL> BG MA> GHKF:E  H? MA> !HFI:GRL ;NLBG>LL :G= A:O> ;>>G K>=  'G MA> HIBGBHG H? F:G:@>F>GM  :GR NEMBF:M> GM EHLL>L PBEE GHM A:O> : F:M>KB:E :=O>KL> >??> !HFI:GRL ?NMNK> K>LNEML H? HI>K:MBHGL:G=?BG:G!HFI:GR MHMA>;>LMH?BMLDGHPE>=@> A:LGH:LL>MLMA:MBMKLBFI:BK>=MA:M:K> GHM:EK>:=RK>=BGMA>!HFI:GRL;HHDL 

2A>!HFI:GRF:BGM:BGLBGLNK:G<>K:@>?HK<>KM:BGEBMB@:MBHG>QIHLNK>LBG:G:FHNGMBM;>EB>O>LBLK>:LHG:;E>

 *>:L>L

2A>!HFI:GR=B=GHMA:O>:GRF:M>KB:EE>:L>H;EB@:MBHGL:M"><>F;>K HK

 'G?HKF:MBHG:;HNM$BG:GGMLPBMA-?? :E:G<>1A>>M0BLD:G=$BG:GGMLPBMA!HG<>GMK:MBHGLH?!K>=BM 0BLD

2A>!HFI:GR=B=GHMA:O>:GR?BG:GGMLPBMAH?? ;:E:G<>LA>>MKBLDHK?BG:GGMLPBMAGMK:MBHGLH? =BMKBLD:M"><>F;>K HK

 1:E> 2K:GL?>K:G=1>KOBML:G=#QMBG@NBLAF>GMLH?*B:;BEBMB>L

2K:GL?>KLH?0><>BO:;E>L0>IHKM>=:L1:E>L

2A>!HFI:GR=B=GHMA:O>:GRMK:GL?>KLH?K><>BO:;E>LK>IHKM>=:LL:E>L?HKMA>R>:KL>G=BG@"><>F;>K HK  2K:GL?>K:G=1>KOBML

 2A>!HFI:GR=B=GHMA:O>:GREH:G>=L>L:M"><>F;>K HK

 :G= 

26.14            

      

2A>!HFI:GR=B=GHMA:O>:GRL>KOBMLHKEB:;BEBMB>L:M"><>F;>K HK

 2A>!HFI:GR=B=GHMA:O>:GRL>=?BG:GML:M"><>F;>K HK

 2A>!HFI:GR=B=GHMA:O>:GRMK:GL?>KLH??BG:GML:<=?HK:LL>=;HKKHPBG@:M"><>F;>K HK 

 2A>!HFI:GR=B=GHMA:O>:GRMK:GL?>KLH?K><>BO:;E>LPBMAK>:M"><>F;>K HK

 2A>!HFI:GR=B=GHMA:O>:GR=HEE:KK>INKHKK>O>KL>K>INK:@K>>F>GML:M"><>F;>K HK

! 5:LA1:E>L

 'GMA>H?MA>!HFI:GRL:LL>MF:G:@>F>GM L>L:K>LHE=:G=K>:=PBMABG=:RLH?MA>L:E>=:M>MH >GA:G<>MA>!HFI:GRLRB>E=HGBMLBGO>LMF>GMIHKM?HEBH

 2A>!HFI:GRA:=GHL>LLHE==NKBG@MA>R>:K?HKMA>R>:K>G=>="><>F;>K :G=K>:=PBMABG =:RLH?MA>L:E>=:M>

 %:BGHK*HLLMHMA>0>IHKMBG@#GMBMR?KHF3GBGLNK>=.E:GL:G=MA>3GBGLNK>=.HKMBHGH?.:KMB:EER'GLNK>=.E:GL

2A>!HFI:GR=B=GHML>KO>:L:G =FBGBLMK:MBO>1>KOB<>L-GER 1- IE:G:=FBGBLMK:MHK?HKNGBGLNK>=:<GM:G=A>:EMA IE:GLHKMA>NGBGLNK>=IHKMBHGH?I:KMB:EERBGLNK>=IE:GL?HKMA>I>KBH=>G=>="><>F;>K 

2A>!HFI:GR=B=GHML>KO>:L:G =FBGBLMK:MBO>1>KOB<>L!HGMK:=:<GM:G= A>:EMAIE:GLHKMA>NGBGLNK>=IHKMBHGH?I:KMB:EERBGLNK>=IE:GL?HKMA>I>KBH=>G=>="><>F;>K 

! +>=B<:K>HK1BFBE:KER1MKN=!HLM :L>=0>BF;NKL>F>GM!HGMK:

 0>O>GN>?KHFMA>!HFI:GRZL+>=B<:K>HKLBFBE:KERLMKN==K>BF;NKL>F>GMR>:K P:L  

  LH?"><>F;>K  MA>!HFI:GRA:LK>=K><>BO:;E>L?KHFMA>?HEEHPBG@I:RHKLPAHL>:<L:K> @K>:M>KMA:GH?MA>!HFI:GRL:FHNGMLK><>BO:;E>?KHFNGBGLNK>=:<GM:G=A>:EMAIE:GLHK 

!>GM>KL?HK+>=B<:K>:G=+>=B<:B=1>KOB<>L   

 'G!HFI:GRZL+>=B<:K>HKLBFBE:KERLMKN==K>BF;NKL>F>GM !HFI:GRA:LK>=:EEHP:G<>:G=K>L>KO>L?HK:=CNLMF>GMH?K>=K>O>GN>L:L:G=B?:IIEB<:;E>

 !+1I>KBH=B<:EERI>K?HKF:N=BMLH?+>=B<:K>K>O>GN>:G=F:RL>>DK>MNKGH?IK>FBNFI:RF>GMLF:=>MHMA>!HFI:GR B? KBLD :=CNLMF>GM ?: GHM IKHI>KER LNIIHKM>= ;R F>=B<:E K> !HFI:GR >LMBF:M>L :G= K>L>KO>L ?HK !+1 :N=BML ;:L>= HG BG?HKF:MBHG :O:BE:;E> :M MA> MBF> MA> >LMBF:M>L :K> F:=>  EMAHN@A MA> !HFI:GR ;>EB>O>LBMF:BGM:BGL:IIKHIKB:M>K>L>KO>L?HKBML>QIHLNK>MHMA>!+1:N=BML :LNEMLKF:M>KB:EER?KHF MAHL>>LMBF:M>L

 "BK>FBNF5KBMM>G.KH=N<>=;R+:G:@BG@%>G>K:E @>GML2ABK=.:KMR =FBGBLMK:MHKL

2A>!HFI:GR=B=GHMA:O>:GRF:M>KB:E=BK>FBNFLPKBMM>GMAKHN@AIKH=N<>=;RF:G:@BG@@>G>K:E:@>GMLHKMABK=I:KMR :=FBGBLMK:MHKL?HKMA>R>:KL>G=>="><>F;>K :G=

 $:BK4:EN>+>:LNK>F>GML

 2A>!HFI:GRA:=GHF:M>KB:E:LL>ML:G=EB:;BEBMB>LMA:M:K>F>:LNK>=:G=K>IHKM>=:M?:BKO:EN>BGMA>?BG:GF>GML :LH?"><>F;>K :G=

 2A>K>P>K>GHF:M>KB:EK>:EBS>=:G=NGK>:EBS>=<:IBM:E@:BGL INKL L:E>L L>MME>F>GML HKMK:GL?>KLBGMHHKHNMH?MA> !HFI:GRL*>O>E?BG:GML=NKBG@HK   2K:GL?>KLBG:G=HNMH?:EEE>O>EL:K>K>=:MMA>>G=H?MA>K>IHKMBG@I>KBH=H?PABMK:GL?>KH<=

 2A>!HFI:GRL?:BKO:EN>F>:LNK>F>GMO:EN:MBHGM>L:K>=>L=BG ;>EHP

 2A>!HFI:GR=B=GHMA:O>:GR=>KBO:MBO>BGLMKNF>GML:M"><>F;>K HK 

2A>?:BKO:EN>LH?MA>!HFI:GRL?BG:GGML:K>;:L>=HGO:EN:MBHGLMA:MBGBGINMLMA:M<:G;>=PBMABG HG>H?MAK>>E>O>ELH?:AB>K:K?HEEHPBG@:K>MA>E>O>ELH?MA>AB>K:K?=>LMRI>H?O:EN:MBHG BG?HKF:MBHGWBGINMLX MA:MJN:EB?B>L:?BG:GMHKEB:;BEBMR?HK>:O>E

T  3G:=CNLM>=JNHM>=IKB<>L?HKB=>GMB<:E:LL>MLHKEB:;BEBMB>LBG:F:KD>ML

26.15            

      

T    'GINML HMA>K MA:G *>O>E  MA:M :K> ;:L>= HG H;L>KO:;E> F:KD>M =:M:  2A>L> BG JNHM>= IKB<>L ?HK LBFBE:K:LL>MLBG:F:KD>ML JNHM>=IKB<>L?HKB=>GMB<:E:LL>MLBGBG:F:KD>ML BGINMLMA:M:K>H;L>KO:;E>MA:M :K>GHMIKB<>LLNK>LMK:M>L:G==BMKBLDL :G=BGINMLMA:M:K>=>KBO>=?KHFHK=;RH;L>KO:;E> F:KD>ML T  ">O>EHI>=?KHFNGH;L>KO:;E>=:M: K>?E>!HFI:GRLHPG:LLNFIMBHGL

$BG:GML:G=EB:;BEBMB>L:K>=;:L>=NIHGMA>EHP>LME>O>EH?BGINMMA:MBLLB@GB?B<:GMMHMA>O:EN:MBHG 5A>G JNHM>=IKB<>LBG:F:KD>ML?HKB=>GMB<:E:LL>ML:G=EB:;BEBMB>L:K>:O:BE:;E> MA>!HFI:GRNL>LMA>L>JNHM>=F:KD>MIKB<>L MH=>M>KFBG>MA>?:BKO:EN>H??BG:GML:G=EB:;BEBMB>L:G=LMA>L>:LL>ML:G=EB:;BEBMB>L:L*>O>E 'GHMA>K<:L>L PA>K>:JNHM>=F:KD>MIKB<>?HKB=>GMB<:E:LL>ML:G=EB:;BEBMB>LBG:G:F:KD>MBL>BMA>KGHM:O:BE:;E>HKGHMH;L>KO:;E> MA> !HFI:GR>LMBF:M>L?:BKO:EN>NLBG@O:EN:MBHGF>MAH=HEH@B>L;:L>=HG:O:BE:;E>:G=H;L>KO:;E>F:KD>MBG?HKF:MBHGHK;R NLBG@ : F:MKBQ IKBE  2A>L> ?BG:GML :G= EB:;BEBMB>L PHNE= MA>G ;> = :L *>O>E   '? JNHM>= F:KD>M IKB<>L:K>GHM:O:BE:;E> MA>!HFI:GR=>M>KFBG>L?:BKO:EN>NLBG@;KHD>KJNHM>LHK:GBGM>KG:E:G:ERLBLH?>:LMF>GMZL ?BG:GK?HKF:G<> :G= <:LA ?EHP IKHC>ML :G= EB:;BEBMB>L F:R ;> = BG *>O>E  >O>G MAHN@AMA>K>F:R;>LHF>LB@GB?B<:GMBGINMLMA:MF:R;>H;L>KO:;E>

2A>O:EN:MBHGF>MAH=L:G=:LLNFIMBHGLNL>=;RMA>!HFI:GRBG>LMBF:MBG@MA>?:BKO:EN>H?=>;ML>L:K>=BL=BG ,HM>

! 2A><:KKRBG@O:EN>L:G=>LMBF:M>=?:BKO:EN>LH?MA>!HFI:GRL?BG:GGML:M"><>F;>K :G=P>K>:L ?HEEHPL

"><>F;>K 

,HM ,>M LL>M .K: @@K>@:M> =FBMM>= 4:EN> !:KKRBG@ 2RI>H?$BG:GGM $:BK4:EN> LL>ML *>O>E *>O>E *>O>E , 4 4:EN>

HG=L 1AHKM2>KF :G=!:LA#JNBO:E>GML                  V  V  V

"><>F;>K 

,HM ,>M LL>M .K: @@K>@:M> =FBMM>= 4:EN> !:KKRBG@ 2RI>H?$BG:GGM $:BK4:EN> LL>ML *>O>E *>O>E *>O>E , 4 4:EN>

HG=L 1AHKM2>KF :G=!:LA#JNBO:E>GML                  V  V  V

'G >O:EN:MBG@ MA> !HFI:GRL F:G:@>F>GM H? BGM>K>LM K:M> :G= EBJNB=BMR KBLD :G= GQIHLNK>L  MA> ?:BK O:EN>L H? :EE :LL>ML:G=EB:;BEBMB>LLAHNE=;>M:D>GBGMHK:MBHG GHMHGERMAHL>IK>L>GM>=:;HO>

" 2A>!HFI:GR=B=GHMA:O>:GR?BG:GGMLPA>K>BMP:LGHMIK:MH>LMBF:M>MA>?:BKO:EN>

# 2A>!HFI:GRA:LGHM>E>=MHNL>MA>G>M:LL>MO:EN>IK:QI>=B>GMMH?:BKO:EN>MHF>:LNK>BMLBGO>LMF>GML

 -MA>K'M>FL

3GNLN:EHK'G?K>JN>GM'M>FL

2A>!HFI:GR=B=GHMA:O>:GRNGNLN:EHKBG?K>JN>GMBM>FL?HKMA>R>:KL>G=>="><>F;>K :G=

0BLD!HKKB=HK

2A> ! >LM:;EBLA>=:M>FIHK:KRKBLDQIBK>=:MMA>>G=H? ?HKJN:EB?B>=BG=BOB=N:E:G=LF:EE @KHNI A>:EMA BGLNK:G<> IE:GL  3G=>K MABL IKH@K:F  A>:EMA BGLNK:G<> L P>K> MH F:D> I:RF>GML MH  HK K><>BO> I:RF>GML?KHF MA>3 1 ">I:KMF>GMH?&>:EMA:G=&NF:G1>KOB<>L&&1 ;:L>=HGMA>BKK:MBHH?:EEHP:;E>M ?BG>=;RMA> !

!41&>:EMA MH@>MA>KPBMABMLLN;LB=B:KB>L ?BE>=:E:PLNBMBG N@NLMMHK>KMA>:IIKHQBF:M>ERFBEEBHGBMP:L HP>=NG=>KMA> ! ZLKBLD>GLM:R>=I>G=BG@MA>1NIK>F>!HNKM=> 3 1 1NIK>F>!HNKMKNE>=MA:MA>:EMABGLNK:G<>LF:RLN>MA>?>=>K:E@HO>KGF>GM?HK:FHNGMLHP>=:L<:E= NG=>KMA> ! ZLM>FIHK:KRKBLD

'G-K MA>!HFI:GRK><>BO>=MA>?NG=LHP>=NG=>KMA> ! LKBLD!HFI:GRK>=MA> KBLDGMH?  :L:GBG:L>MHIK>FBNFK>O>GN>BGMA>?HNKMAJN:KM>KH?

2KHN;E>=">;M0>LMKN

2A>!HFI:GR=B=GHMA:O>:GRMKHN;E>==>;MK>LMKNR>:KL>G=>="><>F;>K :G=

! -MA>K"BLL

+BGBFNF!:IBM:E:G=1NKIENL

26.16            

      

.NKLN:GMMHMA>E:PLH?MA>LM:M>LBGPAB!HFI:GRBLEB<>GL>=MH=H;NLBG>LL MA>!HFI:GRBLK>JNBK>=MHF:BGM:BG: FBGBFNFLNKIENL:G=<:IBM:ELMH?BG>=;RMA>LM:MNM>L:G=K>@NE:MBHGLH?MAHL>LM:M>L  M;HMA"><>F;>K :G=  MA>!HFI:GRP:LBGPBMAMA>FBGBFNFLNKIENL:G=<:IBM:ELMHJNBK>F>GMLH?MA>LM:M>LBGPABGL>=MH=H;NLBG>LL

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

!-4'" 

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

&>:EMA!:K>0>?HKF

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

5ABE>FHLMH?MA>LB@GB?B<:GM:LI> ! ;><:F>>??>=NKBG@HKIKBHKMH I:KMLH?MA> ! MH >OHEO> MAKHN@A MA> IKHFNE@:MBHG H? >Q> HK=>KL  E>@BLE:MBHG  K>@NE:MBHGL :G= @NB=:G<> :L P>EE :L HG@HBG@ EBMB@:MBHG  ==BMBHG:E L MH MA> !  :G= MAHL> K>@NE:MBHGL :G= @NB=:G<> :M MA> ?>=>K:E :G=HK LM:M> E>O>E :K> EBD>ER  :G= MAHL> L:K>EBD>ERMH;>LB@GB?B<:GM %KHPBG@?>=>K:E:G=LM:M>;N=@>M:KRIK>LLNK>LF:D>BMFHK>EBD>ERMA:M:GRL  BGL :M MA> LM:M> E>O>E BG K>LIHGL> MH L MH  HK BGO:EB=:MBHG  K>I>:E HK K>IE:<>F>GM H?  MA> !  :G=HK LBGMA>?NG=BG@E>O>EL:G=HKI:RF>GMF>=>K:EERLNIIHKM>=;>G>?BMIKH@K:FL PBEE;>:=O>KL>MHMA> !HFI:GR $HK>Q:FIE> B?:GR>E>F>GMLH?MA> ! :K>BGO:EB=:M>=HKK>I>:E>=:MMA>?>=>K:EE>O>E MA>!HFI:GR>QI> LM:M>L PHNE= L>>D MH >G:JNBK>F>GML  LN >QBLMBG@ QL K:@>  K>JNBKBG@ K:@> ?HK =>I>G=>GML NI MH :@>   K>JNBKBG@ @N:K:GM>>= K>G>P:;BEBMR H? BGLNK:G<>K:@>:G=IKHAB;BMBG@EB?>MBF>EBFBMLHGBGLNK:G<>K:@>

.HM>GMB:EK>I>:EH?MA> ! HG@HBG@E>@BLE:MBO> K>@NE:MHKR:G=:=FBGBLMK:MBO>IHEBLMHMA> ! MA>K>LNEMLH? ?>=>K:E:G=LM:M>E>O>E>E>G=BG@EBMB@:MBHGG@BG@MA> ! HK?NG=BG@?HKMA>E:P:G= ?>=>K:E;N=@>MG>@HMB:MBHGLMH:M>NG<>KM:BGMR:;HNMMA>NEMBF:M>BFI: ! %BO>GMA>BGA>K>GM=B??BL>>BG@MA>G:MNK>:G=LH??NMNK>LMHMA> ! :G=AHPLM:M>L ;NLBG>LL>L:G=BG=BOB=N:ELPBEEK>LIHG=MH MAHL> L  MA> !HFI:GR <:GGHM IK>=B BFI: L MH MA> !  'M BL K>:LHG:;ER IHLLB;E> MA:M BGO:EB=:MBHG K>I>:EHKK>IE:<>F>GMH?HKHMA>KLMHMA> ! :G=HKLM:M>LZK>LIHGL>LMHLNL BGMA>:@@K>@:M>  :LB@GB?B<:GM:=O>KL>>??>!HFI:GRZL;NLBG>LL>L K>LNEMLH?HI>K:MBHGL:G=<:LA?EHPL

+>=B<:K>

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

2A>!HFI:GRA:LBGO>LM>=LB@GB?B<:GMK>LHNK<>LMH=B<:K>LM:G=:K=L :G=BML+>=B<:K>>??HKMLPBEE MHK>JNBK>LB@GB?B<:GMK>LHNK<>L !+1F:RL>>DIK>FBNF:G=HMA>KK>?NG=L IKHAB;BMMA>!HFI:GR?KHFM:G=HK>GKHEEF>F;>KLBGHKK>?NL>MHI:LLBO>ER>GKHEEF>F;>KLBGHG>HKFHK>H?MA>!HFI:GRZL+>=B<:K>HK +>=B<:K> +>=B<:B==>FHGLMK:MBHGABLMHKB<:EERDGHPG:LW=N:E>EB@B;E>X IE:GL >QMA>!HFI:GR?KHFI:KMB

26.17            

      

HG>HKFHK>+>=B<:K> =N:E>EB@B;E>HK=N:E>EB@B;E>LI>>=LIE:GIKH@K:FL:G=HKBGLMBMNM>HMA>KL:GM:KRI>G:EMB>L:@:BGLMMA>!HFI:GRB?BM?:BELMH@NE:MBHGLHKBML+>=B<:K>JNBK>F>GML

$>=>K:E#FIEHR>>L&>:EMA >G>?BML.KH@K:F

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

" 2A>!HFI:GR=B=GHMA:O>:GR;NLBG>LLBGM>KKNIMBHGBGLNK:G<>K>KB>L?HKMA>R>:KL>G=BG@"><>F;>K HK

# 2A>!HFI:GR=B=GHMA:O>:GRLM:M>MK:GL?>K:;E>:G=GHG MK:GL?>K:;E>M:Q=BML?HKMA>R>:KL>G=BG@"><>F;>K HK 

$ 2A>!HFI:GR=B=GHMA:O>:GRLN;IKBF>FHKM@:@>K>E:M>=KBLD>QIHLNK>L:M"><>F;>K HK

% 2A>!HFI:GR=B=GHMA:O>:GRK>M:BG>=:LL>ML:M"><>F;>K HK

& 2A>!HFI:GR=B=GHMA:O>:GRBGLNK:G<> EBGD>=L>LW'*1X <>F;>K HK

' 2A>!HFI:GR=B=GHMA:O>:FHNGMLMA:MK>:EBS>=HGEB?>BGLNK:G<>:M"><>F;>K HK

 #O>GML1N;L>JN>GM

2RI>' 0>=1N;L>JN>GM#O>GML

1N;L>JN>GM>O>GMLA:O>;>>GK>=MAKHN@A$>;KN:KR ?HKMA>LM:MNMHKRLM:M>F>GMBLLN>=HG$>;KN:KR 

2A>!HFI:GRA:=GHDGHPGK>IHKM:;E>K>=LN;L>JN>GM>O>GML

2RI>'' ,HGK>=1N;L>JN>GM#O>GML

1N;L>JN>GM>O>GMLA:O>;>>GK>=MAKHN@A$>;KN:KR ?HKMA>LM:MNMHKRLM:M>F>GMBLLN>=HG$>;KN:KR 

-G (:GN:KR     MA> !HFI:GR P:L LN;C>> NG=>K 1> !  2ABL :GGN:E ?>> P:L :EEH<:M>= MH BG=BOB=N:E A>:EMA BGLNK>KL ;:L>= HG MA> K:MBH H? MA> :FHNGM H? MA> >GMBMRZL G>M IK>FBNFL PKBMM>G =NKBG@ MA> IK><>=BG@ <:E>G=:K R>:K MH MA> :FHNGM H? A>:EMA BGLNK:G<> ?HK :GR 3 1  A>:EMA KBLD MA:M P:L PKBMM>G =NKBG@ MA> IK><>=BG@ <:E>G=:KR>:K  A>:EMABGLNK:G<>>GMBMRZLIHKMBHGH?MA>:GGN:E?>>;>LI:R:;E>HG<>MA>>GMBMRIKHOB=>LA>:EMABGLNK:G<> ?HK:GR3 1 A>:EMAKBLD?HK>:G=:KR>:K;>@BGGBG@HGHK:?M>K(:GN:KRH?MA>R>:KMA>?>>BL=N> 'G"><>F;>K  MA>:GGN:E?>>P:LK>I>:E>=;>@BGGBG@BG  L:K>LNEMH?MABLK>I>:E MA>K>BLGH:GGN:E?>>I:R:;E>BG:G=MA>K>:?M>K :G=MA>K>?HK>GH>LMBF:M>=LN;L>JN>GM?>>R>:K:LL>LLF>GMP:LK>JNBK>=MH;>K>=?KHFNG:LLB@G>=?NG=LMHLI><>F;>K 

!NKK>GM7>:K .KBHK7>:K

"B=MA>K>IHKMBG@>GMBMRPKBM>:<GM:G=A>:EMABGLNK:G<>IK>FBNFMA:MBL LN;C>$>=>K:E ??HK=:;E>!:K> L

! ?>>:LL>LLF>GMI:R:;E>?HKMA>NI:K  V    ! ! ?>>:LL>LLF>GMI:B=     V " .K>FBNFPKBMM>GLN;C>LLF>GM  V     # 2HM:E =CNLM>=!:IBM:E;>?HK>LNKIENL:=CNLMF>GM     $BO> 7>:K&BLMHKB<:E*BG>

$ 2HM:E =CNLM>=!:IBM:E:?M>KLNKIENL:=CNLMF>GM     $BO> 7>:K&BLMHKB<:E*BG>FBGNL :;HO>

% NMAHKBS>=!HGMKHE*>O>E     $BO> 7>:K&BLMHKB<:E*BG>

& 5HNE=K>IHKMBG@MA> ! :LL>LLF>GM:LH?"><  A:O>MKB@@>K>=:G 0 !:O>E7#1,-  ,H

 0>BGLNK:G<>

!>=>=0>BGLNK:G<>0>IHKM

26.18            

      

1>G>K:E'GM>KKH@:MHKB>L

  K>:GRH?MA>K>BGLNK>KL EBLM>=BG1=NE>1:LGHG :??BEB:M>= HPG>=BG>Q<>LLH?HK= >BMA>K=BK>IK>L>GM:MBO> H??B<>K MKNLM>> HK=BK>

7>L ,H6 

'?R>L @BO>?NEE=>M:BEL ,

   &:O> :GR IHEBL BLLN>= ;R MA> >G K>BGLNK>= PBMA : K>= BG : K MA:G MA> 3GBM>=1M:M>L>QLH?LNL MA:MBLHPG>=BG>Q<>LLH?HK==BK>= :;>G>?B=BMHKHK:GBGLNK>=HK:GRHMA>KI>KLHGGHMIKBF:KBER>G@:@>=BGMA> BGLNK:G<>;NLBG>LL

7>L ,H6

'?R>L @BO>?NEE=>M:BEL ,

1>=>=0>BGLNK:G<>0>IHKMU.:KM

 "H>LMA>:GRK>BGLNK:G<>:@K>>F>GMLBG>??>KPABK>BGLNK>KF:RNGBE:M>K:EER<:G<>E:GR K>BGLNK:G<>?HKK>:LHGLHMA>KMA:GGHGI:RF>GMH?IK>FBNFHKHMA>KLBFBE:K=BM

7>L ,H6

: '?R>L PA:MBLMA>>LMBF:M>=:FHNGMH?MA>:@@K>@:M>K>=NK:E<:G<>EE:MBHG;RMA> K>BGLNK>K:LH?MA>=:M>H?MABLLM:M>F>GM ?HKMAHL>:@K>>F>GMLBGPABEE:MBHGK>LNEMLBG:G>MH;EB@:MBHGH? MA>K>IHKMBG@>GMBMRMHMA>K>BGLNK>K :G=?HKPABL>GMER:<=5A>K>G><>LL:KR  MA>K>IHKMBG@>GMBMRF:RKMA>GMHK:GMB=>QI>KB>G<>H?MA>;NLBG>LLK>BGLNK>=BGF:DBG@MABL >LMBF:M> ,

; 5A:MBLMA>MHM:E:FHNGMH?K>BGLNK:G<>=BMLM:D>G PA>MA>K:L:G:LL>MHK:L:K>=NL> :@K>>F>GMLBGMABLLM:M>F>GM,

 "H>LMA>K>IHKMBG@>GMBMRA:O>:GRK>BGLNK:G<>:@K>>F>GMLBG>??>:FHNGMH?EHLL>LI:B=HK:<= MAKHN@AMA>LM:M>F>GM=:M>F:RK>LNEMBG:I:RF>GMMHMA>K>BGLNK>KH?:FHNGMLMA:M BG:@@K>@:M>:G=:EEHPBG@?HK H??L>MH?FNMN:E=BML?KHFHMA>KK>BGLNK:G<>:@K>>F>GMLPBMAMA>L:F>K>BGLNK>K >Q<>>=MA>MHM:E=BK>FBNF =NG=>KMA>K>BGLNK>=IHEBL

7>L ,H6

'?R>L @BO>?NEE=>M:BEL ,

1>=>=0>BGLNK:G<>0>IHKMU.:KM

 5A:MBLMA>>LMBF:M>=:FHNGMH?MA>:@@K>@:M>K>=N>F>GMLHMA>KMA:GMAHL>NG=>KPAB BGLNK>KF:RNGBE:M>K:EER<:G<>E?HKK>:LHGLHMA>KMA:G?HKGHGI:RF>GMH?IK>FBNFHKHMA>KLBFBE:K=BMLMA:M:K> K>?E>=BG1> H?M>KFBG:MBHGH? **K>BGLNK:G<>:@K>>F>GML ;R>BMA>KI:KMR :LH?MA>=:M>H?MABL LM:M>F>GM 5A>K> G><>LL:KR  MA> K MA> GM HK :GMB= >QI>KB>G<> H? MA> ;NLBG>LL K>BGLNK>=BGF:DBG@MABL>LMBF:M> 

   &:O> :GR G>P :@K>>F>GML ;>>G >Q>= HK >QBLMBG@ :@K>>F>GML :F>G=>=  LBG<> (:GN:KR  H? MA> R>:K H? MABL LM:M>F>GM  MH BG IHEBL HK K> BG ?HK<> HK PABQBLMBG@ K>L>KO>L >LM:;EBLA>= ;R MA> >??>=:M>H?MA>:@K>>F>GM

7>L ,H6

'?R>L PA:MBLMA>:FHNGMH?K>BGLNK:G<>=BM PA>MA>K:G:LL>MHK:K>=NG?HKLNP :@K>>F>GMLHK:F>G=F>GML,

2A>!HFI:GR=B=GHMA:O>NGK>BGLNK:G<>:M"><>F;>K HK

! 2A>!HFI:GR=B=GHMA:O>:GR=>=K>BGLNK:G<>:M"><>F;>K HK

" 2A>!HFI:GRL<>KMB?B>=K>BGLNK>KLK:MBG@A:LGHM;>>G=HPG@K:=>=HKBMLLM:MNLLN;C>OH<:MBHG:M"><>F;>K  HK

# 2A>!HFI:GRA:=GHK>BGLNK:G<>K>BGLNK:G<>=BM=BL:IIEB>L:M"><>F;>K 

 0>MKHLI>ER0:M>=!HGMK:=>M>KFBG:MBHG

26.19            

      

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

.K>FBNFK>O>GN>LN;C>FBGBFNF+*0K>;:M>K>JNBK>F>GMLH?MA> ! BLK>=G>MH?MA>>LMBF:M>=FBGBFNF +*0 K>;:M>L ?HK MA> GM <:E>G=:K R>:K  2A> !HFI:GR >LMBF:M>L MA> FBGBFNF +*0 K>;:M>L ;R IKHC>KM:BGF:KD>ML :L=>?BG>=;RMA> ! ?HK>:BGPAB!HFI:GRHI>K:M>L 2A>FBNFLNL>=BG >LMBF:MBG@ LN;:M>L :K> FH=B?B>= ?HK <>KM:BG :=CNLMF>GML :EEHP>= ;R MA> !  :G= BG : LM:MBLMB<:E =B;BEBMR :=CNLMF>GM?HKMAHL>LM:M>LPBMA:GNF;>KH?F>F;>KLMA:MBLGHMLM:MBLMB<:EER=B;E>

2A>!HFI:GR:<L:FHNGMLI:R:;E>MHHKK><>BO:;E>?KHFMA>?>=>K:E@HO>KGF>GMK>E:M>=MHBML-.+MH IKHOB=>HK:KK:G@>A>:EMAL>KOB<>LNG=>KMA>$#& IKH@K:F?HK?>=>K:E>FIEHR>>L :GGNBM:GML:G=MA>BK=>I>G=>GML 2A>L>  -.+ :G= :IIEB<:;E> @HO>KGF>GM K>@NE:MBHGL >LM:;EBLA IK>FBNF K:MBG@ K>JNBK>F>GML ?HK MA> $#&  IKH@K:F 2A>-.+ MAKHN@ABML-??B<>H?MA>'GLI>G>K:E KBH=B<:N=BMLH?BMLK MABG@L O>KB?RMA:MMA>IK>FBNFL=MHMA>-.+P>K>>LM:;EBLA>=BGPBMAMA>K K>JNBK>F>GMLNG=>KMA>$#& IKH@K:F 2A>L>:N=BMLH?M>GK>LNEMBG?BG=BG@L?HKPAB!HFI:GR>LM:;EBLA>L:LI>L>KO> $HKMAHL>R>:KLNG=>KGHM;>>G:N=BM>=;RMA>-.+ MA>!HFI:GR>LM:;EBLA>L:@>G>K:E:N=BM EB:;BEBMR PAB K>LNEM H? : ABLMHKB<:E LMN=R H? :O>K:@> :N=BM I:RF>GML  'G :==BMBHG  ?HK :EE R>:KL NG=>K  !HFI:GR:GGN:EERI>K?HKFLK:M>K>LNEMBG:FHNGMLHP>=MHHKK><>BO:;E>?KHFMA>-.+  N=BM ?BG=BG@L ABLMHKB<:ELMN=RH?:N=BMI:RF>GML :G=K:M>K>K>LNEM>=BGK>L>KO>LH?  :G=    PABK>K>=:L:@@K>@:M>A>:EMAIHEBL>KO>LBGMA>1M:MNMHKR1M:M>F>GMLH?*B:;BEBMB>L !:IBM:E:G=1NKIENL:M "><>F;>K :G= K>LI>ER

2A>!HFI:GRF:G:@>=A>:EMA<:K>L>KOB<>LNG=>KMA>$#& IKH@K:FBGBMLL>KOB<>:K>:L  -.+K>@NE:MBHGLK>JNBK>MA:M$#& IE:GLF>>M:$#& IKH@K:F LI>:G=F:KD>M 2A>!HFI:GR K>IHKM>=GH$#& +*0K>L>KO>LBG:G=  BG:@@K>@:M>IHEBL>KO>LBG K>LI>ER

 <=K>MKHLI>:K>K>=:L:G:=CNLMF>GMMH>:KG>=IK>FBNFL:G=:K>>LMBF:M>=;:L>=HG<:E MA>!HFI:GRZL>QI>=?BG:GLNEML?HKMA>:IIKHIKB:M>F>=B<:E;>G>?BMK:MBHM:K@>M 

! !HGMK:MKHLI>0:MBG@$>:MNK>L

2A>!HFI:GRA:=G>MIK>FBNFLPKBMM>GH?  MA:MP>K>LN;C>MKHLI>K:MBG@?>:MNK>L?HKMA>R>:K>G=BG@ "><>F;>K K>IK>L>GMBG@H?MHM:EG>MIK>FBNFLPKBMM>G

" +>=B<:EEHLLK:MBHK>;:M>LK>JNBK>=INKLN:GMMHMA>.N;EB<&>:EMA1>KOB<>

     'G=BOB=N:E 1F:EE%KHNI *:K@>%KHNI -MA>K!:M>@HKB>L #FIEHR>K #FIEHR>K PBMAK>;:M>L 2HM:E

.KBHK0>IHKMBG@7>:K  +>=B<:E*HLL0:MBH0>;:M>L'G=  V                +>=B<:E*HLL0:MBH0>;:M>L.:B=  V        V     +>=B<:E*HLL0:MBH0>;:M>L3GI:B=  V  V  V        .ENLK>BGLNK:G<>:LLNF>=:FHNGML 666 666 666 666  V  *>LLK>BGLNK:G<><>=>=:FHNGML 666 666 666 666  V  0>;:M>L3GI:B=G>MH?K>BGLNK:G<> 666 666 666 666   

!NKK>GM0>IHKMBG@7>:K MH ":M>  +>=B<:E*HLL0:MBH0>;:M>L'G=  V  V  V          +>=B<:E*HLL0:MBH0>;:M>L.:B=  V  V  V  V  V  +>=B<:E*HLL0:MBH0>;:M>L3GI:B=  V  V  V          .ENLK>BGLNK:G<>:LLNF>=:FHNGML 666 666 666 666  V  *>LLK>BGLNK:G<><>=>=:FHNGML 666 666 666 666  V  0>;:M>L3GI:B=G>MH?K>BGLNK:G<> 666 666 666 666    

# 0BLD1A:KBG@.KHOBLBHGLH?MA> ??HK=:;E>!:K>

 "B=MA>K>IHKMBG@>GMBMRPKBM>:<GM:G=A>:EMABGLNK:G<>IK>FBNFPAB ??HK=:;E>!:K> L869,H89

26.20            

      

   'FI: ??HK=:;E> !:K> = LL>ML  *B:;BEBMB>L :G= 0>O>GN> ?HK MA> !NKK>GM7>:K

+-3,2 : .>KF:G>GM ! 0BLD =CNLMF>GM.KH@K:F LL>ML  .K>FBNF:=CNLMF>GMLK><>BO:;E>=N>MH ! 0BLD =CNLMF>GM   *B:;BEBMB>LBGGML  0BLD:=CNLMF>GMNL>K?>>LI:R:;E>?HK ! 0BLD =CNLMF>GM  V  .K>FBNF:=CNLMF>GMLI:R:;E>=N>MH ! 0BLD =CNLMF>GMBGGML   V -I>K:MBHGL0>O>GN>#QI>GL>  0>IHKM>=:LK>O>GN>BGIK>FBNF?HK:<GM:G=A>:EMAG= =N>MH ! 0BLD =CNLMF>GM  V  0>IHKM>=BG>QI>GL>L:L ! KBLD:=CNLMF>GMNL>K?>>LBG=I:B=   V ; 2K:GLBMBHG:E ! 0>BGLNK:G<>.KH@K:F LL>ML   FHNGMLK>K:;E>?HKMH ! 0>BGLNK:G<>  V   FHNGMLK>K:;E>?HKMH ! 0>BGLNK:G<>!HGMK:*B:;BEBMR   V   FHNGMLK><>BO:;E>K>E:MBG@MHNGBGLNK>=IE:GL?HKBGLNK:G<> *B:;BEBMB>L  *B:;BEBMB>L?HK=N>MH ! 0>BGLNK:G<>UGHMK>IHKM>=:L<>=>=IK>FBNF  !>=>=K>BGLNK:G<>IK>FBNFLI:R:;E>=N>MH ! 0>BGLNK:G<>   *B:;BEBMB>L?HK:FHNGMLA>E=NG=>KNGBGLNK>=IE:GLBGLNK:G<> -I>K:MBHGL0>O>GN>#QI>GL>  !>=>=K>BGLNK:G<>IK>FBNFL=N>MH ! 0>BGLNK:G<>  0>BGLNK:G<>K>KB>LBGLM:M>F>GM =N>MH ! 0>BGLNK:G<>I:RF>GMLHK>QI>=I:RF>GML  V   ! 0>BGLNK:G<>IHKM>=:L<>=>=IK>FBNF  V < 2>FIHK:KR ! 0BLD!HKKB=HKL.KH@K:F LL>ML   <=K>MKHLI>IK>FBNF=N>MH ! 0BLD!HKKB=HKL  V *B:;BEBMB>L  0>L>KO>?HKK:M>=BMLHKIHEBQI>KB>G<>K:MBG@K>?NG=L=N>MH ! 0BLD!HKKB=HKL  V -I>K:MBHGL0>O>GN>#QI>GL>  #??>MIK>FBNFBGI:B=K><>BO>=       #??>BGK>L>KO>L?HKK:M>=BML  V

 0HEE?HKP:K=H?IKBHKR>:K ! KBLDLA:KBG@IKHOBLBHGL?HKMA>?HEEHPBG@:LL>M@KHLLH?:GRGHG:=FBLLBHG :G=EB:;BEBMR ;:E:G<>L:EHG@PBMAMA>K>:LHGL?HK:=CNLMF>GMLMHIKBHKR>:K;:E:G<>

<="NKBG@MA>.KBHK7>:K 0><>BO>=HK.:B=:LH?MA> 3GL>MME>= :E:G<>L:LH?MA> HG NLBG>LL5KBMM>G !NKK>GM7>:KHG NLBG>LL "B??>K>G<>L =CNLMF>GML 0>IHKMBG@":M>

.KBHK7>:K .KBHK7>:K !NFNE:MBO> !NFNE:MBO> <=*>LL <=*>LL :E:G<>?KHF :E:G<>?KHF >?HK>"><>F;>KH?MA> 5KBMM>G >?HK>"><>F;>K .:RF>GML .:RF>GML 2H.KBHK7>:K 2H.KBHK7>:K .KBHK7>:KL!HE .KBHK7>:KL!HE .KBHK7>:K H?MA>.KBHK7>:K !HE  !HE  :E:G<>L :E:G<>L          0><>BO:;E> .:R:;E> 0><>BO:;E> .:R:;E> 0><>BO:;E> .:R:;E> 0><>BO:;E> .:R:;E> 0>? 0><>BO:;E> .:R:;E> : .>KF:G>GM ! 0BLD =CNLMF>GM .KH@K:F  .K>FBNF:=CNLMF>GMLK><>BO:;E> BGFBNF:=CNLMF>GMLI:R:;E>  BGGML  V  V  V  V  V  V  V  V  V  V  1N;MHM:E ! .>KF:G>GM0BLD =CNLMF>GM.KH@K:F    V  V  V    V  V  V    V ; 2K:GLBMBHG:E ! 0>BGLNK:G<> .KH@K:F   FHNGMLK>K:;E>?HKK:;E>?HK<>BO:;E>K>E:MBG@MH NGBGLNK>=IE:GL  V  V  V  V  V  V  V  V #  V  V  *B:;BEBMB>L?HK=N>MH ! 0>BGLNK:G<>  GHMK>IHKM>=:L<>=>=IK>FBNF  V  V  V  V  V  V  V  V $  V  V  !>=>=K>BGLNK:G<>IK>FBNFL I:R:;E>  V  V  V  V  V  V  V  V %  V  V  *B:;BEBMR?HK:FHNGMLA>E=NG=>K NGBGLNK>=IE:GL  V  V  V  V  V  V  V  V &  V  V  1N;MHM:E ! 2K:GLBMBHG:E 0>BGLNK:G<>.KH@K:F  V  V  V  V  V  V  V  V  V  V < 2>FIHK:KR ! 0BLD!HKKB=HKL .KH@K:F   <=K>MKHLI>IK>FBNF  V  V     V     V     V '  V  V  0>L>KO>?HKK:M>=BMLHKIHEBQI>KB>G<>K:MBG@K>?NG=L  V  V  V  V  V  V  V  V (  V  V  1N;MHM:E ! 0BLD!HKKB=HKL .KH@K:F  V  V     V     V     V  V  V = 2HM:E?HK ! 0BLD1A:KBG@ .KHOBLBHGL    V     V     V     V    V

26.21            

      

#QIE:G:MBHGLH? =CNLMF>GML "N>MHNI=:M>LMHMA>=:M::O:BE:;E>MHMA>!HFI:GRMH<:EMA>KBLD:=CNLMF>GM ' "N>MHK><>BIMH?0BLD!HKKB=HKI:RF>GM

 0HEE $HKP:K=H?0BLD!HKKB=HKL LL>M:G=*B:;BEBMR :E:G<>L;R.KH@K:F >G>?BM7>:K

0BLD!HKKB=HKL.KH@K:F7>:K <="NKBG@MA>.KBHK7>:K 0><>BO>=HK.:B=:LH?MA> 3GL>MME>= :E:G<>L:LH?MA> HG NLBG>LL5KBMM>G !NKK>GM7>:KHG NLBG>LL "B??>K>G<>L =CNLMF>GML 0>IHKMBG@":M>

.KBHK7>:K .KBHK7>:K !NFNE:MBO> !NFNE:MBO> <=*>LL <=*>LL :E:G<>?KHF :E:G<>?KHF >?HK>"><>F;>KH?MA> 5KBMM>G >?HK>"><>F;>K .:RF>GML .:RF>GML 2H.KBHK7>:K 2H.KBHK7>:K .KBHK7>:KL!HE .KBHK7>:KL!HE .KBHK7>:K H?MA>.KBHK7>:K !HE  !HE  :E:G<>L :E:G<>L         0><>BO:;E> .:R:;E> 0><>BO:;E> .:R:;E> 0><>BO:;E> .:R:;E> 0><>BO:;E> .:R:;E> 0>? 0><>BO:;E> .:R:;E> :    <=K>MKHLI>IK>FBNF  V  V     V     V     V  V  V  0>L>KO>?HKK:M>=BMLHKIHEBQI>KB>G<>K:MBG@K>?NG=L  V  V  V  V  V  V  V  V  V  V ;    <=K>MKHLI>IK>FBNF  V  V      V       V      V !  V  V  0>L>KO>?HKK:M>=BMLHKIHEBQI>KB>G<>K:MBG@K>?NG=L  V  V  V  V  V  V  V  V "  V  V <    <=K>MKHLI>IK>FBNF  V  V  V  V  V  V  V  V #  V  V  0>L>KO>?HKK:M>=BMLHKIHEBQI>KB>G<>K:MBG@K>?NG=L  V  V  V  V  V  V  V  V $  V  V = 2HM:E?HK0BLD!HKKB=HKL  V  V     V     V     V  V  V # =!HENFGLMAKHN@A LAHNE=>JN:E# <!HENFGMAKHN@AK>LI>ER

#QIE:G:MBHGLH? =CNLMF>GML "N>MHK><>BIMH?0BLD!HKKB=HKI:RF>GM ! "N>MHK><>BIMH?0BLD!HKKB=HKI:RF>GM

  ! 0BLD!HKKB=HKL0><>BO:;E>:LH?0>IHKMBG@":M>

      #LMBF:M>= FHNGM ,HG <= LL>M :E:G<> 0BLD!HKKB=HKL.KH@K:F7>:K MH;>$BE>=HK$BG:E FHNGML?HK %KHLLH?,HG FHNGM$BE>=PBMA 'FI:BKF>GMHK FHNGMLK><>BO>= :=FBLLBHGL ,HG :=FBMM>= ,>M =FBMM>= LL>M !+1 -MA>K0>:LHGL ?KHF!+1    FHNGM   :       V      V  V  V ;     V    V V V <  VVVVVV = 2HM:E: ; <      V      V  V  V # =!HENFG LAHNE=>JN:E# <!HENFG # =!HENFG LAHNE=>JN:E# <

 !A:G@>BG'G=!E:BFL:G=!E:BFL =CNLMF>GM#QI>GL>

2A> ?HEEHPBG@ M:;E> LAHPL MA> GML H? MA>  BG GM >QI>GL> :G= :@@K>@:M> A>:EMAL>KO>L?HKMA>R>:KL>G=>="><>F;>K :G=

 

:E:G<> (:GN:KR       &>:EMA<:K>K><>BO:;E>      V  :E:G<> (:GN:KR G>MH?A>:EMA<:K>K><>BO:;E>      

'G=K>E:M>=MH !NKK>GMR>:K         .KBHKR>:KL          2HM:EBG=        

.:B=K>E:M>=MH !NKK>GMR>:K         .KBHKR>:KL          2HM:EI:B=        

:E:G<> "><>F;>K G>MH?A>:EMA<:K>K><>BO:;E>        &>:EMA<:K>K><>BO:;E>       

:E:G<> "><>F;>K       

26.22            

      

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

2A>K>A:L;>>GGHLB@GB?B<:GMBGMA>!HFI:GRZLF>MAH=HEH@B>L:G=:LLNFIMBHGLNL>=BG<:EEB:;BEBMR?HK NGI:B=GM>QI>GL>L

 'GM>KF>GML

2A>!HFI:GR=B=GHMA:O>:GRBGM>KF>GML:M"><>F;>K HK

 1MKN=1>MME>F>GML

2A>!HFI:GR=B=GHMA:O>:GRLMKN=L>MME>F>GML:M"><>F;>K HK

 &>:EMA!:K>0><>BO:;E>L

.A:KF:<>NMB<:E0>;:M>0><>BO:;E>L

2A> !HFI:GR K><>BO>L IA:KF:<>NMB<:E K>;:M>L MAKHN@A :G :@K>>F>GM PBMA &+  &+ A:L >F>GML PBMA IA:KF:<>NMB<:EL?HKK>;:M>L PABKMA>!HFI:GRLF>F;>KLABI:LP>EE:LMA>F>F;>KLABIH?HMA>K >MG: IKH@K:FL :G=HK :??BEB:M>L  2A> !HFI:GR K><>BO>L MAHL> K>;:M>L ?KHF &+ >BMA>K =BK>KF>GMLPBMAHMA>K >MG::??BEB:M>L MA:MK>E:M>MHMA>!HFI:GRLF>F;>KLABI 2A>!HFI:GR>LMBF:M>LIA:KF:<>NMB<:E K>;:M>K><>BO:;E>L;:L>=NIHGMA>ABLMHKB<:EI:RF>GMMK>G=L :KO:KB:;E>L  ;:M>L=:K> :IIEB>=MHMA>KBH=L;>EHP NLBG@:?BKLMBG?BKLMHNMF>MAH=HEH@R  M"><>F;>K :G= MA>!HFI:GR A:=IA:KF:<>NMB<:EK>;:M>K><>BO:;E>LH? :G=  K>LI>ERK>?>KMHMA>!HFI:GRL:<L K>E:M>=MHIA:KF:<>NMB<:EK>;:M>K><>BO:;E>LBG,HM>

2A>?HEEHPBG@M:;E>=BLLMA>JN:KM>KERK>O>GN>:G=LN;L>JN>GM<:LAE:MBG@MHMA>IA:KF:<>NMB<:EK>;:M>L =BL=BG,HM>

#LMBF:M>= .A:KF:;:M>L:L .A:KF:;:M>L:L ;:M>L ;:M>L ;:M>L 0>IHKM>=HG$BG:G=HK-MA>KPBL> 0><>BO>=5BMABG 0><>BO>=5BMABGMH 0><>BO>=+HK>2A:G /N:KM>K 1M:M>F>GML !HG?BKF>= ":RLH? BEEBG@ ":RLH? BEEBG@ ":RL ?M>K BEEBG@       V       V  V               V  V               V  V               V  V

           V  V            V  V            V  V            V  V

           V  V            V  V            V  V   V        V  V

0>IK>L>GML:IHKMBHGH?MA>>LMBF:M>=K>;:M>L?HKMA>JN:KM>K>G=BG@"><>F;>K  PABK>I:B=;R &+MHMA> !HFI:GRIKBHKMH"><>F;>K :G=BGOHB

0BLDLA:KBG@K><>BO:;E>L

2A>!HFI:GR=B=GHMA:O>:GR:=FBMM>=KBLDLA:KBG@K><>BO:;E>L:M"><>F;>K HK

-MA>KK><>BO:;E>L

.A:KF:FNG>K:MBHGW"'0X %>G>KB<

2A> !HFI:GR K><>BO>L K>MKHLI> @>G>KB< I>K?HKF:G<> G>MPHKD K>;:M>L W.,0X  HG BML +>=B<:K> ;NLBG>LL MAKHN@A :G :@K>>F>GMPBMA &+  &+A:L>F>GMLPBMAG>MPHKDIA:KF:L?HK.,0 2A>.,0BLI>K?HKF:G<>;:L>= NIHG PA>MA>K MA> I:KMBL A:O> F>M <>KM:BG IK> >LM:;EBLA>= K:M>L LI>= BG MA>  .,0 BL <:E= ;R FNEMBIERBG@ MA> :IIEB<:;E>  G>MPHKD K:M> ;:L>= HG MA> :K?HKF:G<>  2A> .,0 K><>BO:;E>L?BMMA><:M>@HKRH?HMA>KA>:EMA<:K>K><>BO:;E>LI>K11 .,H   $ "  &"  $ #%"  &#

.A:KF:

26.23            

      

2A>!HFI:GRK><>BO>LK>MKHLI>;K:G=.,0HGBML+>=B<:K>;NLBG>LLMAKHN@A:G:@K>>F>GMPBMA &+  LF>GMBHG>= :;HO>  &+A:L>F>GMLPBMAG>MPHKDIA:KF:L?HK.,0 2A>IKH@K:FK<>GM:@>LH? ;K:G= BG@K>=B>GM L  =>I>G=BG@ AHP P>EE MA>R I>K?HKF HG :=A>K>G<> F>:LNK>L  BGE:M>= F>:LNK>L  2A> .,0 :@K>>F>GM ?HK  A:L MAK>> I>K?HKF:G<> F>:LNK>F>GM I>KBH=L >G=BG@ IKBE   N@NLM  :G= "><>F;>K K>LI>ER 2A>.,0K><>BO:;E>L?BMMA><:M>@HKRH?HMA>KA>:EMA<:K>K><>BO:;E>LI>K11 .,H   $ "  &"  $ #%" &#

 .:KMBL

2A>!HFI:GR=B=GHMA:O>:GRI:KMBL:M"><>F;>K HK

 .K>FBNF">?BGL>KO>L

"><>F;>K   *B:;BEBMR<:KKB>=?HKIK>FBNF=>?BGL>KO>L V  ":M>H?MA>FHLMK><>GM>O:EN:MBHGH?MABLEB:;BEBMR   5:L:GMB=BGO>LMF>GMBGNMBEBS>=BGMA><:EL

  GMB=1:EO:@>:G=1N;KH@:MBHG

2A> !HFI:GR =B= GHM K>=N<> BML EB:;BEBMR ?HK NGI:B= L ;R :GR >LMBF:M>= :GMB= L:EO:@> :G= LN;KH@:MBHG :M "><>F;>K HK:LMA>!HFI:GRK>:G=LN;KH@:MBHGHG:I:B=;:LBLPA>G<:LABLK><>BO>=

26.24 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

PART 1 - COMMON INTERROGATORIES GENERAL

1.1 Is the reporting entity a member of an Insurance Holding Company System consisting of two or more affiliated persons, one or more of which is an insurer? Yes [ X ] No [ ] If yes, complete Schedule Y, Parts 1, 1A and 2

1.2 If yes, did the reporting entity register and file with its domiciliary State Insurance Commissioner, Director or Superintendent, or with such regulatory official of the state of domicile of the principal insurer in the Holding Company System, a registration statement providing disclosure substantially similar to the standards adopted by the National Association of Insurance Commissioners (NAIC) in its Model Insurance Holding Company System Regulatory Act and model regulations pertaining thereto, or is the reporting entity subject to standards and disclosure requirements substantially similar to those required by such Act and regulations? Yes [ X ] No [ ] N/A [ ]

1.3 State Regulating? Kansas

1.4 Is the reporting entity publicly traded or a member of a publicly traded group? Yes [ X ] No [ ]

1.5 If the response to 1.4 is yes, provide the CIK (Central Index Key) code issued by the SEC for the entity/group. 0000064803

2.1 Has any change been made during the year of this statement in the charter, by-laws, articles of incorporation, or deed of settlement of the reporting entity? Yes [ ] No [ X ]

2.2 If yes, date of change:

3.1 State as of what date the latest financial examination of the reporting entity was made or is being made. 12/31/2018

3.2 State the as of date that the latest financial examination report became available from either the state of domicile or the reporting entity. This date should be the date of the examined balance sheet and not the date the report was completed or released. 12/31/2018

3.3 State as of what date the latest financial examination report became available to other states or the public from either the state of domicile or the reporting entity. This is the release date or completion date of the examination report and not the date of the examination (balance sheet date). 06/22/2020

3.4 By what department or departments? Kansas Insurance Department

3.5 Have all financial statement adjustments within the latest financial examination report been accounted for in a subsequent financial statement filed with Departments? Yes [ ] No [ ] N/A [ X ]

3.6 Have all of the recommendations within the latest financial examination report been complied with? Yes [ ] No [ ] N/A [ X ]

4.1 During the period covered by this statement, did any agent, broker, sales representative, non-affiliated sales/service organization or any combination thereof under common control (other than salaried employees of the reporting entity), receive credit or commissions for or control a substantial part (more than 20 percent of any major line of business measured on direct premiums) of: 4.11 sales of new business? Yes [ ] No [ X ] 4.12 renewals? Yes [ ] No [ X ] 4.2 During the period covered by this statement, did any sales/service organization owned in whole or in part by the reporting entity or an affiliate, receive credit or commissions for or control a substantial part (more than 20 percent of any major line of business measured on direct premiums) of: 4.21 sales of new business? Yes [ ] No [ X ] 4.22 renewals? Yes [ ] No [ X ]

5.1 Has the reporting entity been a party to a merger or consolidation during the period covered by this statement? Yes [ ] No [ X ] If yes, complete and file the merger history data file with the NAIC.

5.2 If yes, provide the name of the entity, NAIC Company Code, and state of domicile (use two letter state abbreviation) for any entity that has ceased to exist as a result of the merger or consolidation.

1 2 3 Name of Entity NAIC Company Code State of Domicile

6.1 Has the reporting entity had any Certificates of Authority, licenses or registrations (including corporate registration, if applicable) suspended or revoked by any governmental entity during the reporting period? Yes [ ] No [ X ]

6.2 If yes, give full information:

7.1 Does any foreign (non-United States) person or entity directly or indirectly control 10% or more of the reporting entity? Yes [ ] No [ X ]

7.2 If yes, 7.21 State the percentage of foreign control; 0.0 % 7.22 State the nationality(s) of the foreign person(s) or entity(s) or if the entity is a mutual or reciprocal, the nationality of its manager or attorney-in-fact; and identify the type of entity(s) (e.g., individual, corporation or government, manager or attorney in fact).

1 2 Nationality Type of Entity

27 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

8.1 Is the company a subsidiary of a bank holding company regulated by the Federal Reserve Board? Yes [ ] No [ X ] 8.2 If response to 8.1 is yes, please identify the name of the bank holding company.

8.3 Is the company affiliated with one or more banks, thrifts or securities firms? Yes [ ] No [ X ] 8.4 If response to 8.3 is yes, please provide below the names and location (city and state of the main office) of any affiliates regulated by a federal regulatory services agency [i.e. the Federal Reserve Board (FRB), the Office of the Comptroller of the Currency (OCC), the Federal Deposit Insurance Corporation (FDIC) and the Securities Exchange Commission (SEC)] and identify the affiliate's primary federal regulator.

1 2 3 4 5 6 Affiliate Name Location (City, State) FRB OCC FDIC SEC

9. What is the name and address of the independent certified public accountant or accounting firm retained to conduct the annual audit? Ernst & Young LLP; 200 Clarendon Street; Boston, MA 02116 10.1 Has the insurer been granted any exemptions to the prohibited non-audit services provided by the certified independent public accountant requirements as allowed in Section 7H of the Annual Financial Reporting Model Regulation (Model Audit Rule), or substantially similar state law or regulation? Yes [ ] No [ X ] 10.2 If the response to 10.1 is yes, provide information related to this exemption:

10.3 Has the insurer been granted any exemptions related to the other requirements of the Annual Financial Reporting Model Regulation as allowed for in Section 18A of the Model Regulation, or substantially similar state law or regulation? Yes [ ] No [ X ] 10.4 If the response to 10.3 is yes, provide information related to this exemption:

10.5 Has the reporting entity established an Audit Committee in compliance with the domiciliary state insurance laws? Yes [ X ] No [ ] N/A [ ] 10.6 If the response to 10.5 is no or n/a, please explain

11. What is the name, address and affiliation (officer/employee of the reporting entity or actuary/consultant associated with an actuarial consulting firm) of the individual providing the statement of actuarial opinion/certification? Jeffrey J. Drzazgowski, F.S.A., M.A.A.A.; ; 151 Farmington Ave., RE2R; Hartford, CT 06156 12.1 Does the reporting entity own any securities of a real estate holding company or otherwise hold real estate indirectly? Yes [ ] No [ X ] 12.11 Name of real estate holding company 12.12 Number of parcels involved 0 12.13 Total book/adjusted carrying value $ 0 12.2 If, yes provide explanation:

13. FOR UNITED STATES BRANCHES OF ALIEN REPORTING ENTITIES ONLY: 13.1 What changes have been made during the year in the United States manager or the United States trustees of the reporting entity? N/A 13.2 Does this statement contain all business transacted for the reporting entity through its United States Branch on risks wherever located? Yes [ ] No [ ] 13.3 Have there been any changes made to any of the trust indentures during the year? Yes [ ] No [ ] 13.4 If answer to (13.3) is yes, has the domiciliary or entry state approved the changes? Yes [ ] No [ ] N/A [ ] 14.1 Are the senior officers (principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions) of the reporting entity subject to a code of ethics, which includes the following standards? Yes [ X ] No [ ] a. Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; b. Full, fair, accurate, timely and understandable disclosure in the periodic reports required to be filed by the reporting entity; c. Compliance with applicable governmental laws, rules and regulations; d. The prompt internal reporting of violations to an appropriate person or persons identified in the code; and e. Accountability for adherence to the code. 14.11 If the response to 14.1 is No, please explain:

14.2 Has the code of ethics for senior managers been amended? Yes [ X ] No [ ] 14.21 If the response to 14.2 is yes, provide information related to amendment(s). In the Conflict of Interest (COI) Disclosure, Added the Conflicts of Interest mailbox ([email protected]) to provide another channel for contacting the COI Team. In the Gambling section, Updated the language to indicate that all forms of gambling with a pay in or pay out of money or other benefit or item of value is prohibited. In the Gifts, Meals, Entertainment or Other Things of Value section, Added the Compliance Questions mailbox ([email protected]) as a resource for employees. Added a prohibited gift card example to the Q&A graphic. In the Business Firewalls section, updated the language to include examples of prohibited use of competitively- sensitive information, examples of why firewalls are important, and how information firewalls maintain commercial relations with CVS Health clients and suppliers. In the Supplier Engagement section, added a new section on Trade Compliance describing the Companys policy to comply with applicable laws and regulations relating to the import and export of products, goods, and services. 14.3 Have any provisions of the code of ethics been waived for any of the specified officers? Yes [ ] No [ X ] 14.31 If the response to 14.3 is yes, provide the nature of any waiver(s).

27.1 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

15.1 Is the reporting entity the beneficiary of a Letter of Credit that is unrelated to reinsurance where the issuing or confirming bank is not on the SVO Bank List? Yes [ ] No [ X ] 15.2 If the response to 15.1 is yes, indicate the American Bankers Association (ABA) Routing Number and the name of the issuing or confirming bank of the Letter of Credit and describe the circumstances in which the Letter of Credit is triggered.

1 2 3 4 American Bankers Association (ABA) Routing Number Issuing or Confirming Bank Name Circumstances That Can Trigger the Letter of Credit Amount

BOARD OF DIRECTORS 16. Is the purchase or sale of all investments of the reporting entity passed upon either by the board of directors or a subordinate committee thereof? Yes [ X ] No [ ] 17. Does the reporting entity keep a complete permanent record of the proceedings of its board of directors and all subordinate committees thereof? Yes [ X ] No [ ] 18. Has the reporting entity an established procedure for disclosure to its board of directors or trustees of any material interest or affiliation on the part of any of its officers, directors, trustees or responsible employees that is in conflict with the official duties of such person? Yes [ X ] No [ ]

FINANCIAL 19. Has this statement been prepared using a basis of accounting other than Statutory Accounting Principles (e.g., Generally Accepted Accounting Principles)? Yes [ ] No [ X ] 20.1 Total amount loaned during the year (inclusive of Separate Accounts, exclusive of policy loans): 20.11 To directors or other officers $ 0 20.12 To stockholders not officers $ 0 20.13 Trustees, supreme or grand (Fraternal Only) $ 0 20.2 Total amount of loans outstanding at the end of year (inclusive of Separate Accounts, exclusive of policy loans): 20.21 To directors or other officers $ 0 20.22 To stockholders not officers $ 0 20.23 Trustees, supreme or grand (Fraternal Only) $ 0 21.1 Were any assets reported in this statement subject to a contractual obligation to transfer to another party without the liability for such obligation being reported in the statement? Yes [ ] No [ X ] 21.2 If yes, state the amount thereof at December 31 of the current year: 21.21 Rented from others $ 0 21.22 Borrowed from others $ 0 21.23 Leased from others $ 0 21.24 Other $ 0 22.1 Does this statement include payments for assessments as described in the Annual Statement Instructions other than guaranty fund or guaranty association assessments? Yes [ X ] No [ ] 22.2 If answer is yes: 22.21 Amount paid as losses or risk adjustment $ 0 22.22 Amount paid as expenses $ 1,670 22.23 Other amounts paid $ 0 23.1 Does the reporting entity report any amounts due from parent, subsidiaries or affiliates on Page 2 of this statement? Yes [ ] No [ X ] 23.2 If yes, indicate any amounts receivable from parent included in the Page 2 amount: $ 0

INVESTMENT

24.01 Were all the stocks, bonds and other securities owned December 31 of current year, over which the reporting entity has exclusive control, in the actual possession of the reporting entity on said date? (other than securities lending programs addressed in 24.03) Yes [ X ] No [ ]

24.02 If no, give full and complete information relating thereto

24.03 For securities lending programs, provide a description of the program including value for collateral and amount of loaned securities, and whether collateral is carried on or off-balance sheet. (an alternative is to reference Note 17 where this information is also provided) N/A

24.04 For the reporting entity’s securities lending program, report amount of collateral for conforming programs as outlined in the Risk-Based Capital Instructions. $ 0

24.05 For the reporting entity’s securities lending program, report amount of collateral for other programs. $ 0

24.06 Does your securities lending program require 102% (domestic securities) and 105% (foreign securities) from the counterparty at the outset of the contract? Yes [ ] No [ ] N/A [ X ]

24.07 Does the reporting entity non-admit when the collateral received from the counterparty falls below 100%? Yes [ ] No [ ] N/A [ X ]

24.08 Does the reporting entity or the reporting entity ’s securities lending agent utilize the Master Securities lending Agreement (MSLA) to conduct securities lending? Yes [ ] No [ ] N/A [ X ]

27.2 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

24.09 For the reporting entity’s securities lending program state the amount of the following as of December 31 of the current year:

24.091 Total fair value of reinvested collateral assets reported on Schedule DL, Parts 1 and 2. $ 0 24.092 Total book adjusted/carrying value of reinvested collateral assets reported on Schedule DL, Parts 1 and 2 $ 0 24.093 Total payable for securities lending reported on the liability page. $ 0

25.1 Were any of the stocks, bonds or other assets of the reporting entity owned at December 31 of the current year not exclusively under the control of the reporting entity, or has the reporting entity sold or transferred any assets subject to a put option contract that is currently in force? (Exclude securities subject to Interrogatory 21.1 and 24.03). Yes [ X ] No [ ]

25.2 If yes, state the amount thereof at December 31 of the current year: 25.21 Subject to repurchase agreements $ 0 25.22 Subject to reverse repurchase agreements $ 0 25.23 Subject to dollar repurchase agreements $ 0 25.24 Subject to reverse dollar repurchase agreements $ 0 25.25 Placed under option agreements $ 0 25.26 Letter stock or securities restricted as to sale - excluding FHLB Capital Stock $ 0 25.27 FHLB Capital Stock $ 0 25.28 On deposit with states $ 1,816,475 25.29 On deposit with other regulatory bodies $ 0 25.30 Pledged as collateral - excluding collateral pledged to an FHLB $ 0 25.31 Pledged as collateral to FHLB - including assets backing funding agreements $ 0 25.32 Other $ 0

25.3 For category (25.26) provide the following:

1 2 3 Nature of Restriction Description Amount

26.1 Does the reporting entity have any hedging transactions reported on Schedule DB? Yes [ ] No [ X ]

26.2 If yes, has a comprehensive description of the hedging program been made available to the domiciliary state? Yes [ ] No [ ] N/A [ X ] If no, attach a description with this statement.

LINES 26.3 through 26.5: FOR LIFE/FRATERNAL REPORTING ENTITIES ONLY:

26.3 Does the reporting entity utilize derivatives to hedge variable annuity guarantees subject to fluctuations as a result of interest rate sensitivity? Yes [ ] No [ X ]

26.4 If the response to 26.3 is YES, does the reporting entity utilize: 26.41 Special accounting provision of SSAP No. 108 Yes [ ] No [ ] 26.42 Permitted accounting practice Yes [ ] No [ ] 26.43 Other accounting guidance Yes [ ] No [ ]

26.5 By responding YES to 26.41 regarding utilizing the special accounting provisions of SSAP No. 108, the reporting entity attests to the following: Yes [ ] No [ ] • The reporting entity has obtained explicit approval from the domiciliary state. • Hedging strategy subject to the special accounting provisions is consistent with the requirements of VM-21. • Actuarial certification has been obtained which indicates that the hedging strategy is incorporated within the establishment of VM-21 reserves and provides the impact of the hedging strategy within the Actuarial Guideline Conditional Tail Expectation Amount. • Financial Officer Certification has been obtained which indicates that the hedging strategy meets the definition of a Clearly Defined Hedging Strategy within VM-21 and that the Clearly Defined Hedging Strategy is the hedging strategy being used by the company in its actual day-to-day risk mitigation efforts.

27.1 Were any preferred stocks or bonds owned as of December 31 of the current year mandatorily convertible into equity, or, at the option of the issuer, convertible into equity? Yes [ ] No [ X ]

27.2 If yes, state the amount thereof at December 31 of the current year. $ 0

28. Excluding items in Schedule E - Part 3 - Special Deposits, real estate, mortgage loans and investments held physically in the reporting entity's offices, vaults or safety deposit boxes, were all stocks, bonds and other securities, owned throughout the current year held pursuant to a custodial agreement with a qualified bank or trust company in accordance with Section 1, III - General Examination Considerations, F. Outsourcing of Critical Functions, Custodial or Safekeeping Agreements of the NAIC Financial Condition Examiners Handbook? Yes [ X ] No [ ]

28.01 For agreements that comply with the requirements of the NAIC Financial Condition Examiners Handbook, complete the following:

1 2 Name of Custodian(s) Custodian's Address State Street Bank and Trust Company State Street Financial Center; One Lincoln Street; Boston, MA 02111-2900

27.3 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

28.02 For all agreements that do not comply with the requirements of the NAIC Financial Condition Examiners Handbook, provide the name, location and a complete explanation:

1 2 3 Name(s) Location(s) Complete Explanation(s)

28.03 Have there been any changes, including name changes, in the custodian(s) identified in 28.01 during the current year? Yes [ ] No [ X ] 28.04 If yes, give full and complete information relating thereto:

1 2 3 4 Old Custodian New Custodian Date of Change Reason

28.05 Investment management – Identify all investment advisors, investment managers, broker/dealers, including individuals that have the authority to make investment decisions on behalf of the reporting entity. For assets that are managed internally by employees of the reporting entity, note as such. ["…that have access to the investment accounts"; "…handle securities"]

1 2 Name of Firm or Individual Affiliation Kevin J. Casey as Sr. Investment Officer A

28.0597 For those firms/individuals listed in the table for Question 28.05, do any firms/individuals unaffiliated with the reporting entity (i.e. designated with a "U") manage more than 10% of the reporting entity’s invested assets? Yes [ ] No [ X ]

28.0598 For firms/individuals unaffiliated with the reporting entity (i.e. designated with a "U") listed in the table for Question 28.05, does the total assets under management aggregate to more than 50% of the reporting entity’s invested assets? Yes [ ] No [ X ]

28.06 For those firms or individuals listed in the table for 28.05 with an affiliation code of "A" (affiliated) or "U" (unaffiliated), provide the information for the table below.

1 2 3 4 5 Investment Management Central Registration Agreement Depository Number Name of Firm or Individual Legal Entity Identifier (LEI) Registered With (IMA) Filed N/A Kevin J. Casey N/A Not registered

29.1 Does the reporting entity have any diversified mutual funds reported in Schedule D, Part 2 (diversified according to the Securities and Exchange Commission (SEC) in the Investment Company Act of 1940 [Section 5(b)(1)])? Yes [ ] No [ X ] 29.2 If yes, complete the following schedule:

1 2 3 Book/Adjusted CUSIP # Name of Mutual Fund Carrying Value 29.2999 - Total 0

29.3 For each mutual fund listed in the table above, complete the following schedule:

1 2 3 4 Amount of Mutual Fund's Book/Adjusted Carrying Value Name of Significant Holding of the Attributable to the Date of Name of Mutual Fund (from above table) Mutual Fund Holding Valuation

27.4 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

30. Provide the following information for all short-term and long-term bonds and all preferred stocks. Do not substitute amortized value or statement value for fair value.

1 2 3 Excess of Statement over Fair Value (-), or Statement (Admitted) Fair Value over Value Fair Value Statement (+) 30.1 Bonds 20,575,317 21,210,752 635,435 30.2 Preferred stocks 0 0 0 30.3 Totals 20,575,317 21,210,752 635,435

30.4 Describe the sources or methods utilized in determining the fair values: Fair value of long term bonds and preferred stocks are determined based on quoted market prices when available, fair values using valuation methodologies based on available and observable market information or by using matrix pricing. If quoted market prices are not available, we determine fair value using broker quoted or an internal analysis of each investments financial performance and cash flow projections. Short Term investments are carried at amortized cost which approximated fair value. The carrying value of cash equivalents approximated fair value.

31.1 Was the rate used to calculate fair value determined by a broker or custodian for any of the securities in Schedule D? Yes [ ] No [ X ]

31.2 If the answer to 31.1 is yes, does the reporting entity have a copy of the broker’s or custodian’s pricing policy (hard copy or electronic copy) for all brokers or custodians used as a pricing source? Yes [ ] No [ ]

31.3 If the answer to 31.2 is no, describe the reporting entity’s process for determining a reliable pricing source for purposes of disclosure of fair value for Schedule D:

32.1 Have all the filing requirements of the Purposes and Procedures Manual of the NAIC Investment Analysis Office been followed? Yes [ X ] No [ ] 32.2 If no, list exceptions:

33. By self-designating 5GI securities, the reporting entity is certifying the following elements of each self-designated 5GI security: a. Documentation necessary to permit a full credit analysis of the security does not exist or an NAIC CRP credit rating for an FE or PL security is not available. b. Issuer or obligor is current on all contracted interest and principal payments. c. The insurer has an actual expectation of ultimate payment of all contracted interest and principal. Has the reporting entity self-designated 5GI securities? Yes [ ] No [ X ]

34. By self-designating PLGI securities, the reporting entity is certifying the following elements of each self-designated PLGI security: a. The security was purchased prior to January 1, 2018. b. The reporting entity is holding capital commensurate with the NAIC Designation reported for the security. c. The NAIC Designation was derived from the credit rating assigned by an NAIC CRP in its legal capacity as a NRSRO which is shown on a current private letter rating held by the insurer and available for examination by state insurance regulators. d. The reporting entity is not permitted to share this credit rating of the PL security with the SVO. Has the reporting entity self-designated PLGI securities? Yes [ ] No [ X ]

35. By assigning FE to a Schedule BA non-registered private fund, the reporting entity is certifying the following elements of each self-designated FE fund: a. The shares were purchased prior to January 1, 2019. b. The reporting entity is holding capital commensurate with the NAIC Designation reported for the security. c. The security had a public credit rating(s) with annual surveillance assigned by an NAIC CRP in its legal capacity as an NRSRO prior to January 1, 2019. d. The fund only or predominantly holds bonds in its portfolio. e. The current reported NAIC Designation was derived from the public credit rating(s) with annual surveillance assigned by an NAIC CRP in its legal capacity as an NRSRO. f. The public credit rating(s) with annual surveillance assigned by an NAIC CRP has not lapsed. Has the reporting entity assigned FE to Schedule BA non-registered private funds that complied with the above criteria? Yes [ ] No [ X ]

36. By rolling/renewing short-term or cash equivalent investments with continued reporting on Schedule DA, Part 1 or Schedule E Part 2 (identified through a code (%) in those investment schedules), the reporting entity is certifying to the following: a. The investment is a liquid asset that can be terminated by the reporting entity on the current maturity date. b. If the investment is with a nonrelated party or nonaffiliate, then it reflects an arms-length transaction with renewal completed at the discretion of all involved parties. c. If the investment is with a related party or affiliate, then the reporting entity has completed robust re-underwriting of the transaction for which documentation is available for regulator review. d. Short-term and cash equivalent investments that have been renewed/rolled from the prior period that do not meet the criteria in 36.a - 36.c are reported as long-term investments. Has the reporting entity rolled/renewed short-term or cash equivalent investments in accordance with these criteria? Yes [ X ] No [ ] N/A [ ]

27.5 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

OTHER

37.1 Amount of payments to trade associations, service organizations and statistical or rating bureaus, if any? $ 0

37.2 List the name of the organization and the amount paid if any such payment represented 25% or more of the total payments to trade associations, service organizations and statistical or rating bureaus during the period covered by this statement.

1 2 Name Amount Paid

38.1 Amount of payments for legal expenses, if any? $ 0

38.2 List the name of the firm and the amount paid if any such payment represented 25% or more of the total payments for legal expenses during the period covered by this statement.

1 2 Name Amount Paid

39.1 Amount of payments for expenditures in connection with matters before legislative bodies, officers or departments of government, if any? $ 0

39.2 List the name of the firm and the amount paid if any such payment represented 25% or more of the total payment expenditures in connection with matters before legislative bodies, officers or departments of government during the period covered by this statement.

1 2 Name Amount Paid

27.6 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

PART 2 - HEALTH INTERROGATORIES

1.1 Does the reporting entity have any direct Medicare Supplement Insurance in force? Yes [ ] No [ X ] 1.2 If yes, indicate premium earned on U.S. business only. $ 0 1.3 What portion of Item (1.2) is not reported on the Medicare Supplement Insurance Experience Exhibit? $ 0 1.31 Reason for excluding

1.4 Indicate amount of earned premium attributable to Canadian and/or Other Alien not included in Item (1.2) above $ 0 1.5 Indicate total incurred claims on all Medicare Supplement Insurance. $ 0 1.6 Individual policies: Most current three years: 1.61 Total premium earned $ 0 1.62 Total incurred claims $ 0 1.63 Number of covered lives 0 All years prior to most current three years: 1.64 Total premium earned $ 0 1.65 Total incurred claims $ 0 1.66 Number of covered lives 0

1.7 Group policies: Most current three years: 1.71 Total premium earned $ 0 1.72 Total incurred claims $ 0 1.73 Number of covered lives 0 All years prior to most current three years: 1.74 Total premium earned $ 0 1.75 Total incurred claims $ 0 1.76 Number of covered lives 0

2. Health Test: 1 2 Current Year Prior Year 2.1 Premium Numerator 68,361,483 6,716,210 2.2 Premium Denominator 68,361,483 6,716,210 2.3 Premium Ratio (2.1/2.2) 1.000 1.000 2.4 Reserve Numerator 11,283,229 3,434,392 2.5 Reserve Denominator 11,283,229 3,434,392 2.6 Reserve Ratio (2.4/2.5) 1.000 1.000

3.1 Has the reporting entity received any endowment or gift from contracting hospitals, physicians, dentists, or others that is agreed will be returned when, as and if the earnings of the reporting entity permits? Yes [ ] No [ X ]

3.2 If yes, give particulars:

4.1 Have copies of all agreements stating the period and nature of hospitals’, physicians’, and dentists’ care offered to subscribers and dependents been filed with the appropriate regulatory agency? Yes [ X ] No [ ]

4.2 If not previously filed, furnish herewith a copy(ies) of such agreement(s). Do these agreements include additional benefits offered? Yes [ ] No [ ]

5.1 Does the reporting entity have stop-loss reinsurance? Yes [ ] No [ X ]

5.2 If no, explain: The Company does not have stop-loss reinsurance.

5.3 Maximum retained risk (see instructions) 5.31 Comprehensive Medical $ 0 5.32 Medical Only $ 0 5.33 Medicare Supplement $ 0 5.34 Dental & Vision $ 0 5.35 Other Limited Benefit Plan $ 0 5.36 Other $ 0

6. Describe arrangement which the reporting entity may have to protect subscribers and their dependents against the risk of insolvency including hold harmless provisions, conversion privileges with other carriers, agreements with providers to continue rendering services, and any other agreements: Provider contracts contain hold harmless and continuity of coverage provisions.

7.1 Does the reporting entity set up its claim liability for provider services on a service date basis? Yes [ X ] No [ ]

7.2 If no, give details

8. Provide the following information regarding participating providers: 8.1 Number of providers at start of reporting year 27,241 8.2 Number of providers at end of reporting year 42,593

9.1 Does the reporting entity have business subject to premium rate guarantees? Yes [ ] No [ X ]

9.2 If yes, direct premium earned: 9.21 Business with rate guarantees between 15-36 months $ 0 9.22 Business with rate guarantees over 36 months $ 0

28 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. GENERAL INTERROGATORIES

10.1 Does the reporting entity have Incentive Pool, Withhold or Bonus Arrangements in its provider contracts? Yes [ X ] No [ ]

10.2 If yes: 10.21 Maximum amount payable bonuses $ 31,901 10.22 Amount actually paid for year bonuses $ 39,850 10.23 Maximum amount payable withholds $ 0 10.24 Amount actually paid for year withholds $ 0

11.1 Is the reporting entity organized as: 11.12 A Medical Group/Staff Model, Yes [ ] No [ X ] 11.13 An Individual Practice Association (IPA), or, Yes [ ] No [ X ] 11.14 A Mixed Model (combination of above)? Yes [ ] No [ X ]

11.2 Is the reporting entity subject to Statutory Minimum Capital and Surplus Requirements? Yes [ X ] No [ ] 11.3 If yes, show the name of the state requiring such minimum capital and surplus. Kansas, Missouri, 11.4 If yes, show the amount required. $ 4,149,238 11.5 Is this amount included as part of a contingency reserve in stockholder's equity? Yes [ ] No [ X ] 11.6 If the amount is calculated, show the calculation See Notes to Financial Statement - Note 21, Other Items, C., Other Disclosures.

12. List service areas in which reporting entity is licensed to operate:

1 Name of Service Area Allen, Anderson, Atchison, Barber, Barton, Bourbon, Brown, Butler Chase, Chautauqua, Cherokee, Clay, Cloud, Coffey, Comamche, Cowley Crawford, Dickinson, Doniphan, Douglas, Edwards, Elk, Ellis, Ellsworth Franklin, Geary, Greenwood, Harper, Harvey, Jackson, Jefferson, Jewell Johnson, Kingman, Kiowa, Labette, Leavenworth, Lincoln, Linn, Lyon Marion, Marshal, McPherson, Miami, Mitchell, Montgomery, Morris, Nemaha Neosho, Osage, Osborne, Ottawa, Pawnee, Phillips, Pottawatomie, Pratt Reno, Republic, Rice, Riley, Rooks, Rush, Russell, SalineSedgwick, Shawnee, Smith, Stafford, Sumner, Wabaunsee, Washington, Wilson Woodson, Wyandotte

13.1 Do you act as a custodian for health savings accounts? Yes [ ] No [ X ]

13.2 If yes, please provide the amount of custodial funds held as of the reporting date. $ 0

13.3 Do you act as an administrator for health savings accounts? Yes [ ] No [ X ]

13.4 If yes, please provide the balance of funds administered as of the reporting date. $ 0

14.1 Are any of the captive affiliates reported on Schedule S, Part 3, authorized reinsurers? Yes [ ] No [ ] N/A [ X ] 14.2 If the answer to 14.1 is yes, please provide the following:

1 2 3 4 Assets Supporting Reserve Credit NAIC 5 6 7 Company Domiciliary Reserve Letters of Trust Company Name Code Jurisdiction Credit Credit Agreements Other

15. Provide the following for individual ordinary life insurance* policies (U.S. business only) for the current year (prior to reinsurance assumed or ceded): 15.1 Direct Premium Written $ 0 15.2 Total Incurred Claims $ 0 15.3 Number of Covered Lives 0

*Ordinary Life Insurance Includes Term(whether full underwriting, limited underwriting, jet issue, "short form app") Whole Life (whether full underwriting, limited underwriting, jet issue, "short form app") Variable Life (with or without secondary gurarantee) Universal Life (with or without secondary gurarantee) Variable Universal Life (with or without secondary gurarantee)

16. Is the reporting entity licensed or chartered, registered, qualified, eligible or writing business in at least two states? Yes [ X ] No [ ]

16.1 If no, does the reporting entity assume reinsurance business that covers risks residing in at least one state other than the state of domicile of the reporting entity? Yes [ ] No [ ]

28.1 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. FIVE-YEAR HISTORICAL DATA 1 2 3 4 5 2020 2019 2018 2017 2016

Balance Sheet (Pages 2 and 3)

1. Total admitted assets (Page 2, Line 28) 43,709,674 21,557,489 21,723,150 61,893,250 115,953,772

2. Total liabilities (Page 3, Line 24) 17,034,540 4,510,185 8,022,106 10,070,255 42,135,090

3. Statutory minimum capital and surplus requirement 4,149,238 1,591,532 1,614,992 10,988,618 10,988,618

4. Total capital and surplus (Page 3, Line 33) 26,675,134 17,047,304 13,701,044 51,822,995 73,818,682

Income Statement (Page 4)

5. Total revenues (Line 8) 67,938,909 7,418,808 6,043,614 13,107,855 367,873,275

6. Total medical and hospital expenses (Line 18) 41,924,357 3,989,727 4,520,254 9,009,348 291,665,302

7. Claims adjustment expenses (Line 20) 1,068,208 168,456 133,706 439,208 6,605,399

8. Total administrative expenses (Line 21) 6,509,964 791,987 1,577,769 1,299,575 41,609,991

9. Net underwriting gain (loss) (Line 24) 18,436,380 2,468,638 (188,115) 2,359,724 27,992,582

10. Net investment gain (loss) (Line 27) 129,193 586,518 2,270,318 2,273,736 4,869,960

11. Total other income (Lines 28 plus 29) 0 0 0 0 0

12. Net income or (loss) (Line 32) 15,439,760 2,984,530 2,970,501 4,959,970 25,694,844

Cash Flow (Page 6)

13. Net cash from operations (Line 11) 25,171,775 658,699 2,103,400 (1,683,809) (16,375,969)

Risk-Based Capital Analysis

14. Total adjusted capital 26,675,134 17,047,304 13,701,044 51,822,995 73,818,682

15. Authorized control level risk-based capital 2,121,282 795,766 807,496 862,707 11,770,637

Enrollment (Exhibit 1)

16. Total members at end of period (Column 5, Line 7) 3,884 575 1,186 2,349 7,192

17. Total members months (Column 6, Line 7) 38,211 4,572 18,158 32,234 265,590

Operating Percentage (Page 4) (Item divided by Page 4, sum of Lines 2, 3 and 5) x 100.0

18. Premiums earned plus risk revenue (Line 2 plus Lines 3 and 5) 100.0 100.0 100.0 100.0 100.0

19. Total hospital and medical plus other non-health (Lines 18 plus Line 19) 61.7 53.8 74.8 68.7 79.3

20. Cost containment expenses 1.2 1.6 1.5 2.9 1.5

21. Other claims adjustment expenses 0.4 0.7 0.7 0.5 0.3

22. Total underwriting deductions (Line 23) 72.9 66.7 103.1 82.0 92.4

23. Total underwriting gain (loss) (Line 24) 27.1 33.3 (3.1) 18.0 7.6

Unpaid Claims Analysis (U&I Exhibit, Part 2B)

24. Total claims incurred for prior years (Line 13, Col. 5) (1,763,003) 58,729 1,248,445 2,529,515 22,398,235

25. Estimated liability of unpaid claims-[prior year (Line 13, Col. 6)] 684,287 656,091 1,172,316 6,700,078 43,093,030

Investments In Parent, Subsidiaries and Affiliates

26. Affiliated bonds (Sch. D Summary, Line 12, Col. 1) 0 0 0 0 0

27. Affiliated preferred stocks (Sch. D Summary, Line 18, Col. 1) 0 0 0 0 0

28. Affiliated common stocks (Sch. D Summary, Line 24, Col. 1) 0 0 0 0 0

29. Affiliated short-term investments (subtotal included in Schedule DA Verification, Col. 5, Line 10) 0 0 0 0 0

30. Affiliated mortgage loans on real estate 0 0 0 0 0

31. All other affiliated 0 0 0 0 0

32. Total of above Lines 26 to 31 0 0 0 0 0

33. Total investment in parent included in Lines 26 to 31 above. 0 0 0 0 0 NOTE: If a party to a merger, have the two most recent years of this exhibit been restated due to a merger in compliance with the disclosure requirements of SSAP No. 3, Accounting Changes and Correction of Errors? Yes [ ] No [ ] If no, please explain:

29 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. SCHEDULE T PREMIUMS AND OTHER CONSIDERATIONS Allocated by States and Territories 1 Direct Business Only 2 3 4 5 6 7 8 9 Federal Employees Health Life & Annuity Active Accident & Benefits Premiums & Property/ Total Status Health Medicare Medicaid Plan Other Casualty Columns 2 Deposit-Type States, etc. (a) Premiums Title XVIII Title XIX Premiums Considerations Premiums Through 7 Contracts 1. Alabama AL N 0 0 0 0 0 0 0 0 2. Alaska AK N 0 0 0 0 0 0 0 0 3. AZ N 0 0 0 0 0 0 0 0 4. Arkansas AR L 0 0 0 0 0 0 0 0 5. California CA N 0 0 0 0 0 0 0 0 6. CO N 0 0 0 0 0 0 0 0 7. Connecticut CT N 0 0 0 0 0 0 0 0 8. Delaware DE N 0 0 0 0 0 0 0 0 9. District of Columbia DC N 0 0 0 0 0 0 0 0 10. FL N 0 0 0 0 0 0 0 0 11. Georgia GA N 0 0 0 0 0 0 0 0 12. Hawaii HI N 0 0 0 0 0 0 0 0 13. Idaho ID N 0 0 0 0 0 0 0 0 14. Illinois IL N 0 0 0 0 0 0 0 0 15. Indiana IN N 0 0 0 0 0 0 0 0 16. Iowa IA N 0 0 0 0 0 0 0 0 17. Kansas KS L 10,201,506 28,908,472 0 0 0 0 39,109,978 0 18. Kentucky KY N 0 0 0 0 0 0 0 0 19. LA N 0 0 0 0 0 0 0 0 20. Maine ME N 0 0 0 0 0 0 0 0 21. Maryland MD N 0 0 0 0 0 0 0 0 22. Massachusetts MA N 0 0 0 0 0 0 0 0 23. Michigan MI N 0 0 0 0 0 0 0 0 24. Minnesota MN N 0 0 0 0 0 0 0 0 25. MS N 0 0 0 0 0 0 0 0 26. Missouri MO L 0 28,376,928 0 0 0 0 28,376,928 0 27. Montana MT N 0 0 0 0 0 0 0 0 28. Nebraska NE N 0 0 0 0 0 0 0 0 29. Nevada NV N 0 0 0 0 0 0 0 0 30. New Hampshire NH N 0 0 0 0 0 0 0 0 31. New Jersey NJ N 0 0 0 0 0 0 0 0 32. New Mexico NM N 0 0 0 0 0 0 0 0 33. New York NY N 0 0 0 0 0 0 0 0 34. NC N 0 0 0 0 0 0 0 0 35. North Dakota ND N 0 0 0 0 0 0 0 0 36. Ohio OH N 0 0 0 0 0 0 0 0 37. Oklahoma OK L 1,051,849 0 0 0 0 0 1,051,849 0 38. Oregon OR N 0 0 0 0 0 0 0 0 39. Pennsylvania PA N 0 0 0 0 0 0 0 0 40. RI N 0 0 0 0 0 0 0 0 41. South Carolina SC N 0 0 0 0 0 0 0 0 42. South Dakota SD N 0 0 0 0 0 0 0 0 43. Tennessee TN N 0 0 0 0 0 0 0 0 44. TX N 0 0 0 0 0 0 0 0 45. Utah UT N 0 0 0 0 0 0 0 0 46. Vermont VT N 0 0 0 0 0 0 0 0 47. Virginia VA N 0 0 0 0 0 0 0 0 48. Washington WA N 0 0 0 0 0 0 0 0 49. West Virginia WV N 0 0 0 0 0 0 0 0 50. Wisconsin WI N 0 0 0 0 0 0 0 0 51. Wyoming WY N 0 0 0 0 0 0 0 0 52. American Samoa AS N 0 0 0 0 0 0 0 0 53. Guam GU N 0 0 0 0 0 0 0 0 54. Puerto Rico PR N 0 0 0 0 0 0 0 0 55. U.S. Virgin Islands VI N 0 0 0 0 0 0 0 0 56. Northern Mariana Islands MP N 0 0 0 0 0 0 0 0 57. Canada CAN N 0 0 0 0 0 0 0 0 58. Aggregate other alien OT XXX 0 0 0 0 0 0 0 0 59. Subtotal XXX 11,253,355 57,285,400 0 0 0 0 68,538,755 0 60. Reporting entity contributions for Employee Benefit Plans XXX 0 0 0 0 0 0 0 0 61. Total (Direct Business) XXX 11,253,355 57,285,400 0 0 0 0 68,538,755 0 DETAILS OF WRITE-INS 58001. XXX 58002. XXX 58003. XXX 58998. Summary of remaining write-ins for Line 58 from overflow page XXX 0 0 0 0 0 0 0 0 58999. Totals (Lines 58001 through 58003 plus 58998)(Line 58 above) XXX 0 0 0 0 0 0 0 0 (a) Active Status Counts: L - Licensed or Chartered - Licensed insurance carrier or domiciled RRG 4 R - Registered - Non-domiciled RRGs 0 E - Eligible - Reporting entities eligible or approved to write surplus lines in the state 0 Q - Qualified - Qualified or accredited reinsurer 0 N - None of the above - Not allowed to write business in the state 53 (b) Explanation of basis of allocation by states, premiums by state, etc. Allocation by state is based on the employer group's state of domicile.

38 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc.

SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP PART 1 - ORGANIZATIONAL CHART

CVS Health Corporation (DE) EIN: 05-0494040 CVS Foreign, Inc. (NY) EIN: 05-0497953

CVS Pharmacy, Inc. (RI) EIN: 05-0340626

CVS Caremark Indemnity, Ltd. 75% (BM) Coram Clinical Aetna Inc. Caremark Rx, L.L.C. EIN: 05-0500188 Trials, Inc. *1 (PA) (DE) (DE) EIN: 23-2229683 EIN: 20-8404182 40

RxAmerica, L.L.C. Part D Holding Company, CVS Caremark Part D Caremark Ulysses (DE) L.L.C. Services, L.L.C. Holding Corporation EIN: 87-0548860 (DE) (DE) (NY) EIN: 61-1715010 EIN: 33-1113587 EIN: 11-2580136

SilverScript Insurance Accendo Insurance UAC Holding, Inc. MemberHealth, Company Company (DE) L.L.C. (TN) (UT) EIN: 27-1298765 (DE) EIN: 20-2833904 EIN: 06-1566092 EIN: 87-0804047 NAIC: 12575 NAIC: 63444

This organizational chart reflects the insurance entity reporting system and identifies the relationship between the ultimate parent and all member insurers. The ultimate controlling company is a Fortune 7 company with numerous subsidiaries, the majority of which do not interact with the insurance entities. (1) Insurers/HMO’s Percentages are rounded to the nearest whole percent and based on ownership of voting rights. Double borders indicate entity has subsidiaries shown on the same page. Bold borders indicate entity has subsidiaries shown on a separate page.

*1 Coram Clinical Trials, Inc. is also 25% owned by Aetna Life Insurance Company ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP

PART 1 - ORGANIZATIONAL CHART

100% Aetna Inc.

(1) (PA)

100% 100% 100% 100% 100% 100% 100% 100% 100% Aetna Aetna Aetna Life Aetna Health Aetna Health Aetna Health Health Re, Inc. Echo Merger Aetna Health Holdings, Financial Holdings, Insurance Company and Insurance Insurance Sub, Inc. Corporate LLC LLC Life Insurance Company of Company Services LLC Company New York

06-6033492 06-0876836 57-0805126 23-2710210 27-2192415 (DE) (DE) (DE) (DE) (1) (CT) 60054 (1) (CT) 78700 (1) (NY) 84450 (1) (PA) 72052 (1) (VT) 13980

100% 100% 100% 100% 100% 100% 0.28% 0.28% 0.28% CVS Health Phoenix Data Active Health ASI Wings, AUSHC Continental Life CVS Cabot CVS Shaw , LLC Clinical Trial Solutions LLC Management, Inc. LLC Holdings, Inc. Insurance Company of Holdings Inc. *2 Holdings Inc. *3 *4 Sevices LLC Brentwood, Tennessee

40.1 62-1181209 (CT) (DE) (DE) (DE) (CT) (1) (TN) 68500 (DE) (DE) (DE)

100% 100% 55% 100% Health Data & Aetna Integrated PHPSNE American Continental Management Informatics, Inc. Parent Insurance Company Solutions, Corporation *1 Inc. 20-2901054 (DE) (PA) (DE) (1) (TN) 12321

100% Aetna International Inc.

(CT)

*1 PHPSNE Parent Corporation is also 45% owned by third parties. *2 CVS Cabot Holdngs Inc. is also 99.72% owned by Coram Clinical Trials, Inc. *3 CVS Shaw Hoidngs Inc. is also 99.72% owned by Coram Clinical Trials, Inc. *4 Omnicare, LLC is also owned by CVS Cabot Holdings Inc and CVS Shaw Holdngs Inc., each with 49.86% ownership. ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP

PART 1 - ORGANIZATIONAL CHART

100% Aetna International Inc.

(CT)

100% 100% 100% 100% 77% 100% 100% 100% 100% Aetna Insurance Aetna Health Aetna Global Benefits Aetna Life & Casualty PT Aetna Aetna Global Benefits Aetna (Shanghai) Aetna Global Aetna International (Singapore) Pte. Ltd. Insurance Company (Bermuda) Limited (Bermuda) Ltd. Management (Singapore) PTE. LTD. Enterprise Services Holdings Limited Ex Pat LLC of Europe DAC Consulting Co. Ltd.

(1) (SGP) (1) (IRL) (BMU) (1) (BMU) (IDN) (SGP) (CHN) (GBR) (DE)

99.98% 100% 100% 49% 49% 100% 100% 100% Indian Health Organisation Aetna (Beijing) Enterprise Aetna Insurance Virtual Home Aetna Global Benefits Aetna Global Benefits Goodhealth Worldwide Spinnaker Private Limited *3 Management Services (Hong Kong) Health Care L.L.C. (Middle East) LLC *2 (Europe) Limited (Asia) Limited Topco Limited Co., Ltd. Limited *4

(IND) (CHN) (HKG) (ARE) (ARE) (GBR) (HKG) (BMU) 40.2

80% 100% 100% 100% 100% 49% 25% 49% 25% PT. Aetna Global Goodhealth Worldwide Aetna Global Benefits Aetna Global Spinnaker Health Care Aetna Health Insurance Aetna Holdings Minor Health Benefit Indonesia *1 (Global) Limited (Asia Pacific) Limited Benefits Limited Bidco Limited Management Co. Ltd. (Thailand) Public (Thailand) Limited Enterprise Co. *5 Company Limited *6 *7 Ltd. *8

(IDN) (BMU) (HKG) (ARE) (GBR) (THA) (THA) (THA) (THA)

100% 28% 100% 51% 75% Aetna Holdco Aetna Health Insurance Aetna Services Health Care Minor Health 23.00% 0.02% (UK) Limited (Thailand) Public (Thailand) Limited Management Co. Enterprise Co, PT Aetna Indian Health Company Limited *6 *9 Ltd. *5 Ltd. *8 Management Organisation Private Consulting Limited *3 (GBR) (THA) (THA) (THA) (THA)

(IND) (IND) 46% 100% 100% Aetna Health Insurance Aetna Global Aetna Insurance (Thailand) Public Benefits (UK) Company Limited Company Limited Limited *6 (THA) (GBR) (1) (GBR)

*1 PT. Aetna Global Benefits Indonesia is also 20% owned by Suhatsyah Rivai, Aetna's Nominee. *2 Aetna Global Benefits (Middle East) LLC is also 51% is owned by Euro Gulf LLC, Aetna's Nominee. *3 Indian Health Organisation Private Limited is 0.019857% owned by Aetna Global Benefits (Asia Pacific) and 99.980143% owned by Aetna Global Benefits (Singapore) PTE. LTD. *4 Virtual Home Health Care L.L.C. is also 51% owned by CBD Commercial Brokers LLC, Aetna's Nominee *5 Health Care Management Co. Ltd. Is also owned by Aetna Global Benefits (Bermuda) Limited (1 share). *6 Aetna Health Insurance (Thailand) Public Company Limited is also owned by Aetna Global Benefits (Bermuda) Limited (1 share), Ms. Srisa-ard Sansanapongpherchar (1 Share), Mr. Jitphasong Itsaraphakde (1 Share); Mrs. Suphee Wattana (1 Share); and Mr. Buncha Tanphragorn (1 Share) *7 Aetna Holdings (Thailand) Limited is also 51% owned by Mr. Paiboon Sutantivorakoon plus Aetna Benefits (Bermuda) Limited owns 1 share. *8 Minor Health Enterprise Co, Ltd is is also (1 share) owned by Aetna Global Benefits (Bermuda) Limited *9 Aetna Services (Thailand) Limited is also (1 share) owned by Aetna Global Benefits (Bermuda) Limited and (1 share) owned by Aetna Global Holdings Limited ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP

PART 1 - ORGANIZATIONAL CHART

100% Aetna Health Holdings, LLC

(DE)

100% 100% 100% 100% 100% 100% 100% 100% Aetna Health Aetna Health Aetna Health Aetna Health Aetna Health Aetna Health of Aetna Health Aetna Network of California Inc. Inc. Inc. Inc. Michigan Inc. Inc. Services LLC Inc.

81-4345344 95-3402799 23-2442048 59-2411584 58-1649568 01-0504252 23-2861565 52-1270921 (CT) (1) CA (1) (CT) 95935 (1) (FL) 95088 (1) (GA) 95094 (1) (ME) 95517 (1) (MI) 95756 (1) (NJ) 95287

100% 100% 100% 100% 100% 100% 100% 100% 100% Aetna Better Aetna Health Aetna Health Aetna Dental Aetna Dental Aetna Dental Aetna Better Aetna Florida Aetna Better Health Inc. Inc. Inc. of California Inc. Inc. Health Inc. Inc. Health of Inc. California Inc. 40.3 45-2634734 22-2663623 76-0189680 06-1160812 22-2990909 06-1177531 26-2867560 80-0671703 47-5178095 (1) (NY) 14408 (1) (NY) 95234 (1) (TX) 95490 (1) (CA) (1) (NJ) 11183 (1) (TX) 95910 (1) (CT) 13174 (FL) (1) (CA)

100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Aetna Better Aetna Better Aetna Health Aetna Better Aetna Better Aetna Better Aetna Better Aetna Better Aetna Better Aetna Better Aetna Better Health Inc. Health Premier of Ohio Inc. Health, Inc. Health Inc. Health Inc. Health Inc. Health of Texas Health of Health of Health of Plan MMAI Inc. Inc. Oklahoma Inc. Washington, Inc. North Carolina Inc.

20-2207534 27-2512072 47-3850677 80-0629718 46-3203088 45-2764938 27-0563973 74-1844335 81-1143850 81-5030233 82-3333789 (1) (GA) 12328 (1) (IL) 14043 (1) (OH) 15805 (1) (LA) 15616 (1) (NJ) 15611 (1) (OH) 14229 (1) (PA) 13735 (1) (TX) 95040 (1) (OK) 15919 (1) (WA) 16242 (1) (NC)

100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Schaller Anderson Cofinity, Inc. Aetna Specialty Aetna Health Aetna RX Aetna Ireland Inc. @ Credentials Inc. iTriage, LLC Delaware Aetna Aetna Student Medical Pharmacy, Management, Home Delivery, Physicians Medicaid Health Agency Administrators, LLC LLC LLC Care, Administrators Inc. Incorporated Incorporated LLC

73-1702453 (DE) (DE) (DE) (DE) (DE) (DE) (DE) (DE) (1) (DE) (AZ) (MA) ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc.

SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP

PART 1 - ORGANIZATIONAL CHART

100% Aetna Health Holdings, LLC

(DE)

100% 100% 100% 100% 100% 100% 100% 100% 100% Aetna Risk Coventry Coventry Coventry Consumer Coventry Health Coventry Health Coventry Health Aetna Health MHNet Specialty Assurance HealthCare Transplant Advantage, Inc. Care National Care National Care of Illinois, Inc. of Iowa Inc. Services, LLC Company of Management Network, Inc. Network, Inc. Accounts, Inc. Connecticut Corporation 26-1582982 47-2049117 62-1411933 01-0646056 26-1293772 20-5185442 20-8070994 37-1241037 42-1244752 (MD) (CT) (DE) (DE) (DE) (DE) (DE) (1) (IL) 74160 (1) (IA) 95241

100% 100% Mental Health MHNet of

40.4 Network of New Florida, Inc. 100% 100% 100% 100% 100% 100% 100% 100% York IPA, Inc. Coventry Health Care Aetna Better Aetna Health Inc. Aetna Better Health Aetna Better Health Coventry Health Care Coventry Health Care Coventry Health of Kansas, Inc. Health of of Michigan Inc. of Missouri LLC of Missouri, Inc. of Nebraska, Inc. and Life Insurance 37-1448790 20-4276336 Kansas Inc. Company (NY) (FL)

48-0840330 81-3370401 74-2381406 20-1052897 43-1707094 43-1372307 42-1308659 75-1296086 (1) (KS) 95489 (1) (KS) 16072 (1) (LA) 95173 (1) (MI) 12193 (1) (MO) 95318 (1) (MO) 96377 (1) (NE) 95925 (1) (MO) 81973 100% Mental Health Associates, Inc.

100% Aetna Better 72-1106596 Health of Kentucky (LA) 100% 100% 100% 100% 100% 100% 100% 100% Insurance Company Coventry Aetna Better HealthAssurance Aetna Aetna Better Health Aetna Health of Coventry Health Care Coventry Health Care Prescription Health of Pennsylvania, Inc. HealthAssurance of Tennessee Inc. Utah Inc. of Virginia, Inc. of West Virginia, Inc. Management Nevada Inc. Pennsylvania, Inc. 47-3279217 Services, Inc. (1) (KY) 15761

47-0854096 81-3564875 23-2366731 47-4352768 20-4416606 87-0345631 54-1576305 55-0712129 (NV) (NV) (1) (PA) 11102 (1) (PA) 15827 (TN) (1) (UT) 95407 (1) (VA) 96555 (1) (WV) 95489 ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP

PART 1 - ORGANIZATIONAL CHART

100% Aetna Health Holdings, LLC

(DE)

100% 100% 100% 100% Florida Health Plan 100% 100% Group Dental Medical 100% Aetna Pharmacy Administrators, LLC bswift LLC First Health Service, Inc. Examinations of Prodigy Health Management Group Corp. New York, P.C. Group, Inc. Services LLC 20-1130063 52-1801446 74-2879984 (FL) 36-4391310 20-1736437 (MD) (NY) (DE) (DE) (DE) (DE)

100% 100% 100% 100% 100% Aetna Better Carefree Insurance Coventry Health First Health Life & Claims 100% Health of Florida Inc. Services, Inc. Plan of Florida, Inc. Health Insurance Administration 40.5 Group Dental Company Corp. Service of Maryland, Inc. 65-0986441 59-3750548 65-0453436 38-2242132 52-1320522 (1) (FL) 95114 (FL) (1) (FL) 95266 (1) (TX) 90328 (MD) 52-2056201 (1) (MD) 95846

100% 100% 100% 100% 100% 100% Niagara Re, Inc. Performax, Inc. Scrip World, LLC Precision Benefit Meritain Health, American Health Services, Inc. Inc. Holding, Inc.

(NY) (DE) (UT) (DE) (NY) (OH)

100% 100% 100% 100% Administrative U.S. Healthcare Prime Net, Inc. Professional Risk Enterprises, Inc. Holdings, LLC Management, Inc.

(AZ) (OH) (OH) (OH) ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP

PART 1 - ORGANIZATIONAL CHART

100% Aetna Health Holdings, LLC

(DE)

100% 39.5% 0.2% 100% 100% Aetna Health Aetna ACO Aetna ACO Adminco, Inc. Aetna Better Inc. Holdings, Inc * Holdings, Inc *1 Health of Illinois Inc.

23-2169745 27-2186150 (1) (PA) 95109 (DE) (DE) (AZ) (1) (IL) 14053

50% 50% 51% 50% 50% Texas Health + Innovation Health Banner Health Allina Health Sutter Health Aetna Health Holdings, LLC *2 and Aetna Aetna Insurance and Aetna Insurance Health Insurance Holding Company Health Insurance Holding Company Holding Company LLC *5 Holding Company LLC *3 LLC *4 LLC *6 40.6 45-5527797 81-5212760 81-5112888 82-2171057 (TX) (DE) (DE) (DE) (DE)

100% 100% 100% 100% 100% 100% Texas Health + Innovation Banner Health Allina Health Sutter Health Sutter Health Aetna Health Health Insurance and Aetna and Aetna and Aetna and Aetna Insurance Company Company Health Insurance Insurance Administrative Insurance Company Company Services LLC Company

81-4749336 46-0674828 81-5281115 82-2091197 82-2560624 81-5290023 (1) (TX) 16121 (1) (VA) 15097 (1) (AZ) 16058 (1) (MN) 16194 (DE) (1) (CA)

100% 100% 100% Texas Health + Innovation Health Banner Health Aetna Health Plan, Inc. and Aetna Plan Inc. Health Plan Inc.

47-5548221 46-0682197 81-5290023 (1) (TX) 16132 (1) (VA) 15098 (1) (AZ) 16059

*1 Aetna ACO Holdings Inc. is owned by Aetna Life Insurance Company (302 shares); Aetna Health Inc. (PA) (198 shares); and Aetna Health Holdings, LLC (1 share). *2 Innovation Health Holdings, LLC is also 50% owned by Inova Health System Foundation. *3 Texas Health + Aetna Health Insurance Holding Company LLC is also 50% owned by Texas Health Resources. *4 Banner Health and Aetna Health Insurance Holding Company LLC is also 49% owned by Banner Health. *5 Allina Health and Aetna Insurance Holding Company LLC is also 50% owned by Allina Health. *6 Sutter Health and Aetna Insurance Holding Company LLC is also 50% owned by Sutter Health Plan Products Organization, LLC. ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc.

SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP

PART 1 - ORGANIZATIONAL CHART

100% Aetna Financial Holdings, LLC

(DE)

100% 100% 100% 100% 100% 100% Aetna U. S. Healthcare Aetna Workers’ Managed Care Aetna Behavioral Aetna Capital Asset Advisors, Properties, Inc. Comp Access, LLC Coordinators, Inc. Health, LLC Management, LLC LLC

(DE) (PA) (DE) (DE) (DE) (DE) 40.7

100% 100% 100% 100%* Horizon Behavioral Aetna Card PayFlex Aetna Partners Services, LLC Solutions, LLC Holdings, Inc. Diversified Fund, LLC

(DE) (CT) (DE) (DE)

100% 100% 100% 100% 100% 100% Health and Human Employee Resources Work and Family The Vasquez PayFlex Resource Center, Assistance for Living, LLC Benefits, Inc. Group Inc. Systems USA, Inc. Inc. Services, LLC

33-0052273 (1) (CA) (KY) (TX) (NJ) (IL) (NE)

* Aetna Capital Management, LLC owns 100% of the voting rights of Aetna Partners Diversified Fund, LLC (“APDF”). APDF is a fund of hedge funds and certain subsidiaries of CVS Health Group invest in this fund, which does not confer any managing or controlling ownership interests in APDF. ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. SCHEDULE Y - INFORMATION CONCERNING ACTIVITIES OF INSURANCE MEMBERS OF A HOLDING COMPANY GROUP

PART 1 - ORGANIZATIONAL CHART

100% Aetna Life Insurance Company

06-6033492 (1) (CT) 60054

100% 100% 100% 60.3% 100% 100% 25% AHP Holdings, Inc. Aetna Ventures, PE Holdings, LLC Aetna ACO Aetna Resources Canal Place, LLC Coram Clinical LLC Holdings, Inc. *1 L.L.C. Trials, Inc. *7

(CT) (DE) (CT) (DE) (DE) (DE) (DE)

100% 100% 100% 50% 50% 51% 50% 99.72% 99.72% Aetna Insurance Aetna Life AE Fourteen, Texas Health + Innovation Health Banner Health Allina Health CVS Cabot CVS Shaw Company Assignment Incorporated Aetna Health Holdings, LLC *2 and Aetna Aetna Insurance Holdings Inc. *8 Holdings Inc. *9 of Connecticut Company Insurance Health Insurance Holding Company Holding Company Holding Company LLC *5 LLC *3 LLC *4 06-1286276 81-5212760 81-5112888 (1) (CT) 36153 (CT) (CT) (TX) (DE) (DE) (DE) (DE) (DE) 40.8

50% 100% 100% 100% 100% 49.86% Sutter Health Texas Health + Innovation Health Banner Health Allina Health Omnicare LLC and Aetna Aetna Health Insurance Company and Aetna and Aetna * 10 Health Insurance Insurance Company Health Insurance Insurance Holding Company Company Company LLC *6 82-2171057 81-4749336 46-0674828 81-5281115 82-2091197 (DE) (1) (TX) 16121 (1) (VA) 15097 (1) (AZ) 16058 (1) (MN) 16194 (DE)

100% 100% 100% 100% 100% Sutter Health Sutter Health Texas Health + Innovation Health Banner Health and Aetna and Aetna Aetna Health Plan, Inc. and Aetna Administrative Insurance Plan Inc. Health Plan Inc. Services LLC Company 47-5548221 46-0682197 81-5290023 82-2560624 81-5290023 (1) (TX) 16132 (1) (VA) 15098 (1) (AZ) 16059 (DE) (1) (CA)

*1 Aetna ACO Holdings Inc. is owned by Aetna Life Insurance Company (302 shares); Aetna Health Inc. (PA) (198 shares); and Aetna Health Holdings, LLC (1 share). *2 Innovation Health Holdings, LLC is also 50% owned by Inova Health System Foundation. *3 Texas Health + Aetna Health Insurance Holding Company LLC is also 50% owned by Texas Health Resources. *4 Banner Health and Aetna Health Insurance Holding Company LLC is also 49% owned by Banner Health. *5 Allina Health and Aetna Insurance Holding Company LLC is also 50% owned by Allina Health. *6 Sutter Health and Aetna Insurance Holding Company LLC is also 50% owned by Sutter Health Plan Products Organization, LLC. *7 Coram Clinical Trials, Inc. is also 75% owned by CVS Pharmacy, Inc. *8 CVS Cabot Holdings Inc. is also .28% owned by Aetna Inc. *9 CVS Shaw Holdings Inc. is also .28% owned by Aetna Inc. *10 Remaining .28% owned by Aetna Inc. CVS Cabot Holdings Inc. and CVS Shaw Holdings Inc. each owning 49.86%. ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. OVERFLOW PAGE FOR WRITE-INS NONE

44